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ABSTRACT
Tritium NMR studies provide a convenient way of obtaining detailed information about 
conformational equilibria, dynamic processes and specific interactions in protein-ligand 
complexes provided that suitably ^H-labelled molecules aie available. In this study [7,9- 
^H]- and [3',5',7-^H]folic acid, and [3',5',7-^H]methotrexate were synthesised and the 
NMR spectra of their complexes with Lactobacillus casei dihydrofolate reductase 
(DHFR) were assigned and analysed as a function of pH (DHFR-folate complexes) and 
temperatuie (DHFR-methotrexate complexes). From these data it was possible to obtain 
further evidence about the orientation of the pteridine ring in the complexes, and to 
monitor the dynamic processes in the bound ligands. In the NMR spectra of the 
ternaiy complexes of the ^H-labelled folic acids with DHFR and NADP”*~, each labelled 
tritium gave rise to multiple signals, confirming previous findings that there aie three 
interconverting, pH dependent, conformational forms of bound folate (forms I, Ila and 
lib) in the ternary complex. The folate benzoyl ring could be shown to be in essentially 
the same enviromnent in the different forms witli the major differences being associated 
with the pterin ring. The appearance of a single resonance for tire 3',5'-tritons showed 
that the benzoyl ring is flipping rapidly in all tlnee forms. In contrast, the methotrexate 
binary complex and also the ternary complex with NADPH were shown to exist as a 
single conformational state with the benzoyl ring flipping rate being too slow to give a 
single averaged signal for tlie 3',5'-tr*itium nuclei over the temperature range 283 - 313 K. 
^H{1h} Nuclear' Overhauser enliancernent experiments have been conducted on the 
small molecules, pHjdimetliyl sulphoxide, [3',5',7-^H]folic acid and [3',5',7- 
^Hjmethotrexate as a prelude to ^H-^H heteronuclear NOE experiments on binary and 
ternary complexes formed using Lactobacillus casei DHFR and the ligands [3',5',7- 
^Hjrnethotrexate and [3',5',7-3H]folic acid.
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Chapter 1: Introduction
1. INTRODUCTION
The aim of this Thesis is to explore methods of studying ligand binding to the 
enzyme dihydrofolate reductase (DHFR) using tritium labelled ligands in conjunction 
with tritium nuclear magnetic resonance (NMR) spectroscopy. The ligands are 
selectively labelled with tritium (^H) and the signals from these sensitive nuclei detected 
in the NMR spectrum, assigned and used to monitor the interactions and dynamic 
processes in protein-ligmrd complexes. The aim is to understand the molecular factors 
controlling the specificity of ligand binding. More explicitly, the objectives are as 
follows:
• To explore the potential of tritium nuclear magnetic resonance spectroscopy in 
protein-ligand complexes
• To selectively label tire ligands, folate and methotrexate, to high specific 
activities with tritiimi
• To char acterise the specific interactions between groups on the ligand and protein
• To characterise the conformational changes accompanying ligand binding
• To measure the conformational equilibria in the various complexes
• To monitor the changes in intramolecular dynamic processes
This chapter provides an introduction to tritium and its uses. The properties of 
the radioisotope and methods currently employed for the synthesis, purification and 
analysis of tritiated compounds ar e reviewed. Other areas of literature are covered in the 
subsequent chapters in which the topics to which they relate ar e introduced.
The application of tritium NMR spectroscopy is discussed in relation to 
determining the extent and distribution of tritium labelling in simple and complex 
molecules, whilst examples from the literature illustrate how the technique has found use 
in addressing the questions of mechanism and stereochemistry in small molecules and 
biochemical and biological systems.
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1.1. GENERAL INTRODUCTION TO TRITIUM
Isotopically labelled compounds find widespread use in chemical and 
biochemical reseaich. Generally speaking, isotopes can be divided into two classes, 
stable and radioactive. The stable isotopes and 1^0 can be detected
and measured by a variety of spectroscopic teclmiques. Mass spectrometry and nuclear 
magnetic resonance (NMR) spectroscopy are the most important although high 
performance liquid cliromatography (HPLC) and infia-red spectroscopy have also been 
used. For many applications stable isotopes are incorporated into a compoimd at close to 
100% isotopic emichment.
However, radioisotopes have fomid more widespread uses partly because of their 
detection at tracer levels by liquid scintillation counting (Birks, 1964). Consequently, 
this allows isotope incorporations to be much lower than for their stable counterparts. 
From the time that they began to be freely available radioisotopes as tracers have been 
widely and successfully used as essential tools for reseaich problems in biological 
studies and organic chemistry (Evans, 1992).
Compounds have been labelled with radioisotopes such as and ^^Cl but
the most widely used radiolabelled compoimds aie tliose labelled with and tritium 
(^H) (Evans, 1981). Although compoimds ai'e normally preferred for studies of 
metabolism, and in pharmacology, the relative ease of labelling complex molecules with 
tritimn, together with the properties of tiitimn (Table 1.1) and the enormous versatility of 
the isotope, often makes tritium labelled compomids the ti'acers of choice for many 
investigations (Evans, 1974a).
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1.2. TRITIUM AND ITS USES
There are tlrree established isotopes of hydrogen namely hydrogen or protium 
(^H), deuterium (^H) and tritium (^H). The discovery of higher isotopes has been 
reported (New Scientist, 1963a, b), however their existence is a controversial matter in 
view of their highly imstable nature. Much has been written on tritium and deuterium 
and a newcomer to the subject would be advised to study the respective standard 
reference works of Evans (1974a) and Thomas (1971). Both isotopes effectively 
duplicate the highly diversified chemistiy of the parent element hydrogen and not only 
act as tracers for tliat element, but also as labels for a carbon skeleton. In the latter case 
they simply replace hydrogens in an organic or biological compound.
Unlike hydrogen and deuterium, tiitimn is a radioactive isotope and as such 
decays by the emission of low energy p radiation as follows,
Table 1.1 summaiises some important physical properties of tritium.
Production 6Li(n,a)3H
Radiation P (100%)
Half-life 12.3 years
Decay constant 1 .8x 10-9s“1
Max. p-energy, Ep^iax 18.6 KeV
Mean p-energy, Ep^iean 5.7 KeV
Max. specific activity (per site) 29.12 Ci/mmol
Dissociation energy, T2 -> 2T 4.59 eV
Ionisation energy, T ^  T"^  + e“ 13.55 eV
Table 1.1.
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Tritium has certain unique advantages over other useful radioisotopes, especially 
its closest rival It is the cheapest radioisotope of its kind and this makes large-scale 
tracer experiments possible. The half-life of 12.3 years is conveniently long as not to 
introduce experimental difficulties although short enough to reduce concern over 
production and the storage of lai'ge quantities. The extremely high specific activities 
(max. 29.3 Ci/mmol per site) compared for example to (max. 62 mCi/mmol per site) 
malce it an excellent choice for use by the pharmaceutical industry, for example in the 
fields of drug metabolism and receptor binding studies (Hawkins, 1988). Although 
is still dominant in the former field, the use of tritium is necessary for compounds whose 
normal physiological concentrations aie extremely low without significantly affecting 
the normal metabolic process. However, in receptor-ligand binding studies, where high 
specific activities aie required (O'Comiell et a l, 1993) the use of tritium is essential.
The excellent autoradiographic properties, due to the wealaiess of the p-radiation 
and the high resolution obtained, malces tritium the first choice in much biological tracer 
work. The low energy and low penetrating power (10"4 cm in photographic film) of the 
tritium P-radiation permits precise localisation and measui'ement on autoradiographs (to 
within less than 1 p.m) of the atom that disintegrates. In practice a sample containing the 
radioactive material is brought into contact with a photographic emulsion and the P- 
pai'ticles fr om the tritium disintegration cause the same effect on the silver halide grains 
as light. This leads to a photographic image on the emulsion which allows the 
radioactivity to be located. This technique may also be used as a means of chemical 
purification when used in conjunction with thin layer clii'omatography (tic). However, a 
radiocliromatogram scanner provides a much quicker and more accurate identification of 
the distribution of radioactivity on a tic plate or paper.
Low toxicity and comparative ease of labelling procedures are other obvious 
reasons for the extensive use of tritium when studying biochemical and chemical reaction 
pathways and mechanisms (Evans, 1974a).
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1.3. TRITIATION PROCEDURES
Compounds labelled to high specific activities with tritium are increasingly 
required for studies of interactions of biologically active compounds with 
macromolecules such as receptors and enzymes. The traditional methods of preparing 
such labelled compounds most commonly fall into two categories,
(1) Hydrogen isotope exchange reactions
(2) Direct chemical synthesis
In practice, tritium attached to atoms other than carbon is often labile because of 
its acidic or basic nature and consequently only the preparation of those compoimds 
containing caibon-tritium bonds are considered.
1.3.1. Hydrogen Isotope Exchange Reactions
The preparation of tritium-labelled compounds by isotope exchange reactions 
invariably results in a 'generally' labelled compound, i.e. a compound in which the 
tritimn atoms are distributed in a general or random pattern tlrroughout the molecule. 
The labelling is seldom miiform.
There ar e two general exchange labelling procedmes which are currently applied 
to the preparation of tr itiated compounds,
(i) Isotope exchange with tritium gas
(ii) Isotope exchange with tritiated solvents
and the procedure selected depends on the nature and behaviour of the compound to be 
labelled under the experimental conditions (Myasoedov, 1993). A comparative study of 
platinum catalysed reactions using tritium gas and tritiated water as the isotope somces
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was imdertaken by Williams and his group (Williams et a l, 1991) in conjunction with 
NMR spectroscopy. The group were able to compare detailed incorporation patterns 
obtained by the two methods. They concluded that alkyl exchange in alkylbenzenes was 
generally less when HTO rather than tritium gas was the isotope soince. A featur e of the 
tritium gas results was the very high incorporation in alkyl groups, especially hydrogens 
on a car bon atom adjacent to an aromatic ring. In contrast, the total amount of tritium in 
the alkyl position of straight-chained alkylbenzenes labelled by HTO exchange increased 
as the number of alkyl vj aromatic protons increased. It was observed that the alkyl and 
aromatic tritiation rates were more nearly equal in the case of HTO exchange than with 
T2 gas, and this could be a reflection of a lower sensitivity of the HTO exchange process 
to the structme of the alkylbenzene substrate. It was also shown that in contrast to the 
products of HTO exchange reactions being free from any hydrogenation or 
dehalogenation by-products, hydrogenation products from tritium gas reactions were 
present and usually constituted a maximum of 25% of the radioactrvity yield.
13.1.1, Isotope Exchange with Tritium Gas
Hydrogen isotope exchange of organic compoimds with tritium gas was first 
recognised by Wilzbach in 1957 (Wilzbach, 1957) and has been described in some detail 
elsewhere (Wenzel, 1962). Although there have been numerous modifications of this 
radiation-catalysed exchange procedure, the problems associated with the purification of 
the products and the relatively low molar specific activities normally achieved have 
made the meüiod of limited use. Furthermore, the rate of labelling for this procedure has 
been quoted as taking place at the rate of one percent of tritium per day (Ziffero, 1957) 
and this is inconveniently slow in most instances where longer exposure times increase 
the risk of radiation damage to the compound. Recent publications (Myasoedov et al, 
1977, 1992; Zolotarev et a l, 1991) have shown that the application of catalysts to the
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Wilzbach method considerably increases the degree of label incorporation as well as its 
selectivity, and suggest that this teclmique of solid state isotope exchange may open new 
avenues in the preparation of tritium-labelled organic compounds.
A more widely used method involving the use of gaseous tritium for 
heterogeneous catalytic isotope exchange is that developed by Evans in the early 1970's 
(Evans et a l, 1974b). This procedme is based on the ability of hydrogen atoms 
occupying certain positions in a molecule to exchange with tritium gas in the presence of 
a metal hydrogen transfer catalyst (usually Pd or Pt) in neutral or basic solution. 
Palladium oxide supported on bmiurn sulphate has been shovm to be the most useful 
catalyst (Kuhn and Hass, 1955), although palladium supported on calcium carbonate or 
charcoal are also effective. This method has found applications witli a wide variety of 
organic compoimds as reflected in numerous publications (Bmicel and Jones, 1987, 
1990) and is especially suitable for labelling benzylic compounds, steroids and drugs 
(Evans, 1974a, b). The results obtained by this catalysed gas-exposure teclmique show 
the tritiated products to be of high specific activity and purity and specific labelling may 
often be obtained.
13.1.2. Isotope Exchange with Tritiated Solvents
Hydrogen-tritium isotope exchange reactions in solution are normally catalysed 
by homogenous or heterogeneous catalysts. The applicability of this general teclmique is 
restricted only by the stability of the substrate under the exchange conditions and it is 
admirably suitable for compounds that are moderately stable in solution at temperatures 
up to 150°C.
Exchange reactions in solution under the influence of heterogeneous hydrogen 
transfer catalysts, the most widely used of the methods for obtaining generally labelled 
organic compounds, involves heating the substrate for a few hours (5 - 20 lirs) in a
Chapter 1: Introduction
tritiated solvent (tritiated acetic acid or water) in the presence of a pre-reduced catalyst. 
A wide range of heterogeneous catalysts (Pt, Pd, Ni, Co, Fe, Rli etc.) in supported or 
unsupported forais have been employed (Evans, 1974a), platinum being the most active. 
Compounds labelled by this procedure include for example amino acids (Gravel and 
Hundeshagen, 1959), pyrimidines and nucleosides (Taylor et a l, 1957) and steroids 
(Fukushima and Gallagher, 1952; Simmonds, 1993). The adaptation of heterogeneous 
metal catalysed hydrogen isotope exchange to heterocyclic compomids has been 
thoroughly reviewed by Calf and Garnett (1973).
A large number of organic compoimds can also be specifically labelled imder 
homogeneous conditions by taking advantage of the wealcly acidic char acter exhibited by 
some carbon-hydrogen bonds (Jones, 1973). Thus in the presence of a suitable base, 
specific ionisation may occur allowing the intermediate carbanion to abstract a triton 
from an appropriately tritiated solvent to yield the radiolabelled product. Some 
compounds such as the p-diketones are sufficiently acidic to permit labelling to talce 
place even in neutral solution at room temperature. For weaker acids such as ketones, 
strong bases such as hydroxide ions are required to produce the intermediate carbanion 
(Thomas, 1971).
Treatment of many organic compounds with str ong acid results in protonation. 
Subsequent proton loss (if it involves other than the introduced hydrogen atoms) can 
provide a means of exchange. A wide range of acids have been employed to label 
essentially electron rich aromatic compoimds and many such studies of acid-catalysed 
tritiations have been reported (Norman and Taylor, 1965; Evans, 1974a; Orchin and 
Bollinger, 1975).
Many kinds of Lewis acids have been used to induce exchange and of these ethyl- 
aluminium dichloride (EtAlCl2) is amongst the most reactive (Long et a l, 1975; Elvidge 
et a l, 1977).
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1.3.2. Direct Chemical Synthesis
Catalytic exchange procedures are expedient methods which rarely give the 
sufficiently high specific activity necessary for radioiimmmo-assay and binding studies. 
This can be facilitated by direct chemical synthesis, which is the most accurate and 
reliable way of labelling compounds with tritium. Starting materials for the syntheses of 
tritium-labelled compoimds by this route are tritium gas, tritiated water and tritiated 
metal hydrides. Reduction reactions are the most significant and even complex organic 
molecules are labelled by simple one step reductions. Reactions of this type fall into 
tlrr ee main categories,
(i) Reduction of unsaturated compounds
(ii) Reduction with tritiated metal hydrides
(iii) Reduction by catalytic halogen-tritiurn replacement
1.3.2.1. Reduction o f Unsaturated Compounds
Hydrogenation of unsaturated compounds by tire catalytic addition of tritiurrr gas 
is one of the most converrierrt and simplest methods for the introductiorr of tritiunr irrto a 
irrolecule. Carbon-carbon aliphatic double and triple borrds are reduced by a metal 
catalyst in the presence of tr itium gas.
CH3(CH2)4C^CCH2C=C(CH2)7C00H
(1)
T2 , Lindlar
CH3(CH2)4CT=CTCH2CT=CT(CH2)7C00H
(2)
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Using catalyst systems such as Pd/C, Pd/BaSOq. and Rlr/Al20g a wide variety of 
tritiated compounds have been prepared, for example, the partial reduction of octadeca- 
9,12-diynoic acid (1) gives tritiated linoleic acid (2) (Lemmon et al, 1959).
1.3.2.2. Reduction with Tritiated Metal Hydrides
Unsaturated groups other than caibon-caibon bonds can also be reduced to give 
tritiated products and in these cases tritiated reducing agents are employed. Most widely 
used are the metal tritides or mixed metal hydrides such as sodium or lithium borotritides 
and lithium aluminium tritide. Typically, the groups which are reduced include 
aldehydes, ketones, carboxylic acids, esters and nitiiles. This method gives strictly 
specific labelling and the tritimn atoms are located only on the carbon atom forming the 
unsatmated group. For example the hormone adrenalin (4) is labelled specifically at the 
7-position by the reduction of the coiTesponding ketone (3) with sodium borotritide 
(Kaplan, 1954).
7 NaBI^T / = \  7
\ — OOOLNHMe ---------- »  B D - V  ))— CFOLNHMe
/ /  V J '  Œ
eo^
(3) (4)
In recent publications Andres et al (1990, 1992) have detailed a method for the 
simple and facile generation "in situ" of lithium tritide, an excellent starting material for 
the carrier-fr ee preparation of many labelled reagents including LiAlT^, LiEtgBT, LiBT^ 
and BugSnT. Compounds labelled by this route are tritiated at close to maximum 
specific activity and if this work could be extended to the tritides of sodium and 
potassium, as well as the use of other Lewis acids, the range of tritiated reagents would 
be significantly increased.
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1.3.2.3. Reduction by Catalytic Halogen-Tritium Replacement
The final important method of direct chemical synthesis involves the replacement 
of a halogen atom by tritium under catalytic conditions (similar to those used in 
hydrogenation reactions).
RX + T2 - >  TX + RT
TX + OH- - >  THO + X- X = Halogen
A nmnber of experimental aspects have to be considered when undertaking this 
type of reaction. Firstly, it can be seen that only half of the tritium employed can be 
incorporated into the molecule, the remainder is lost as the tritiated halide, TX, which is 
likely to seriously poison the catalyst. This is a paiticular problem when iodine is 
involved (Baltzly, 1967). Usually such problems can be prevented by neutralising the 
tritium halide formed during the reaction with an excess of a weak base such as 
triethylamine.
A high degree of specific labelling is normally achieved if the rate of the halogen- 
tritiimi replacement reaction is fast. Reaction times vary according to the substrate and 
catalyst, but as a general rule, iodinated compounds react faster than the corresponding 
bromo- and chloro-derivatives with fluorinated compounds seldom being employed. In 
the case of slow reactions, the build-up of tritium as tritiated water in solution may result 
in metal catalysed hydrogen isotope exchange reactions. Although such exchange with 
compounds in solution is usually slow at room temperature, this phenomenon can result 
in some non-specific labelling and has been observed with halogenated derivatives of 
folic acid (Zalazewski et a l, 1970, Evans et a l, 1979).
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1.4. PURIFICATION AND ANALYSIS OF TRITIUM 
COMPOUNDS
The ability to isolate the tracer compound in high radiochemical and chemical 
purity is a measine of the success of any isotopic labelling procedures. This is dependent 
on the availability of reliable, rapid and accurate methods for radioactive measui'ement of 
the isotope and techniques for the identification of the labelled compound.
Tritium is usually detected and measuied by liquid scintillation counting (Birks, 
1964; Evans, 1974a). The method offers a high detection efficiency, ease of sample 
preparation, absence of self-absorption and reproducibility of results. Two problems 
associated with it, namely quenching effects and sample solubility can fiequently be 
overcome (Jaiswal, 1974).
The principle of the method is the conversion of the p-radiation energy into 
photoelectrons producing chaige pulses which can be amplified and counted by a scaling 
circuit. In practice, the radioactive sample is dissolved in a solution containing a 
scintillation solvent and solute. As the tritium undergoes nuclear disintegration the p- 
energy transferred to the scintillant solvent can appear* as energy of ionisation, 
dissociation or excitation of the solvent molecules. The solvent excitation energy is then 
transfeiTed to the molecules of a fluorescent solute which return to the ground state by 
emitting quanta of light in the visible or near ultra-violet region.
Because of the decomposition of radioactive compoimds by self-irradiation, 
particularly those at the high specific activities required for many investigations, 
impiu'ities are always likely to be present. It is therefore important to be able to perform 
quick and reliable checks on the pmity of the labelled compounds after pmification, and 
before use.
Techniques involving cliromatography (Sheppard, 1972) aie well suited to 
radiolabelled compounds because of the small chemical weights involved. The types of
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clu'omatography normally employed include paper and thin-layer plate chiomatogiaphy 
(tic) and gas-liquid cliromatography. The former two methods are restricted to analysing 
non-volatile compounds while the latter may be used to analyse gases or volatile liquids 
or solids.
Quantitative determination of tritimn in paper and thin-layer plate 
clii'omatography may be achieved when the cliromatograms aie assessed in conjunction 
with autoradiography, chromatogram scanning or direct comiting of the activity by p- 
liquid scintillation measurement. The most widely used and accmate method for 
quantitative interpretation of radiochromatograms is by scanning; both paper and thin- 
layer chromatograms can be scanned (Carleton and Roberts, 1961). The same 
precautions as those for paper and thin-layer plate clii’omatography of the corresponding 
unlabelled compomids must be taken. However, a further problem which must be 
considered when using these techniques is the possible radiochemical decomposition of 
the compoimd on the paper (Moses, 1962) or on the thin-layer plate, particulaily when 
high specific activity compomids are involved.
Gas-liquid or gas-solid chromatographic methods aie often used for the analysis 
and sepai ation of tritiated compounds, par ticularly the more volatile compomids to which 
paper or thin-layer methods caimot be applied.
More recently, high performance liquid clii'omatography (HPLC) (Hawk, 1979; 
Pry de and Gilbert, 1979) has played an ever more important role for obtaining 
radiolabelled compounds of very high quality. HPLC plays an equally important role in 
the analysis of tritium labelled compomids and can often detect trace impmities 
midetected by paper or thin-layer chromatographic processes.
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1.5. TRITIUM NUCLEAR MAGNETIC RESONANCE 
SPECTROSCOPY
Since the first report of tritium nuclear magnetic resonance (NMR) spectroscopy 
by Tiers in the early 1960's (Tiers et al, 1964), the teclmique has been developed by the 
pioneering work of the Amersham-Smrey University group (Evans et a l, 1985) into a 
powerful and essential teclmique in the analysis of tritiated material. Although NMR 
spectroscopy is an inlierently insensitive method, by comparison with, for example, 
ultraviolet spectroscopy (usefiil for determination of mass and to confirm structure), it 
has proved to be the most powerful and far reaching method for investigating molecular' 
processes as well as routine determination of labelling patterns.
The triton, like the proton, has a spin quantum number I = 1/2, therefore it is a 
suitable nucleus for high resolution magnetic resonance spectroscopy. Selected magnetic 
properties of tr itium along with those of other radionuclides used in the life sciences are 
shown in Table 1.2. Some consequences of these magnetic properties of the tritium 
nucleus malce NMR spectroscopy particularly useful. Firstly, tritium has a high 
nuclear magnetic moment (p. )^ which causes the value of the rnagnetogyric ratio (y^ = 
P-t/Ir) to be higher than for any other nucleus in the Periodic table. Consequently at a 
field of 2.114 T, the NMR frequency is 90 MHz and the NMR frequency is 96 
MHz. In practice this results in a slightly larger spectral dispersion (by the factor yy/y^ 
= 1.06664) in the ^H NMR spectra compared with the ^H NMR spectra at the same field 
and, moreover, the high rnagnetogyric constant renders tire tr'iton the most receptive and 
sensitive nucleus to NMR detection. The high receptivity, along with effectively zero 
natur al background abundance of the isotope results in detection of the isotope at very 
low isotopic abundances. In practice, a sample containing 0.5 mCi at a single site 
(maximum 29.1 Ci) will give a satisfactory signal to noise ratio after one hours 
accumulation (at 320 MHz) (Evans et ah, 1985).
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Fulthermore, the chemical shifts of tritium nuclei should be closely similar to 
those of hydrogen nuclei, in corresponding environments (Al-Rawi et a l, 1974). This is 
particularly important because the vast body of data available on proton chemical sliifts 
can then be applied directly to NMR, thus greatly facilitating interpretation.
Tritium NMR spectroscopy, imlike for example proton NMR spectroscopy, is not 
in general used to establish the structme of an unknown compound. More usually, it is 
used to establish the position and distribution of tritium atoms within a tritiated 
compound of laiown structure. The intensity of the tritium signals give directly the 
relative amomits of the isotope in each position. Signal splitting may give information 
on the stereochemistry of tritimn atoms in nearby positions, because the magnetic 
interaction between a proton and triton nuclei on adjacent carbon atoms will depend on 
their relative geometry in space. Tliis information is of special importance, for example, 
in the study of the biochemical transformation of steroids (Altman & Silberman, 1977a, 
b; Chambers, 1978). In some cases, fuither stereochemical information may be obtained 
by measui'ing triton-proton couplings in NMR spectra without proton spin 
decoupling, or with specific proton decoupling. The use of spin decoupling techniques 
effectively destroy couplings between adjacent magnetic nuclei and greatly reduce the 
complexity of multiple signals but can cause selective signal enliancement in an NMR 
spectrum. The phenomenon of signal enliancement is knovm as nuclear” Overhauser 
enhancement (NOE) and is discussed in detail, in general terms, in the literature (Noggle 
and Schirmer, 1971) and more recently Kaspersen et al have discussed nuclear 
Overhauser effects in NMR spectroscopy (Kaspersen et al., 1987).
Tritium NMR spectroscopy is undoubtedly the best method for locating the 
position(s) of the label in tritiated compounds and for determining the 
stereochemistry and relative extent of labelling (Bloxsidge et a l, 1981). This is 
important for many tracer applications of tritium compounds where a knowledge of the
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precise position and configuration at the position of the label is essential (Kaspersen et 
a l, 1993).
Although has been utilised extensively as a tracer, it has received relatively 
little use as an NMR label in biological systems. However, with the advent of Fouiier 
transform NMR spectrometers (Al-Rawi, 1974) and quadratuie detection, the detection 
sensitivity has increased and the teclmique has found use in addr essing the questions of 
mechanism and stereochemistry in small molecules and is increasingly being applied to 
biochemical (Libor et a l, 1980; Dive et a l, 1991) and biological studies (Newmark et 
al, 1990).
The configmation of tritium labelled methyl groups in small molecules has been 
studied by NMR spectroscopy. Ever since the initial disclosure, by Aiigoni and co­
workers (Lüthey et a l, 1969), of methods to synthesise the enantiomers of a methyl 
group caiTying one atom each of ^H, and and to distinguish the R ftom the S 
enantiomer of such an entity, there has been considerable fascination with chiral methyl 
groups and their use to analyse stereochemical problems in chemistry and biochemistry. 
Examples of this type of study include the stereochemistry of proton elimination in the 
biosynthesis of tritiated cycloartenol (Altman et aL, 1978), the stereochemistry of the 
incorporation of the methyl groups of 'chiral methyl valine' into methylene groups in 
Cephalosporin C (Abraham et a l, 1983), and more recently. Floss and his group 
demonstrated for the first time tliat the configuration of stereogenic (chiral) methyl 
groups could be assigned by direct NMR analysis of a molecule containing an intact 
CHDT group (Anet et a l, 1989).
Applications of NMR spectroscopy have extended to studies of 
conformational analysis and proton-exchange kinetics in simple molecules. As an 
illustration of the usefulness of tritium in isotopic perturbation studies, Anet described 
results obtained in a low temperatme integration study of H]cyclohexane (Anet et al, 
1990). Integration of the axial and equatorial tritium signals in the NMR spectrum of
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the labelled substrate at -88°C showed that in agreement witli previous NMR work 
with pHJcyclohexane, tritium preferred the equatorial site. A year later, Dixon 
published the first "in situ" measui'ements of acid- and base-catalysed proton exchange 
kinetics using NMR spectroscopy (Dixon et aL, 1991). The method allowed the 
measurement, in the same NMR tube, of the kinetic acidities of several compounds with 
a broad range of rates, examples included benzene and jp-xylene reacting with caesium 
cyclohexylamide in cyclohexylamine.
As the power of the instrumentation increased, so the application of NMR 
spectroscopy progressed to the study of laiger biochemical molecules, however there 
have been relatively few examples of tritium NMR studies with protein systems (Evans 
J. et ah, 1984).
An essential requirement for understanding protein structuie and fimction is 
laiowledge of the thiee dimensional structure. Historically, crystallographic methods 
have been used towards this end, but recently these have been supplemented by NMR 
studies of proteins at high magnetic fields, in one, two and thiee dimensions, usually in 
conjunction with specific isotope enriclnnent. Only very recently, Gehi'ing and Williams 
utilised ^H NMR spectroscopy to probe protein structure and dynamics (O'Coimell et aL, 
1993a, b). The group used ^H NMR studies of specifically tritiated derivatives of 
tosylchymotrypsin to examine the properties of the tosyl group in this protein. 
Irradiation at the proton frequency of samples of the specifically tritium labelled 
enzymes produced a 3fj{lH} NOE, consistent with dipolar interactions with 
neighbouring protons being an important component of tritium relaxation. The curly 
brackets { } are used to indicate the resonance which has been irradiated in the NOE 
experiment. The natuie of the tritium-proton interactions was explored further by means 
of two-dimensional proton-tritium nucleai* Overhauser experiments. The results obtained 
indicated that multidimensional NMR studies of fairly large molecules by the use of 
introduced tritium as a heteronuclear probe were feasible.
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Tritium NMR spectroscopy has also extended the capability of NMR 
spectroscopy for studying, for example, anomeric specificity to slowly exchanging 
processes at low stoichiometries of tritiated ligand to binding studies. The first detection 
of an enzyme-substrate complex by NMR spectroscopy was described by Evans J. et 
al in 1986. The group attempted to elucidate the mechanism and structure of the 
labelled porphobilinogen, [^HJPBG, with deaminase using NMR spectroscopy. 
From the results they were able to suggest the involvement of a sulfliydryl group as the 
nucleophilic enzyme group that binds the substrate and also demonstrated the catalytic 
competence of this complex by displacing bound [^HJPBG with unlabelled PEG. 
However, the ^H NMR spectra of this study have subsequently been reinterpreted to 
accormnodate the miexpected findings of a C-C bond between substrate and enzyme, in 
terms of a broad ^H signal at ô 3.28 ppm (Evans J. et al, 1986), which was thought to be 
due to initial (and transitory) attacliment of the substrate at the second cysteine residue 
conserved in human and Escherichia coli (E. coli) deaminase (Scott et a l, 1988).
The technique has also been used to study the binding of tritimn labelled maltose 
to its transport protein fiom E. coli, maltose binding protein (MBP)(Williams et al, 
1989). The sugars were labelled specifically at the reducing end and titrated into a 
sample of the protein. The high sensitivity of ^H NMR spectroscopy along with the 
vastly simplified ^H NMR spectrum, when compared to the ^H NMR spectrmn of the 
same complex, gave invaluable information as to the location of the tritium labels in the 
bound complex. As the mole ratio, maltose to MBP, was increased, signals ftoni the free 
maltose were also observed in the ^H NMR spectrum. Heteronuclear NOE experiments 
added to the information already available horn the ^H NMR studies.
This study was extended to the family of linear maltodextrins (of which maltose 
is the smallest)(Gelu'ing et al, 1991) and the authors were able to show the existence of 
two bomid p-maltotriose resonances in rapid exchange and assigned them as two distinct 
sugar-protein complexes.
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Cleaiiy, it can be seen that relatively little has been published in this area 
and the work presented in tliis thesis will help to confirm the suitability of tritium NMR 
spectroscopy to studying protein-ligand complexes.
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1.6. THESIS OUTLINE
Following this introductory chapter, the thesis is divided into tlu'ee main
experimental chapters followed by a final smnmary. The layout is as follows:
• Chapter 2 describes tlie labelling and pui'ification of the ligands, folate and 
methotrexate, to high specific activity with tiitimn. The distribution and extent of the 
tritium labelling is determined by tritium NMR spectroscopy.
• Chapter 3 presents infonnation relating to substiate, inliibitor and coenzyme binding 
to Lactobacillus casei (L. casei) dihydrofolate reductase, with paiticulai" regard to 
using selectively tritiated ligands in conjunction with tritium NMR spectroscopy. 
Tritium NMR studies of [3',5',7-^H] folate, [7,9-^H] folate and [3',5',7- 
^Hjmethoti'exate binding to L. casei DHFR, with NADP"*" and NADPH as coenzyme, 
aie presented. The effects of pH and temperatuie on the binary and ternary 
complexes have been investigated and the results discussed in relation to existing ^H, 
13c, NMR and X-ray crystallographic data for the DHFR complexes.
• Chapter 4 details the use of the nuclear Overhauser effect (NOE) in small molecules 
and macromoleculai' systems. The results from 3h (1h } heteronuclear NOE 
experiments on small molecules ai'e presented and the feasibility of the teclmique for 
observing 3h {1h } NOEs between protein and tritiated ligands is discussed.
• Chapter 5 is devoted to providing a brief summary of the results in previous chapters, 
with fui'tlier discussion on the implications of these results. Some suggestions on 
possible areas of future work aie also included.
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2. LABELLING OF LIGANDS
2.1. INTRODUCTION
2.1.1. Background
The term 'molecular recognition' is one which is increasingly used to describe 
specific interactions between molecules. It refers to the ability of a receptor molecule to 
bind some molecules more tightly than others, due to the fact that non-covalent 
interactions between the receptor and these substrate molecules aie more favourable, i.e., 
the receptor molecules have the ability to discriminate between closely related substrates. 
This is a key determinant of chemical reactivity, enzyme catalysis and many other 
fundamental processes, e.g., DNA synthesis and protein biosynthesis.
There are foui' types of interaction that contribute to the binding of the receptor 
and substrate molecules: electrostatic (ionic), hydiogen bonding, van der Waals and 
hydrophobic (Kollnian, 1989) and these will be discussed in more detail in subsequent 
chapters. Broadly speaking, most of the work carried out in this area has been involved 
with determining and understanding small molecule/laige molecule interactions. The 
interaction of an enzyme with a substrate (or ligand) is a typical example of such 
molecular recognition. A detailed understanding of this type of recognition is often the 
vital component for the design of novel drugs and pharmaceutical agents based on the 
inhibition of a key enzyme in a pathogenic organism. Enzyme inliibition also has 
implications for the design of new agro-chemicals, for example as herbicides (Cooper et 
al, 1987).
The design of new molecules which specifically bind very tightly to a selected 
protein is an important area of increasing interest within the domain of molecular 
recognition. Thus, by studying the vaiious properties of receptor-ligand complexes, it
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should be possible not only to illuminate specific biological problems, but also to gain 
insight into the general rules governing intermoleculai” interaction thereby leading to the 
design of new molecules.
The use of powerful spectroscopic methods has been a key feature in much of the 
recent work. The employment of NMR spectroscopy has been the most popular and this 
technique has provided considerable insight into the regions of complexes of small 
molecules with complicated proteins. The first protein whose binding site was analysed 
by studying the NMR spectra of tlie protein, as well as that of the ligand, was bovine 
pancreatic ribonuclease A (Meadows & Jardetzky, 1968; Meadows et al, 1969). The 
inliibitor used in this complex was cytidine 3'-monophosphate. From that time on there 
have been many receptor-ligand complexes that have been studied by NMR spectroscopy 
(Roberts & Jardetzky, 1970; Fesik, 1991).
HgN
5
8^ ;  NH
ioNH— ^
FH2 (6)
COgH
HoN
FH4(7)
HOgC
NADPH + H+
DHFR
NADP
COgH
HOgC
Figure 2.1. Reduction of dihydrofolate (FHg, 6) to teti ahydi'ofolate (FH4 , 7) by NADPH as catalysed by 
dihydrofolate reductase (DHFR)
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In the present study the receptor of interest is the enzyme dihydrofolate reductase 
(DHFR) which catalyses the reduction of 7,8-dihydi*ofolate (FH2, 6)(Figui’e 2.1) (and 
folate (5a)) to 5,6,7,8-tetraliydrofolate (FH4, 7) using NADPH as a coenzyme (Blakley, 
1985). Tetrahydrofblate (7) is a one carbon carrier in various synthetic pathways, 
including the synthesis of thyrnidylate from uridine, a step essential for DNA replication 
and therefore for cell division. Thus, DHFR is required to maintain tlie cellular pool of 
reduced tetrahydrofolate in cells that are synthesising DNA and antifolate drugs act by 
selectively inhibiting this key enzyme in invasive cells. Typical antifolate drugs in 
clinical use are methotrexate (8) and trimethoprim (9).
O HI
HN
CO2H
HO2C
Folate (5a)
NH NH. COoH
Methotrexate (8)
NH
OCH
OCH; 
Trimetlioprim (9)
Figure 2.2. Sti'uctures of the substi'ate folate (5a) and antifolate drugs, methotrexate (8 ) and tiiinethoprim
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The amino acid sequences for the enzyme have been determined from a number 
of species (Bolin et a l, 1982; Matthews et a l, 1985). Structural studies have also been 
performed on several complexes of dihydiofblate reductase (Antonjulc et a l, 1984; 
Hammond et a l, 1987), with the result that DHFR is well characterised and an ideal 
choice for interpreting the molecular* basis of the specificity of protein-ligand 
interactions.
Since its introduction in 1963 by Forsén and Hoffinan (1963), the double 
resonance transfer of saturation NMR experiment has been widely used to study 
relatively slow chemical exchange processes in organic and biological systems (Cayley 
et aL, 1979; Clore et a l, 1981). In biological applications, e.g., for a ligand binding to 
an enzyme, saturation transfer experiments have been particularly useful for locating the 
resonances of bound ligands, which cannot be observed directly in the NMR spectrum, 
by finding the iri'adiation frequencies at which transfer of saturation to the corresponding 
resonances of the free ligand is observed. Saturation transfer experiments have been 
used to study the binary complex of L. casei dihydrofolate reductase with NADP"^ (Hyde 
et a l, 1980a) and the ternary complex with folate (Hyde et aL, 1980a; Clore et aL, 1981).
Feeney and colleagues (Birdsall et aL, 1982; Cheung et aL, 1993) have shown 
that it is often necessary to resort to isotopic labelling teclmiques to assign resonances in 
ligands which are so tightly bound to the protein that transfer of saturation methods 
camrot be used to comiect signals from boimd and free species. In the past, and 
^^N-labelled ligands have been used (Birdsall et aL, 1982, 1987) for example, the use of 
l^C selectively enriched folates has provided a direct way of monitoring the different 
conformational states in the DHFR-fblate-NADP"^ complex (Cheimg, 1993). However, 
this approach suffers from the fact that the synthesis of the isotopically labelled ligands 
requires considerable effort (Cheung er al, 1993; Cowart et a l, 1994) and also that the 
nuclei are relatively insensitive to NMR detection. The latter factor makes it difficult to 
carry out Idnetic measmements using line shape analysis.
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The present work explores the use of tritium NMR spectroscopy in combination 
with specifically tritiated ligands in studies of protein-receptor interactions. In principle, 
the use of tritium NMR spectroscopy to examine tritiated bound ligands offers a useful 
additional method of directly studying protein-ligand complexes. Although the attractive 
features of the nucleus for NMR studies have been amply demonstrated in studies of
small molecules (Evans et a l, 1985), the potential value of this nucleus for studies of 
protein-ligand interactions has hardly been exploited (Geliring et al., 1991; O'Connell et 
at., 1993a, b). In contrast to the time consuming and expensive ^^C and ^^N syntheses, 
the incorporation of tritium at very high specific activity can usually be achieved in a 
one- or two-step process (see Section 1.3 and Evans et al., 1985). Furthermore, it is 
often possible to modify the synthesis in order to incorporate the label at different sites. 
The tritiated sites can then be detected directly in the NMR spectra, fiirthermore there 
are no background signals present.
The work presented in this thesis is concerned with examining the tritium NMR 
spectra of complexes of Lactobacillus casei DHFR and selectively tritiated folates and 
methotrexate labelled at sites designed to probe multiconformational behaviour and 
dynamic processes in these complexes. Hence, this chapter is concerned with the 
labelling of the ligands, folate (5a) and methotiexate (8), to high specific activity with 
tritium, and the determination of the distribution and extent of tritium labelling, by 
tritium NMR spectroscopy.
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2.1.2. Literature Overview
Tritium labelled folic acid (5b) and methotrexate (8) are both extensively used in 
biomedical research. For studies in which the tritium is used as a tracer to follow the fate 
of the intact molecule, the specificity of tritium labelling is normally unimportant. 
However, in studies where the possibility of metabolism or chemical alteration of the 
compound aiises, it is very important to know the distribution of tritium in the tracer 
compound (Evans, 1974a). In the present study, a laiowledge of the position and extent 
of tritium labelling is imperative when assigning the signals in tlie ^H NMR spectra for 
the different conformations of the tritium labelled ligand/enzyme complexes.
The preparation of the 'specifically' labelled compounds by catalytic 
dehalogenation of 3',5'-dibromofolic acid (10) and 3',5'-dichloromethotrexate (11) with 
tritium gas (Zakrzewski et a l, 1970) is perhaps the classical example of non-specific 
labelling. Chemical degradation (Zakrzewski et al, 1970) indicated that a substantial 
proportion of the tritium was located at the C-9 position of both folic acid (5b) and 
methotrexate (8).
Several other methods have been used for the isotopic labelling of folic acid and 
are as follows
(a) exposui'e to tritium gas (Wilzbach method) (Jolms, 1961)
(b) platinum (Ft) or palladium (Pd) catalysed H/T exchange in HTO 
or acetic acid (Zakrzewski et a l, 1970)
(c) Pd catalysed dehalogenation using tritium gas (Evans, 1979)
(d) acid catalysed H/D exchange in D2O (Hachey et a l , 1978)
All give different patterns of labelling and the earlier studies were investigated by 
time consuming chemical degradation and physical methods. However, subsequent 
studies (Evans et a l, 1979, 1985) have reinforced the benefits of the direct and non
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destructive NMR spectroscopic teclmique for establishing patterns of tritium 
labelling and this is now the method chosen by most groups.
Figure 2.3, Str ucture of folic acid analogues
œ%H
OOjH
COMPOUND R R' X
Folic Acid (5b) OH H H
Methotrexate (8) NH2 CH] H
3',5'-Dibromofolic Acid (10) OH H Br
3',5'-Dichloromethotrexate (11) NH2 CH3 Cl
For methotrexate (8) labelled by catalytic dehalogenation of 3',5'- 
dichloromethotrexate (11) the NMR data (Evans, 1985) shows that in contrast to the 
results obtained by chemical degradation methods (Zalaezweski et a l, 1970), the 3',5'- 
and 7-positions are exclusively labelled, with no tritium at the 9-methylene position.
As previously stated, contradictory results have been obtained in research 
concerning the specificity of isotopic labelling by the procedure of catalytic
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dehalogenation of 3',5'-dibromofolic acid (10). In studies of tritium labelling Zala’zewsld 
et al (1970) reported that only 35 - 42% of the label was at the 3j5'-positions with the 
remainder of the isotope incorporated at C-7 and C-9. In later research, Evans et al 
(1979) observed similar isotopic distribution although 3',5'-labelling ranged from 42 to 
73% of the total tritium. Gregory and Toth (1988, 1989) reported that the preparation of 
[3',5'-2H]folic acid by catalytic dehalogenation with deuterium gas yielded little or no 
incorporation of the isotope at C-7 or C-9, and as a follow up to this study Gregory 
(1990) reported modifications to the previous catalytic dehalogenation procedure that 
permitted complete deuterium labelling of folic acid at the 3',5'-positions. The major 
procedrrr al changes reported were the preliminary removal of exchangeable protons fr om 
the substrate 3 ', 5 '-dibromofblic acid and the catalytic dehalogenation reaction conducted 
in D2O. In this study of Gregory (1990), NMR analysis was employed to provide a 
direct indication of the extent of deuterium labelling of the 3',5'-positions and other sites 
within the molecule. The spectral data obtained confirmed the high degree of specificity 
of labelling of the 3',5'-positions which is in contrast to the distribution of tritium 
obtained under analogous reaction conditions (Zaltrzewski et a l, 1970, Evans et al, 
1979). Although Evans observed, by NMR spectroscopy, that the extent of tritium 
labelling of C-7 and C-9 varied markedly among batches of palladium on calcium 
carbonate employed, consistent labelling of these positions was observed. The NMR 
data for the deuterium labelling study confirmed previous observations (Gregory and 
Toth, 1988, 1989) that little or no labelling of C-7, C-9 or other positions occured by 
deuterium-proton exchange under the conditions of the reaction. It is still unclear 
whether the difference in labelling specificity between tritium and deuterium reflects a 
true isotopic effect or a difference in the nature of the catalysts employed.
In this study, where high specific activities are required, folic acid (5b) and 
methotrexate (8) were labelled with tritium by catalytic halogen-tritium replacement of 
3',5'-dibromofblic acid (10) and 3',5'-dichloromethotrexate (11) respectively, using
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tritium gas with palladium on calcium caihonate as the catalyst (Evans et a l, 1985). 
3 ',5 '-Dichloromethoti'exate (11) was first synthesised according to Mailinelli & 
Chaykovsky (1980). Labelling with tritium was also achieved by a procedure using 
catalysed exchange between tiitium gas and folic acid (5b) in solution to give folic acid 
labelled exclusively in the 7- and 9-positions (Evans et a l, 1979). Tritium NMR 
spectroscopy was used to detemiine the patterns and extent of labelling in the tritiated 
compounds.
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2.2. EXPERIMENTAL
2.2.1. Materials and Equipment
Tritium gas was supplied by Amersham International, folic acid, 3',5'- 
dibromofolic acid and methotrexate were obtained from Sigma Chemical Company. 5% 
Pd/CaCO] was obtained from Aldrich Chemical Company.
The pH measurements were carried out using a Hanna Instruments HI8417 pH 
meter equipped with a combination glass electrode. Tritiated samples were counted with 
a Beckman LS 100 liquid scintillation coimter by using Unisolve E liquid scintillant.
The ultra-violet (UV) absoiption spectra were recorded on a Cecil CE272 
spectrophotometer. The UV absorbance of the tritiated folic acid (12, 13) in 0.1 M 
NaOH was measured at 282 nm, 8232 ~ 25 100 M"lcm"^ (Waller et a l, 1948). For 
methotrexate (14) in 0.1 M NaOH, tluee UV absorbances were measured: 257 nm, S257 
= 23 000 M"lcm"l; 302 nm, S302 = 22 000 M '^cnr^; 370 mu, S370 = 7000 M“^cm~l 
(Seeger et a l, 1949).
The radiochemical pmity was determined by radiocluomatogram scanning 
(Berthold LB 2842 Radiochi'omatogram Scanner) of the tic plates (precoated fluorescent 
silica gel, 5 x 20 cm, Schleicher & Schuell F1500/LS 254). Known standards were used 
on the tic plates for visual comparison with the radiolabelled samples.
The developing tanlc was purged with nitrogen and kept in the dark. The plate 
was allowed to run for tluee hours. The solvent system used was propan-1-ol (3): 
aimnonium hydioxide, 0.3 M (1), folic acid, Rf = 0.6; metliotrexate, Rf = 0.5.
1h  and 3H(^H-decoupled) NMR spectra were recorded in deuterated solvents 
using a Bruker AC-300E (300 MHz) spectrometer. Typically, 128 transients and 30 000 
transients were collected for ^H and ^H spectra respectively, with widths of 3846 Hz and 
using 16K data points, zero filled to 32 K data points.
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2.2.2. Experimental Methods 
2,2,2A, The Tritium Gas Line
The synthesis of tiitiated ligands by either catalytic exchange in solution or direct 
chemical synthesis with tritiuiu gas was carried out on the tritiimi gas line (Figure 2.4). 
Hydrogen or deuterium may, of course, be substituted for tritimn gas as starting material 
for the preliminary studies. The apparatus is designed to transfer a measmed quantity of 
tritimn gas to the reaction vessel. It is constructed from stainless steel high performance 
liquid chromatography equipmerrt which is comiected to Pyrex glassware via glass-metal 
seals.
The 'business end' of the appar atus is the tritiation tree which is shown in detail in 
Figure 2.5. It consists of a burette (5.0 cin^, 28 cm length) with a 250 crn^ bulb at the 
base. The top of the burette is comiected, via a four way junction piece (behind the plate 
on the diagram), to the manifold, tritium gas ampoule and the reaction flask, each of 
which may be isolated via Wliitey swagelock™ SS-41S1 taps 1, 2, 3 and 4. The tree is 
comiected to the main manifold at tap 1. Comiected to the base of the tree is a mercury 
reservoir (300 crn^) which is in tmn connected to the main manifold at tap 5.
A vacuum pump is connected to the apparatus at A and the vacuum 
attained may be read fr om the vacuum gauge (C). Volatile tritiated material is collected 
in the liquid nitrogen trap which is connected to the main manifold by silicon rubber high 
vacumii tubing. A helium balloon, comiected via a teflon 3-way interflow tap, may be 
attached to the apparatus by the groimd glass joint, D.
All glass jomts are lubricated witli Apeizon grease, all stopcocks are made of 
teflon and the tubing connecting the manifold to the tritimn tree is silicon rubber high 
vacuum tubing.
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Figure 2.4. Tritium gas-line for handling multi-Curie quantities of tritium gas
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Figure 2.5. Detail of the tritiation tree
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2,2,2,2, Operation o f the Tritium Gas Line
The vacuum pump is staited when all taps except for A and 5 are closed. Liquid 
nitrogen should be present in the trap dewar to contain any solvent vapour from the 
reaction vessel. A balloon of helium is then attached to the apparatus at D and tap E is 
opened. The reaction vessel containing catalyst, substrate, solvent and a stirrer bar is 
attached to 3. The stirrer bar* is a short piece of paper clip encapsulated in a glass tube 
manufactured from the tip of a disposable pipette. An ampoule of tritiimi gas (4.0 Ci, 
1.68 cm^) is now attached to 2. A 20 cm^ round bottomed glass flask with a ground 
glass tap and filled with helium is attached to the other side arm at tap 2. Air can now be 
evacuated from the burette by closing tap 5 and by opening tap 1 to the manifold and 
carefully opening tap 4 to the burette; the mercury level should be very close to the tap.
Air is most effectively removed from the reaction flask by freezing the contents 
with liquid nitrogen before opening tap 3. Tap 2 is now opened to evacuate the entire 
manifold, reaction vessel and glassware coimected to the tritium ampoule.
The vacuum is then closed off at tap A and helium gas allowed into the system 
until the Edwards vacuum gauge reads atmospheric pressuie. Tap 4 is opened carefully 
to allow about 2 cm^ of helium into the bmette. The helium is then closed off via tlie 3- 
way tap F and the system re-evacuated by opening A. Tap 4 is caiefully opened to 
evacuate the buiette, the mercury level should again be very close to the tap.
This 'sweeping' process is repeated twice more with helium, then all of the taps in 
the tritium tree, 1, 2, 3 and 4 are closed and the air is now evacuated fr om the mercury 
reservoir by opening tap 5. The line behind the tiitium tiee, leading to the reservoir, is 
then swept with helium as before and evacuated.
Taps 1, 2, 3 and 5 are now opened and left to evacuate for a ftuther 20 minutes. 
After this time taps 1, 2, 3 and 5 are closed and the liquid nitrogen removed fr om around 
the reaction vessel.
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The glass breakseal of tlie tritium ampoule is broken by the magnet contained in 
the side-arm at 2. Taps 2 and 4 are opened and a drop in the mercury level in the burette 
provides visual confirmation that tlie brealcseal has broken and tritium gas is being 
transferred into the burette. Tap 5 is opened and as the mercury flows to fill the vacuum 
in the reservoir it draws the tritium gas out of the ampoule and into the 250 cm^ bulb 
below the burette. Wlien the flow has ceased 2 and 4 should be closed. Tap 5 is now 
very CAREFULLY opened to the atmosphere, to prevent brealcage of the graduated tube. 
Once the pressmes have equilibrated the volume of tritium gas that has been transferred 
may be measured from the graduations on the burette. If insufficient tritium has been 
transferred, the process may be repeated.
The gas can now be transferred to the reaction mixtuie by opening taps 3 and 4. 
Because there is a vacuum in this region, the mercuiy level has a tendency to rush into 
the four way junction and reaction vessel. Hence, caie must be taken when transferring 
tlie gas. Tap 4 can be closed when the desired quantity of gas has been transferred over 
and the remaining gas can be safely stored in the burette for future use. The stirrer can 
now be switched on, A closed, the vacuum pump shut off (air bleed) and the dewar 
removed fiom the trap.
After the desired reaction time, helium may be introduced into the reaction 
vessel to ensure maximum incorporation of the tritium into the substrate. The helium is 
initially transferred from the round bottom flask into the burette as before, and then with 
taps 3 and 4 open and 5 open to the atmosphere the helium is transferred into the reaction 
vessel. Stirring is recommenced with taps 3, 4 and 5 open; the level in the buiette can 
then be monitored, to check if any further tritium gas is talcen up in the reaction.
After the desired time taps 3, 4 and 5 aie closed and the reaction vessel is re- 
fi-ozen in liquid nitrogen. Tap 5 is then open to the vacuum to evacuate the mercury 
reservoir. The tritiuni-helium mixture is transferred back into tlie buiette by opening taps 
3 and 4. When all of the tritium-helium gas has been transferred, taps 3, 4 and 5 are
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closed, the reaction vessel allowed to waim to room temperature and removed from the 
tritiation tree and the manifold shut down as described previously. The catalyst may now 
be filtered out and purification of the tritiated products carried out.
A summary of weights, reaction times and yields is given in Table 2.1. The 
reaction times for the dehalogenation of 3',5-dibromofblic acid (10, 40 minutes) and 
3',5'-dichloromethotrexate (11, overnight) reflect the relative reactivities of these 
halogens to hydrogenolysis (Freifelder, 1971). Deoxygenated solvents and nitrogen- 
flushed tanlcs (in the dark) were used thioughout to prevent decomposition of the light- 
sensitive compounds.
Chapter 2: Labelling of Ligands 40
oom
CNm On
VOCN
CN CNCN
cncn cn
(30
oo
00
cncn
Ou
m
mcn
ao
vd
•1
•S
>>II
i
g
p5
CNI
H
Chapter 2: Labelling of Ligands 41
2.2,2.3, Preparation o f [3 7,9-^H]Folic Acid (12)
3',5'-Dibromofolic acid (10, 5.0 mg, 0.078 mmol) and 5% palladium on calcium 
cai'bonate (10.2 mg) in 4% sodium hydroxide (0.5 cm^) were stirred for 40 minutes in 
the presence of tritium gas (2 Ci) on the tritium gas line. After this time, helium gas was 
allowed into the reaction vessel and the reaction mixtuie was stiiTed for a further ten 
minutes to ensure the maximum incorporation of tritium gas. The catalyst was 
immediately filtered out through a cotton wool/celite pad and the filtrate was adjusted to 
pH 7.0 ± 1.0 pH unit, using dilute HCl. The solution was then frozen in liquid nitrogen 
and lyophilised. The crude folic acid was taken up in distilled water (0.5 cm^) and any 
insoluble material was solubilised with 4% NaOH; the solution was then 
chromatographed for five horns on Whatmann 3MM clrromatography paper using 0.5% 
K2CO3 solution as the developing solvent. The folic acid band (Rf = 0.6) was identified 
by a marker (yellow in white light and UV absorbing) and by autoradiography. The folic 
acid band was extracted with warm water and its concentration in solution determined 
spectrophotometrically (&2S2 ^  25 100 M"^cm"l in 0.1 M NaOH), the solution was then 
lyophilised. The average radiochemical yield was about 50 rnCi and the estimated 
specific activity at this stage was 40 - 50 Ci/rnmol. The folic acid salt was ion- 
exchanged on a DEAE cellulose column (1x25 cm) to remove radiochemical impurities 
formed on storing the preparation (Zalcrzewski, 1966). The column was eluted with a 
lineal' gradient consisting of water (250 cm^) in the mixing flask and 2 M ammonium 
acetate, pH 6.9 (250 cm^) m the reservoir. The ultia-violet absorption of the effluent 
was monitored at 288 nm 26 OOOM"lcm"l in H2O (1): NH4OAC, 2M(1)).
Fractions of about 7 cm^ were collected witli an automated sample collector, the folic 
acid typically eluting between ftactions 49 - 59. The fractions were tested for 
radioactivity by taking 10 pL aliquots, pipetting into 5 cm^ of Unisolve E scintillant and 
counting. The ftactions containing folic acid were pooled and lyophilised until all the
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ammonium acetate was removed. The residue was dissolved in water and the content of 
folic acid was determined spectrophotometrically. The average yield was 30 mCi of 
folic acid (12) of specific radioactivity 32 Ci/mmol. The folic acid (12) obtained was 
purged with nitrogen, sealed and stored at -IS^C.
1h  NMR (D2 O, Figure 2.7(a)):- 5 8.6 (s, 1 H, H-7), 7.7 (d, 2 H, .78.5 Hz, H-2',6'), 6.8 
(d, 2 H, J8.5 Hz, H-3',-5'), 4.4 (q, 1 H, J4.5 Hz, a-CH), 4.2 (s, 2 H, H-9), 2.1 (m, 2 H,y- 
CH2), 2.0 (m, 2 H, P-CH2).
3 h  NMR (D2 O, Figure 2.7(b)):- 3 8.7 (s, 1 T, T-7), 6.9(s, 2 T, T-3',-5'), 4.5(s, 1 T, T-9). 
Radio-tlc (Figure 2.9):- 98.5% pure.
2,2 2 4, Preparation o f [7,9-^H]Folic Acid (13)
Folic acid (5b, 10.0 mg, 0.023 mmol) and 5% palladium on calcium carbonate 
(37 mg) in 4% NaOH (0.75 cm^) were stirred for 1.5 hours in the presence of tritium gas 
(2 Ci) on the tritium gas line. Helium gas was allowed into the reaction vessel and the 
reaction mixture stirred for a further one horn* to ensure maximum incorporation of the 
tritium gas. The folic acid was then extracted from the solution following the procedure 
described above. After the Whatmami 3MM cluomatography stage the average yield 
was about 60 mCi and the estimated specific activity was 10 - 2 0  Ci/mmol. The folic 
acid (13) was further purified as described earlier and the average yield was 15-20 mCi 
of folic acid (13) of specific radioactivity 5 Ci/mmol. The folic acid (13) obtained was 
purged with nitrogen, sealed and stored at -18°C.
1 r  NMR (D2 O, Figure 2.7(a)):- 8 8.6 (s. 1 H, H-7), 7.7 (d, 2 H, J8 .5  Hz, H-2',6’), 6.8 
(d, 2 H, /8 .5  Hz, H-3',-5'), 4.4 (q, 1 H, J4.5 Hz, a-CH), 4.2 (s, 2 H, H-9), 2.1 (m, 2 H, y- 
CH2), 2.0 (m, 2 H, P-CH2).
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3 h  NMR (D2 O, Figure 2.7(c)):- Ô 8.7 (s, 1 T, T-7), 4.6 (s, 1 T, T-9).
Radio-tlc:- 99.9% pure.
2,2,2.5, Preparation o f [3 ',5  ^7-^H]Methotrexate (14)
3',5'-Dichloromethotrexate (11, 6.5 mg, 0.012 mmol) and 5% palladimn on 
calcium carbonate (24.3 mg) in 4% NaOH (0.75 cm^) were stirred for 16 hours in the 
presence of tritium gas (2 Ci) on the tritium gas line. Helium gas was allowed into the 
reaction vessel and the reaction mixture was stirred for a further one horn* to ensure 
maximum incorporation of tritium gas. The methotrexate was then extracted from the 
solution following the procedure described previously. After the Wlratmann 3MM 
chromatography stage the average yield was about 40 mCi and estimated specific activity 
was 8 - 1 0  Ci/mmol. The methotrexate (14) was further purified as described earlier for 
folic acid (12) and the average yield was 5 - 1 0  mCi of methotrexate (14) of specific 
radioactivity 9 Ci/mmol. The methotrexate (14) typically elutes from the DEAE 
cellulose column in fractions 32 - 42. The methotrexate (14) obtained was pinged with 
nitrogen, sealed and stored at -18°C.
1 h  NMR (D2 O, Figure 2.8(a)):- 8 8.5 (s, 1 H, H-7), 7.7 (d, 2H , J  8.9 Hz, H-2',6'), 6.9 
(d, 2 H, J9 .0  Hz, H-3',-5'), 4.8 (s, 2 H, H-9), 4.2 (q, 1 H, J4 .6  Hz, a-CH), 3.1 (s, 3 H, - 
CH3). 2.2 (m, 2 H, y-CHg), 2.0 (m, 2H, p-CHj).
3 h  NMR (D2 O, Figure 2.8(b)):- 8 8.7 (s, 1 T, T-7), 7.0 (s, 2 T, T-3',-5').
Radio-tlc (Figure 2.10):- 96.8% pure.
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2.3. RESULTS
The results (Figures 2.7 to 2.10 and Table 2.2) indicate that [3',5',7,9-^H]folic 
acid (12) and [3',5',7-^H]methotrexate (14) have been prepared by the catalytic tritium- 
halogen replacement of the corresponding 3',5'-dibromofolic acid (10) and 3',5'- 
dichloromethotrexate (11), respectively. [7,9-^H]Folic acid (13) was prepared in 
solution by catalytic exchange of folic acid (5b) with tritium gas.
Figures 2.7 to 2.8 show the and NMR spectra of tlie labelled ligands. The 
signals in each case have been assigned from the corresponding spectrum. 
Tritimn incorporation and distribution data are given in Table 2.2 and the radio-tlc data 
for tritium labelled folic acid (13) and methotrexate (14) are given in Figiues 2.9 and 
2 . 10.
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HN-
CQjH
[3',5',7,9-3H]FoIicacid(12)
HN-
HN
[7,9-3H]Folic acid (13)
\ 3 '
OOjH
[3',5',7-3H]Methotrexate (14)
Figure 2.6. Structures of the tiitiated ligands
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HOD
2’,6'
ULA_
PPM
( a )  NMR specti um of Folic acid (5) in D2 O at 300 MHz
3',5'
— 1------------------ r5 4
PPM
(b ) ^H NMR spectrum (^H-decoupIed) of [3',5',7,9-^H]Folic acid (12) in D2 O
9 8 7 6 5 4 3
PPM
( c )  N M R  spectrum (^H-decoupIed) of [7,9-^H]Folic acid (13) in D2O
Figure 2.7. Proton and tritium NMR spectra of Folic acid
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 A.
HOD
CH3
PPM
(a ) NMR spectrum of Methotiexate (8) in D2 O at 300 MHz
(b) ^H NMR spectrum (^H-decoupled) of [3',5',7-^H]Methotrexate (14) in D2 O
Figure 2.8. Proton and tritium NMR spectra of Methotrexate
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Table 2.2. Patterns of Labelling, Relative Incorporation (%) and Radiochemical Purity (%) of the 
Ligands
Compound Chemical Position(s) Relative Purity by
(NM R Solvent) Shift Labelled Incorporation Radio-tlc
Ô (ppm) (%) (%)
[3',5',7,9-3H]Folate 8.50 7 32
(12) 6.74 3’, 5' 64 98.5
pH 7.6 4.44 9 4
(D aO
[7,9-3H]Folate (13) 8.57 7 42
pH 7.8 99.9
(D 2 O) 4.52 9 58
[3',5',7-3h ]-
Methotrexate (14) 8.66 7 57
pH 7.4 96,8
(D2 O) 6.98 3% 5' 43
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Figure 2.9. Radio-tlc of Folic Acid (13)
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Figure 2.10. Radio-tlc of Methotrexate (14)
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Figure 2.11. NMR spectrum of 3',5'-Dibromofolic acid (10) in D2 O at 300 MHz
Figure 2.12. NMR spectium of 3',5'-Dichloromethotrexate (11) in D2 O at 300 MHz
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2.4. DISCUSSION
2.4.1. Tritium NMR Spectra
The tritimn NMR spectra (Figmes 2.7(b) and 2.8(b)) show that catalytic 
halogen/tritium replacement in 3',5'-dibromofolic acid (10) and 3',5'- 
dichloromethotrexate (11) gave, in addition to the label at these sites a substantial 
amount of label at the 7-, and in the case of folic acid the 9-position, as expected. Steric 
hindrance of the N-10 methyl group to the binding of the methotrexate to the catalyst is 
the probable cause of the lack of label at the 9-position in this compound. That these 
positions aie catalytically labile is shown by the fact that catalytic exchange in solution 
with tritium gas of folic acid (5b) and methotrexate (8) introduces a label into these 'non­
specific' positions. Also, it has been suggested that the proportion of tritium in these 
general positions increases with respect to the specific positions with increasing time.
2.4.2. Variation of Catalyst
It has been reported that the use of different batches of catalyst leads to totally 
different patterns of labelling in folic acid and methotrexate (Lenlc, 1979). Figures 2.13, 
2.14 & 2.15 show the tritium NMR spectra of folic acid (12 and 13) and methotrexate 
(14) labelled by halogen replacement with a different batch of 5% palladium on calcium 
carbonate to that used in the main work. As might be predicted from a tritimn labelling 
procedme in which two different reactions occm* (i.e., hydrogen-tritimn exchange and 
halogen-tritimn replacement), the relative distribution of the tritimn label can vary 
greatly depending on the activity of the catalyst, time of reaction, etc. Table 2.3 shows 
the results obtained using different batches of 5% Pd/CaCOg and the effect on the
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distribution of the label in [3',5',7,9-^H]folic acid (12), [7,9-^H]folic acid (13) and 
[3',5',7-^H]methotrexate (14) with the reaction time being kept constant.
Table 2.3. Distribution of tr itium label as a function of catalyst batch
Batch Age of 5% Distribution of Label by Tritium 
No. Pd/CaCOg NMR Spectroscopy (%) 
(years) 3', 5' 7 9
Compound
[3',5',7,9-3H]Folic acid 
(12)
New batch 
1 
5
64
61
80
32
37
20
[7,9-3h ]FoUc acid 
(13)
New batch 
1 
5
42
56
95
58
44
5
[3',5',7-^H]Methotrexate 1 New batch 43
(14) 2 1 70
57
30
The tritium NMR spectra and the data detailed in Table 2.3. show that the 
greatest variation in incorporation of the label occurs at the 7- and 9-positions suggesting 
that these sites are very sensitive to changes in catalyst morphology. Heterogeneous 
catalysts are very ill-defined materials, the active sites often being associated with 
surface irregularities. A lai’ger molecule, such as folic acid has fewer degrees of freedom 
in adsorption onto these active sites which must have just the right geometry. Hence, 
when labelling folic acid (5b) and methotrexate (8) to liigh specific activities it is a wise 
precaution to ensure that the catalyst gives the desired labelling pattern. For the present
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Study the catalyst was chosen to give good incorporation into the 3',5'-positions (64%) 
whilst ensuring a reasonable quantity in the 7-position of [3',5',7,9-^H]fblic acid (12). 
This enabled the signals from the 3',5'- and 7-positions to be readily observed in the 
tritium NMR binding studies, whereas for [7,9-^H]folic acid (13) it was necessary to 
maintain a balance between incorporation into the 7- and 9-positions. As very little is 
laiown about the binding of the H-9 region, the ^H incorporation at this site needed to be 
higher than at the 7-position. This would ensuie a good signal to noise ratio in the ^H 
NMR spectrum of the enzyme-folate-NADP~^ complex, in this region of interest. For 
[3',5',7-^H]methotrexate (14) the area of interest is tlie benzoyl ring. Previous ^H NMR 
studies of methotrexate complexes with dihydrofolate reductase have never been able to 
detect signals for the 3',5'-protons for either Hie binary or ternary complexes, therefore 
maximum incorporation of the label into the 3',5'-positions was desirable to increase the 
chances of observing the tritium signals, if possible, in the ^H NMR spectrum. The 
maximimi level of incorporation into these positions with any batch of catalyst was 57%.
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Figure 2.13. NMR spectrum (%-decoupIed) of [3',5',7-^H]folic acid (12) prepared with 5% 
Pd/CaCO  ^(batch 3, five years old)
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Figure 2.14. NMR spectrum (^H-decoupled) of [7,9-^H]foIic acid (13) prepared with 5% Pd/CaCOg 
(batch 2 , one year old)
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Figure 2.15. NMR spectrum (^H-decoupled) of [3',5',7-^H]methotrexate (14) prepared with 5% 
Pd/CaCOg (batch 2, one year old)
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2.4.3. Decomposition of pH]Folic Acid
All radiochemicals are prone to decomposition - tritium compounds more so than 
carbon-14 (Evans, 1984). In order to assess the stability of a sample of [3',5',7,9- 
^H]folic acid (specific activity 30 Ci/mmol) under the conditions employed for storage 
of the DHFR-[^H]folate-NADP'^ complex betw^een overnight NMR experiments, the 
tritium NMR spectra of the sample were obtained after 2, 7 and 14 days (Figure 2.16). 
The sample was stored in a sealed NMR tube at +4°C. The NMR spectra show the 
appearance and growth of tln*ee new signals as the storage time increases. This suggests 
that decomposition has occurred via cleavage of the C-9, N-10 bond to give the pteridine
(15) and j?-aminobenzoylglutamic acid (16) moieties. The chemical shift of the 
postulated pteridine fragment (ô 8.95 ppm) compares favourably with that reported for 
the 7-tritium in [7-^H]pterin-6-car'boxylic acid (Lenk, 1979). The possible structures for 
the decomposition products are given in Figure 2.17.
OH
COjHHN
HjN
CO,H
Y = -D or -OD
Figure 2.17. Structures of possible decomposition products
The Y group arises from the solvent (D2O) addition to the appropriate radical 
produced by radiation-induced bond cleavage.
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(a) After two days
(b) After seven days
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(c) After 14 days
Figure 2.16. NMR spectra (%-decoupIed) of [3',5',7,9-^H]FoIate (12) in D2 O obtained following 
storage at 4°C for (a) two days, (b) seven days & (c) 14 days.
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Figure 2.18. Radioactivity profile of [3',5',7,9-^H]folate (12) from an analytical column of DEAE- 
cellulose. Decomposition products formed on storing at 4°C for 14 days.
hi
Fractions from DEAE-Cellulose Column
In order to assist in the determination of the tritiated contaminants present in the 
14 day old sample of folic acid (12), analytical column chromatography was carried 
out. The DEAE-cellulose column was prepared in the same way as previously described. 
Elution was accomplished with a linear gradient of 250 cm^ of water in the mixing flask 
and 250 cm^ of 2M ammonium acetate (pH 6.9) in the reservoir. Fractions of 7 cm^ 
were collected at a flow rate of 0.8 cm^/min. Figure 2.18. shows the radioactivity profile 
of the fractions as they emerged from the column. 10 pL Aliquots of the eluent were 
added to 4 cm^ portions of Unisolve E liquid scintillant and counted. Three radioactivity 
peaks are noted. The folic acid peak (peak 1) is known to elute from the column in 
fractions 45 - 55, while labelled decomposition products were present in fractions 20 - 22 
(peak 111) and 27 - 29 (peak 11). The latter components comprised 4.8 and 9.4% 
respectively. It is thought that peak 11 corresponds to tritiated p-aminobenzoylglutamic 
acid (16) as identified by Zakrzewski et al. (1970) and peak 111 could be due to the other 
postulated decomposition product, [7-^H]pterin-6-carboxylic acid (15) (Zakrzewski, 
1966). In this particular case, decomposition has been accelerated by the relatively high 
specific activity of the sample (30 Ci/mmol) and the storage temperature (+4°C).
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2.5. CONCLUSIONS
Heterogeneous exchange labelling methods aie often regarded as irreproducible 
and this may be as a result of the variety of destructive teclmiques formally used for 
analysis of the reaction products. It is cleai* that the direct observation of labelled 
positions thi'ough the application of tritimn NMR spectroscopy is a much more 
satisfactory approach (Evans et a l, 1985; Jaiswal et al, 1992).
It has been shown by tritium NMR spectroscopy that folic acid (5b) and 
methotrexate (8) can be selectively labelled with tritium. Through careful choice of 
experimental procedure and catalyst batch, it has been possible to incorporate tritium 
labels into positions in the ligands pertinent to studies of the binding in ligand-DHFR 
complexes. Prepamtion of [3',5',7,9-^H]folic acid (12) and [3',5',7-^H]methotrexate (14) 
was achieved by catalytic halogen/tritimn replacement in 3',5'-dibromofolic acid (10) and 
3 ',5'-dichloromethotrexate (11), respectively, and incorporation of the label into the 7- 
and 9-positions exclusively of folic acid (13) was achieved by catalytic H2/T2 exchange 
of folic acid (5b) in solution with tritium gas. The present results compare favourably 
with previous work (Evans et a l, 1979), even tliough some of the experimental 
procedures have been modified.
For the present work, it was important to achieve selective labelling of the ligand 
chosen. For methotrexate (8), labelling was needed at the pteridine H-7 and benzoyl 
3',5'-positions. Although 'ring flipping' of the benzoyl ring has been characterised in the 
enzyme complex with 3',5'-difluoromethotrexate, it has proved impossible to obtain 
similai* information for the parent compound because the 2',3',5' & 6' proton signals of 
bomid methotrexate have never been detected directly in ^H spectia (this results from a 
combination of broad methotrexate ^H signals and the presence of overlapping protein 
signals). The tritium labelled compound offers a means of directly observing nuclei at 
these positions and of studying their line shape changes as a function of temperature
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without the usual interference from overlappmg signals. Such measuiements will allow 
the measmement of the rate of ring-flipping of the benzoyl ring within the protein-ligand 
complex. The chemical shifts of the benzoyl ring protons of bound methotrexate will 
aid in assessing whetlier or not the ring is occupying the same binding site as does the 
benzoyl ring of folate where the chemical shift datam already loiown for the benzoyl 
ring protons in the bound ligand.
Folate (5) has been labelled at the same positions as those for methotrexate (8) 
and a parallel set of NMR experiments will be canied out aimed at the problems outlined 
above. The results will provide the basis for interesting structural comparisons between 
the substrate and inhibitor binary and ternary complexes.
In order to monitor the multiple conformations (seen in slow exchange) for the 
DHFR-folate-NADP"^ complex by tritium NMR, folic acid has been labelled m the 3'-,5'- 
,7-positions and 7-,9-positions. Selective labelling of [7,9-^H]folic acid (13) will allow 
the binding of the H-9 region to be studied, as very little information is available on this 
ar ea of the molecule, fr om previous studies.
The results presented in this chapter clearly show that the pattern of labelling 
obtained is crucially dependent upon the batch of catalyst employed in the labelling 
procedure. Hence, care must be talcen to ensuie that the catalyst chosen gives the desired 
labelling patterns for the relevant studies, as discussed previously for folate and 
methotrexate.
Fur thermore, when undeitalcing the ^H NMR binding studies, the decomposition 
of ^H-folic acid must be considered. The DHFR-pHJ-folate-NADP"^ samples will be 
stored in D2O, in a sealed NMR tube at 4®C, during the day prior to pH change and the 
series of NMR experiments over consecutive nights. The ^H NMR results shown in 
Figme 2.16 indicate that [3',5',7,9-^H]folate (12) undergoes decomposition over a period 
of 14 days, when stored at 4°C in a sealed NMR tube. It will be important to note the 
positions, in the NMR spectrum, of the signals ar ising from the decomposition products.
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to ensure that these signals are not confused with those resulting form the different 
conformations observed for bound ^H-folate in tlie DHFR-[3',5',7,9-^H]folate-NADP"^ 
ternary complex.
Clearly tritium NMR spectroscopy provides a relatively cheap and convenient 
teclmique not only of determining the proportion of tritium in the labelled positions, but 
is also an excellent method for monitoring decomposition of the labelled ligands.
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3. TRITIUM NMR STUDIES OF FOLATE AND 
METHOTREXATE BINDING TO LACTOBACILLUS 
C 4 œ / DIHYDROFOLATE REDUCTASE
3.1. INTRODUCTION
The enzyme dihydrofolate reductase (DHFR) has become a well-established 
target for drug action since it was identified about 30 yeai's ago. Clinically useful drugs 
whose activity originates from DHFR inliibition include the antibacterial agent 
trimethoprim (9), and methotrexate (MTX, 8) which has extensive use as an 
antineoplastic agent. The pharmacological importance of DHFR together with its 
conveniently small size (M^ 18 - 25 000 in most species) has led to intensive studies of 
the enzyme over the last 10-15 years.
The literature covering DHFR-related research is extensive and there have been a 
number of excellent reviews (Blakley, 1984; Champness et a l, 1986; Kraut & Matthews, 
1987) recently published. Considerable effort has gone into structural studies involving 
the enzyme from various sources and high-resolution crystal structures have been 
determined for DHFR from Lactobacillus casei {L. casei) and other organisms in a 
number of ligand complexes (Matthews et al, 1978; Baker et a l, 1983; Bolin et a l, 
1982; Filrnan et a l, 1982). In the NMR spectrum, a substantial number of the ^H 
resonances of Z. casei DHFR have been assigned (Hammond et a l, 1986; Carr et a l, 
1991; Soteriou et a l, 1993), and in addition resonances of bound ligands have been used 
to characterise their modes of binding (Birdsall et ah, 1982, 1983; Feeney et a l, 1983, 
1991; Cheung et a l, 1993). A nimiber of studies of DHFR by site-directed mutagenesis 
have been reported (Birdsall et a l, 1989a; Andrews et a l, 1991), while an enormous 
range of DHFR inliibitors has been synthesised over the last 40 years (Roth & Cheng, 
1982). This considerable background of information has helped provide an improved
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imderstaiiding of the factors which control the specificity of ligand binding and hence, 
the insight necessary for the rational design of novel ligands.
Much of the work has been directed at defining the conformations of the bound 
inhibitors and in characterising specific interactions between the ligands and the protein. 
The techniques available for addressing these questions; mutagenesis, NMR and kinetic 
studies of the protein are all well developed and documented. The information and 
understanding available thus make this an ideal system in which to investigate the 
molecular basis of the specificity of protein-ligand interactions.
The aim of this chapter is to present information relating to substrate, inhibitor 
and coenzyme binding to L  casei DHFR, with particular regard to using selectively 
tritiated ligands in conjunction with tritium NMR spectroscopy. Firstly, the relevant 
background information is reviewed. This is followed by ^H NMR studies of [3',5',7- 
3H]folate, [7,9-^H]folate and [3',5',7-^H]methotrexate binding to L  casei DHFR, with 
NADP"'~ and NADPH as coenzyme. These experiments were conducted as a function of 
pH and temperature. Finally, the results are explained in relation to understanding the 
molecular factors controlling the specificity of ligand binding which involves (i) 
characterising the specific interactions between groups on the ligand and protein, (ii) 
characterising the conformational changes accompanying ligand binding, (iii) measuring 
the conformational equilibria in the various complexes and (iv) monitoring the changes 
in intramolecular dynamic processes.
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3.2. BACKGROUND INFORMATION ON DHFR
3.2.1. Role in Cellular Metabolism
Dihydrofolate reductase is a widely distributed enzyme which catalyses the 
reduction of 7,8-dihydrofolate (FH2, 6) to 5,6,7,8-tetrahydrofolate (FH4, 7) using 
nicotinamide adenine dinucleotide phosphate (NADPH, 17) as the coenzyme, as follows:
NADPH + H+ + H2folate NADP+ + H^folate
The enzyme from some sour ces, also catalyses a much slower reduction of folate (5):
2NADPH + 2H+ + folate -> 2NADP+ + H^folate
The product of this reduction, tetrahydrofolate is used in a number of important 
biosynthetic pathways, in which it takes part in a shuttle mechanism, alternately 
accepting and donating various one-carbon functionalities (Hitchings, 1983). For 
example, in the biosynthesis of methionine, homocysteine is methylated using the methyl 
group of 10-rnethylFH4.
H. H °
1
NH2
O' O'
r '" " ^ o - 1 1 —p—0—p —'II II0 0
^OH
NH2
HO  HO OI0 = P —o  1O'
NADPH (17)
Figure 3.1. Schematic representation of NADPH
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The fate of FH4 is different in the biosynthesis o f thymidylate as shown in Figure
3.2. The 5,10-methylene derivative of FH4 acts as a cofactor for thymidylate synthase in 
its méthylation of deoxyuridylate. The methyl group of thymidylate is formed from the 
5,10-methylene moiety of the cofactor, along with the hydrogen at C-6, FH2 being 
produced in the process. This enzyme is unique in that it represents the sole de novo 
path for thymidylate synthesis and is the only enzyme that uses a cofactor in which the 
H^fblate is oxidised during one-carbon transfer. Thymidylate is an essential building 
block for DNA. Inhibition of DHFR can thus lead to disruption of DNA synthesis and 
death in rapidly proliferating cells. This property has made DHFR such an important 
clinical target, especially in the treatment of certain bacterial infections and cancers.
Inhbftort
NADP*
HNR
NADPH.H*
HNR DHFR
ThymktytateSynthaM
CHj— NR
OjPOHjC o
5,10-Methyteno FH4
S«dna
Serine Hydraxymethyteoa transferase
Gtydne
Figure 3.2. Schematic representation of the role of dihydrofolate reductase in the biosynthesis of 
thymidylate
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3.2.2. Structural Studies
The structui'e of DHFR isolated from vaiious sources has been the subject of such 
intensive study over the last 20 years that DHFR is rapidly becoming one of the best 
imderstood enzyme structures. Many tools have been used in elucidating the structure of 
DHFR, with the greatest advances in insight resulting form X-ray crystallography, 
sequencing, and more recently, NMR studies.
3.2.2,L X-Ray Crystallographic Studies
3 .2 .21 .1 . Primary Sequence o f DHFR
The amino acid sequences of many different species of DHFR are known 
(Champness et al.y 1986); a representative set is shown in Table 3.1. It can be seen that 
there is greater homology between DHFRs fi*om vertebrate sources (75 - 90%) than 
between bacterial DHFRs (25 - 40%). The similarity between animal and bacterial 
DHFR is 20 - 30% and enzyme from animals is generally about 25 residues longer than 
tlie bacterial proteins.
Crystallographic studies (Freisheim & Matthews, 1984) of the enzyme 
architecture have revealed a conservation of three dimensional structure far more 
pronounced than the extent of residue identity between amino acid sequences. Kr aut and 
Matthews (1987) have shown that in all cases the substrate binding cleft is highly 
conserved: linear alignment of DHFR fr om 11 different sources shows that 12 residues 
are strictly conserved, and each of them is located in or near the active site. It would 
appear' that the insertion/deletion differences between the enzymes have little effect on 
the overall geometry of their structure.
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3.2.2.I.2. Three Dimensional Structure
The first X-ray diffraction investigation of DHFR was cai'ried out on crystals of 
the Escherichia coli (& coli) enzyme complexed with MTX (Matthews et a l, 1977); this 
was followed shortly by a study of the ternary complex of L. casei DHFR containing 
boimd NADFH and MTX (Matthews et al y 1978, 1979). The structui es originally 
deduced have subsequently been refined against 1.7 Â diffraction data (Bolin et al, 
1982; Filman et a l, 1982). A schematic representation of the polypeptide backbone 
folding for the L. casei DHFR-methotrexate-NADPH ternary complex is shown in Figure
3.3, The dominant feature of the DHFR structure is a central eight-stranded (3-sheet 
flanlced on either side by alpha helices. These strands have been designated by Matthews 
et al. as pA to pH, pA being nearest the amino terminus and pH nearest the carboxyl 
terminus, the alpha helices are assigned aB, aC, aE, aF, the letter designating the P- 
strand that follows the a-helix in the primary sequence The remainder of the residues 
consist of loops, some quite large, that join the elements of secondary structure.
The enzyme smface is marked by a large cavity, 15 Â deep, cutting across one 
face, between the B and C helices. This cavity is larown to be the active site of binding 
and is lined by hydrophobic side chains, indicating the importance of hydrophobic and 
van der Waals interactions in the binding of substrates arrd inliibitors. The only polar 
side chain in this cavity is Asp-26, which has been shown by mutagenesis experiments 
(Jimenez et a l, 1989) to participate in inliibitor and substrate bindirrg. The cofactor, 
NADPH, occupies the lower half of the active site, with its nicotinamide ring presumably 
positioned for hydride transfer to FH2 in the catalysed reductiorr (Filman et al., 1982). In 
its extended conformation, the cofactor is bound with the diphosphate bridge between the 
N-termini of helices C and F near the lower edge of the p-sheet and with the adenosine 
moiety on the opposite side of the sheet.
Chapters: Tritium NMR Binding Studies 71
/3A / ^ N
Figure 3.3. Backbone ribbon drawing of L  casei DHFR-methotrexate-NADPH ternary complex. 13- 
Strands (represented by aiTOws) and a-heiices are labelled. The approximate position of every tenth 
residue is indicated (Bolin et aL^  1982)
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Methotrexate is bound in the upper part of the cleft in much the same manner 
reported for folic acid (Oefher et a l, 1988). This is not surprising considering that 
methotrexate is a close structural analogue of folic acid. The p-aminobenzoylglutamate 
portions of the two ligands interact similarly with DHFR, and the pteridine ring system 
of each compound binds in the same region of the protein. However, the pteridine rings 
are flipped approximately 180° about the C-2 to 2-amino bond witli respect to one 
another (Bolin et a l, 1982; Charlton et a l, 1985). The differences in capability of the 
two ligands (4-oxo vs 4-amino) for hydrogen-bonding is thought to explain these 
differences in their modes of binding, coupled with the observation that, unlike folate or 
FH2, the N-1 atom of methotrexate is protonated in its complex with DHFR and can 
interact ionically with an active site carboxyl group e.g., a side chain from an aspartate or 
a glutamate.
X-Ray crystallographic data (Filman et a l, 1982) indicate that methotrexate binds 
to bacterial enzymes in an open conformation with the pteridine ring nearly 
perpendicular to tlie aromatic ring of its /?-aminobenzoyl group: the overall conformation 
is similar in both the binary and ternary complexes (Matthews et a l, 1978). The 
pyrimidine edge of the pteridine ring is deeply buried in the active site cavity, but the p- 
aminobenzoylglutamate side chain extends out of the cavity to the surface, and the 
glutamate moiety is draped across aB. The a-carboxylate is positioned to interact 
ionically with an invariant arginine residue, Arg-57, through a pair of hydrogen bonds. 
In die L. casei enzyme the inhibitor's y-cai'boxylate is within hydrogen bonding distance 
of His-28 (Bolin et al, 1982), and nuclear magnetic resonance data are consistent with 
this interaction (Antonjuk et a l, 1984).
The pteridine ring of methotrexate makes extensive non polar contacts with 
protein backbone and side chain atoms of pA, the loop pA aB, and aB. In the L  
casei DHFR-MTX-NADPH ternary complex (Figure 3.4.) additional van der Waals 
contact with the pteridine ring are made by the side chain of Leu-19 and the nicotinamide
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ring of NADPH, which lie against the face of the pteridine ring adjoining the 
nicotinamide binding site. These additional contacts between MTX and the nicotinamide 
moiety in the ternary complex, together with the accompanying desolvation of the 
pteridine ring due to NADPH binding could explain the co-operative effects that NADPH 
and MTX have on each other's binding. However, conformational changes in the 
enzyme structure, accompanying ligand binding may also contribute.
Arg 31A rg 5 7
H.s 28  
•PKe 30
J A sp 2 6'',.L eu 2 7  /Leu 54
Ala 97
Phe 49
NADPH
(behind) Leu 19
Figure 3.4. Schematic diagram showing the binding of MTX to L  casei DHFR in the ternaiy complex 
(Hitchings and Roth, 1980).
The pteridine ring of MTX is protonated at N-1 (Cocco et ah, 1983) and forms an 
ionic bond with the carboxyl group of Asp-26. The carboxyl group is nearly coplanar 
with the pteridine ring and this interaction is mediated through hydrogen bonds donated 
by the N-1 hydrogen and a hydrogen of the 2-amino group. The second hydrogen of the 
2-amino group associates with a fixed water molecule, which in turn is hydrogen bonded 
to the side chain hydroxyl of Tlir-116. This threonine is strictly conserved in all species 
of DHFR, and the bridging water molecule has also been observed in every refined 
DHFR structure studied to date. Therefore, it is a reasonable assumption that this 
interaction is an important structural component for substrate binding. Besides N-1, the
Chapter 3: Tritium NMR Binding Studies 74
only other endocyclic ring nitrogen involved in hydrogen bonding is N-8. There is a 
structurally conserved fixed water molecule, water-253, 3.3 Â fiom N-8, lying directly in 
line with its lone pair orbital. In turn, this water molecule is hydiogen bonded to Asp-26, 
Trp-21 and to another fixed water molecule. The 4-amino group of methotrexate is 
hydrogen bonded to backbone carbonyl oxygens of Leu-4 and Ala-97 (Bolin et al, 
1982).
3,2,2,2. Nuclear Magnetic Resonance Studies
The power of NMR spectroscopy as a tool for the study of protein-ligand 
interactions arises first from the fact that the spectrum contains at least one signal fiom 
each amino acid residue in the protein, and secondly fiom the considerable sensitivity of 
the spectral parameters, such as chemical shift, to molecular interactions and 
conformation. However, there are some disadvantages of using this particular teclmique. 
The proton NMR spectra from the protein are very complex because of the many atoms 
involved, and it is usually difficult to resolve the resonances of more than a small 
fiaction of the amino acid residues, though this problem can be paitially overcome by 
various methods of spectral simplification, notably selective deuteration. While X-ray 
crystallographic studies, as discussed previously, provide very detailed structural 
information they do require the samples to be studied as crystals. NMR has the 
advantage that it examines the complexes in solution and does not require crystals. 
However, the availability of X-ray structural data on some complexes is often crucial for 
achieving a detailed interpretation of the NMR data obtained either on the same or on 
related complexes for which no X-ray structural data are yet available. In addition to the 
studies aimed at understanding the specificity of ligand binding, there have been several 
efforts (Howell et al., 1986; Andrews et a l, 1989) to determine the details of the enzyme 
mechanism, the understanding of which is still not complete.
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Feeney and co-workers (Way et al, 1975; Feeney et a l, 1981; Birdsall et al, 
1982, 1987; Clore et a l, 1984; Charbon et a l, 1985; Searle et a l, 1986; Cheung et a l, 
1993) have employed NMR spectroscopy extensively to study complexes of L. casei 
DHFR with various substrates and inhibitors in order to obtain detailed information 
about the protein-ligand binding in these complexes. Such investigations contribute to 
the understanding of both binding specificity and catalytic mechanism by providing 
information about individual interactions between groups on the ligand and on the 
protein and by characterising the conformational changes in the ligand and protein which 
accompany ligand binding. For complexes where multiconformational forms are present, 
the conformational equilibria in these complexes may be measured and changes in intra- 
and inter-molecular- dynamic processes observed on complex formation (such as rates of 
flipping in boimd inliibitors e.g., methotrexate (Clore et al., 1984) and trimethoprim 
(Cheung et a l, 1986)) can then be defined.
Because of the rapid developments in methods of assigning resonances in 
complex protein spectra and in methods of interpreting NOB data in structural terms it 
seems likely that NMR will become increasingly used for providing detailed 
conformational information in the solution state.
3.2.2.2.1, Assignment o f Protein Signals
In order to obtain detailed information from NMR spectra of protein complexes it 
is first necessary to make specific resonance assignments for the ligand and protein 
signals. Ligand resonance assigmnents are relatively easy to achieve either directly by 
using selective isotopic labelling (l^C, l^N or ^H) (Way et aL, 1975; Cheung et al., 
1993) or indirectly fi’om transfer of saturation or 2D exchange experiments which 
comiect signals in bound and hee ligand species (Hyde et al, 1980 a, b).
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Until recently it was much more difficult to obtain protein resonance assignments 
for moderately sized proteins. Early assigmnent studies on L  casei DHFR relied on 
correlating X-ray structural data with NOE data from protons in close proximity, thus 
assuming that the crystal and solution conformations are similar. Birdsall et al. (1977a) 
showed that it was possible to resolve the C-2 peaks of the histidine imidazole rings in 
DHFR, by ^H NMR spectroscopy at 100 MHz, and the effects of pH and the binding of 
substrates and inhibitors on the chemical shifts of the C-2 protons were reported. It was 
shown that the C-2 proton resonances of four of the histidine residues were perturbed by 
the binding of substrates or inhibitors. Matthews (1979) proposed assigmnents for the 
six histidine residues observed by Birdsall and colleagues (1977a), based on the tliree- 
dimensional structure of the ternary complex (Matthews et a l, 1978, 1979) and the 
chemical shift changes produced by the formation of the binary substrate or inliibitor 
complexes (Birdsall et a l, 1977a). Subsequent determination of the amino acid sequence 
of the enzyme (Freisheim et a l, 1978) showed that it contained seven histidine residues 
and later NMR studies at 270 MHz (Wyeth et a l, 1980) described the identification of 
the seventh resonance at very low field in the enzyme-methotrexate and enzyme- 
trimethoprim complexes.
In order to examine other aromatic residues it was necessaiy to resort to isotopic 
incorporation experiments to allow the signals for the individual amino acids to be 
resolved. For example, London and co-workers (1979) incorporated [y-^^CJtryptophan 
into dihydrofolate reductase fiom Streptococcus faecium and detected the l^C 
resonances fiom tryptophans in the labelled enzyme. Several workers (Kimber et a l, 
1978; Feeney et al, 1980; Searle et a l, 1986) have shown how protein ^H NMR spectra 
can be simplified by selective deuteration, and this method has been used to study the 
five tyrosine residues in L. casei DHFR (Feeney et al., 1977a).
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F igure 3.5. A comparison of the aromatic region of the 270 MHz NMR spectra of normalL. casei 
DHFR (top), and of a selectively deuterated analogue (bottom), in which the only remaining aromatic 
protons are those in the 2- and 6-positions of the five tyrosine residues (Feeney et a l, 1977a).
Ill this study, a selectively deuterated enzyme containing deuterated 
phenylalanine, tryptophan and histidine and [3,5-^H2]tyrosine gave a NMR spectrum 
in which the only signals in the ar omatic region were those of the 2,6-protons of the five 
tyrosine residues, and the effects of ligand binding on individual tyrosines were then 
studied in detail. As shown in Figure 3.5., replacement of all the aromatic protons except 
the 2,6-protons of the tyrosine residues in DHFR, leads to a dramatic simplification of 
the aromatic region of the NMR spectrum. The overlapping absorption bands of 91 
aromatic protons aie now reduced to resonances from 10 protons (two from each tyrosine 
residue).
In subsequent work, Feeney et al (1980a) reported how tryptophan residues 
could be monitored in a similar manner by examining a sample of dihydrofolate 
reductase in which all the aromatic protons except the C-2 protons of tryptophan were 
replaced by deuterium; this enabled the signals from the four tryptophan residues to be 
detected directly.
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Another approach leading to the resolution of resonances from individual amino 
acid residues is to introduce a fluorine atom (^^F) into the system as an NMR probe, 
either by using fluorine containing ligands or by the incorporation of fluorine labelled 
amino acids into the protein (Kimber et al., 1977). Feeney and co-workers characterised 
the effects of ligand binding on individual tyrosine and tryptophan residues in the protein 
by measui'ing the ^^F spectra at 94.1 MHz of L. casei DHFR containing either 3- 
fluorotyrosine or 6-fluorotryptophan (Kimber et al, 1978). Although this procedure 
provided a convenient and sensitive method for monitoring the effects of ligand binding 
on tryptophan and tyrosine residues, there was always the possibility that the 
introduction of fluorinated residues could perturb the enzyme structure and its 
interactions with the ligands. Moreover, the selective deuteration approach has the 
important advantage that it is unlikely to cause any problems of this type.
More recent studies have taken advantage of the increasingly powerful NMR 
spectrometers available. Hammond and co-workers (1986) studied Lactobacillus casei 
dihydrofolate reductase in solution by one- and two-dimensional ^H NMR spectroscopy 
at 500 MHz. By using a combination of NMR methods in conjunction with the refined 
crystal structure of the enzyme-methotrexate-NADPH complex (Bolin et a l, 1982; 
Filman et al., 1982), resonances were assigned for 32 of the 162 residues of the enzyme. 
These were widely distributed through the structure of the protein and included all the 
histidine and tyrosine residues, as well as several valine, leucine, isoleucine and 
phenylalanine residues. The general procedure adopted by Hammond and co-workers for 
making Ipl NMR resonance assigmnents consisted of three stages. First, resonances 
comiected by spin-spin coupling (and hence arising û'orn the same residue) were 
identified by spin-decoupling or COSY experiments. In some cases it was possible to 
identify the type of residue using the pattern of spin-spin comiectivities, although 
selective deuteration (Birdsall et a l, 1984) was used to provide unambiguous 
identification. Secondly, the resonances from protons that were close together in space
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(within about 5 Â) were identified by one- and two-dimensional nucleai- Overhauser 
enhancement (NOE) experiments. Selective deuteration again proved valuable in 
ensuring the necessaiy selectivity, paidiculaily in the one-dimensional experiments 
(Birdsall et a l, 1984). Finally, the crystal structure was searched for assignments 
consistent with all data. For resonances having chemical shifts substantially different 
fi-om the "random coil" values, calculations fr om the crystal structure of the effects of the 
magnetic anisotropy of aromatic rings on the chemical shifts were used as an additional 
coirstraint on possible assignments. Both the NOE-derived proximity relationships and 
the "ring curTent" shift calculations were used only in a semi-quantitative way, in view of 
the limitations to the precision of the NOE measurements and the accuracy of the shift 
calculations.
Lactobacillus casei DHFR has 24 aromatic residues (seven His, five Tyr, eight 
Phe and four Trp). At least four of these (His-28, Phe-30, Phe-49 and Trp-21) are 
directly involved in the active site and others, such as His-22 are nearby. As a follow up 
to their previous studies, the Mill Hill group reported the complete assignment of the 
resonances of these residues for the L. casei DHFR-rnethotrexate complex (Birdsall et 
a l, 1990), using a combination of selective deuteration and 2D-NMR teclmiques at 600 
MHz, similar to those previously employed. These methods relied upon the assumption 
that the crystal and solution structures are similar. At that time, the sequential 
assignment method, which is based on correlating NOE data with sequence information 
(Wutlrrich, 1986) could not easily be applied to proteins the size of DHFR (162 residues) 
due to severe ^H chemical degeneracy.
The introduction of methods involving l^N and isotope editing of ^H 
spectra provided new possibilities for assigning ^H spectra of larger proteins. Over the 
last few year's several relayed 2D and 3D l^N/^H and l^C/^H NMR experiments have 
been developed and proved to be useful for assigning ^H spectra of isotopically labelled 
proteins comparable in size to DHFR (Driscoll et al, 1990). These 3D heteronuclear’
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NMR teclmiques have been applied to L. casei dihydi'ofolate reductase, in order to malce 
sequential ^H, l^N and resonance assignments for most of the protein residues 
(Frenldel et a l, 1990; CaiT et al., 1991, Soteriou et a l, 1993). A uniformly ^^N-labelled 
sample of L. casei DHFR was prepared and subjected to NOESY-FIMQC and 
HOHAHA-HMQC 3D experiments (HMQC is a heteronuclear multiple quantmn 
coherence experiment which detects protons directly bonded to l^N and characterises 
them by their appropriate l^N chemical shift). These experiments gave the NOES Y and 
HOHAHA crosspealcs involving the relevant NH protons edited in slices according to the 
l^N chemical shifts of each particular- amide nitrogen (Carr et a l, 1991).
By applying these various methods to the DHFR-MTX complex backbone 
resonance assigmnents were obtained for 147 of the 162 residues in DHFR and side- 
chain assigmnents for more than 80 residues (Carr et al., 1991). Later experiments using 
HCCH-COSY and HCCH-TOCSY methods on a l^N/^^C labelled sample of Z. casei 
DHFR gave essentially all the back-bone and side chain assigmnents (Soteriou et al, 
1993). It was revealed, by an analysis of the data (NOE patterns and non-exchanging 
NH protons) that the p-sheet and most of the helical secondary structure seen in the 
crystal is essentially retained intact in solution. It was also shown that assignments made 
previously using the crystal structme/NOE data correlation method were all in agreement 
with those obtained using the sequential assignment method. Sequence-specific 
assignments for the y-, ô- and ô'- protons of the 13 leucine residues in DHFR-MTX were 
obtained by correlating NOE and crystal structme data (Hammond et a l, 1986; Carr et 
a l, 1991). In addition, this approach was used to make stereospecifrc assignments for 
the methyl resonances from 12 of tlie 13 leucine residues (confirmed later by examining 
selectively deuterated DHFR incorporating (26",4jR)[5,5,5-^H3]leucine (Ostler et a l, 
1993)). Soteriou and coworkers (1993) confirmed all these previous leucine 
assignments, using solely protein-sequence data and the highly sensitive NMR 
techniques of 3D I^ c /Ih  HCCH-COSY and HCCH-TOCSY with a uniformly 13c/15n
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labelled DHFR-MTX sample. It was observed that since the original leucine 
assignments, including the stereospecifrc assignments for the methyls, were dependent 
upon networks of long-range interr esidue NOEs, tlie agreement indicated that tlie overall 
tertiary structure of L. casei DHFR must be similar in solution and in the crystal state.
Comparison of the leucine residue assignments obtained from the crystal-based 
method with those from the sequential assignment method indicates that as well as the p- 
sheet and most of the helical secondary structure, the tertiary structur'e is also retained. 
In addition, inter-residue NOEs involving many other assigned side-chain protons 
(particularly aromatic resonances (Birdsall et al, 1990)) also confirm the observation 
that the crystal and solution structur es are universally similar*.
The assigned signals have been used as reporter groups to provide information on 
conformational changes in several complexes formed by substrate analogues binding to 
wild-type and mutant dihydrofolate reductases (Hammond et a l, 1986).
3.2.2.2.2. Assignment o f Ligand signals
For weakly binding ligands which show fast exchange behaviom* on the NMR 
chemical shift time scale, there is no problem with signal assigmnent. As increasing 
amounts of the ligand are added to the protein solution, the ligand signals (which are 
averaged signals from the free and bound ligand signals) appear in the spectrum with 
increasing intensities and shift progressively towards the chemical shifts of the free 
ligand. A detailed analysis of the binding curve obtained by plotting the observed 
averaged chemical shifts for the ligand signal against the ligand concentration yields the 
bound and free chemical shifts and the binding constant. NMR signals from nuclei in 
fragments of methotrexate and trimethoprim such as p-aminobenzoyl-L-glutamic acid 
and 2,4-diaminopyrimidine are usually in fast exchange (Birdsall et a l, 1980).
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For tightly bound ligands such as methotrexate and trimethoprim, slow exchange 
behaviour is observed and separate signals are detected for free and bound ligands. In 
these cases the assignments can be made directly by using analogues containing selective 
isotopic substituents (^H, or ^^N): the differences in the NMR spectra of the 
complexes formed with normal and isotopically labelled ligands can be used to locate the 
positions of the bound ligand signals (Cheung et al, 1986, 1993).
Transfer of saturation measuiements have been used to comiect signals from 
bound and free ligands in spectra from complexes showing slow exchange behaviour if 
they have sufficiently rapid dissociation rates (> 1 sec"l) to allow the transfer of 
saturation to compete favomably with relaxation mechanisms (Way et al., 1975; Hyde et 
al., 1980a; Clore et a l, 1981).
Studies of bound ligands have been shown to be pai'ticularly useful in monitoring 
ionisation states (Birdsall et al., 1977b; Feeney et al., 1977b; Cheung et al., 1993), 
multiple conformations (Gronenborn et al., 1981; Birdsall et al., 1982; 1987) and 
dynamic processes within the binding site of the complex (Clore et al., 1984; Cheung et 
a/., 1986; Searle ef a/., 1988).
3.2.3. The Binding of Ligands to Dihydrofolate Reductase
3.2.3.1. Measuring Ionisation States
X-Ray diffraction has provided detailed information on the conformation of 
bound inhibitors and these have been discussed in detail in section 3.2.2. The X-ray data 
of Matthews et al (1978) for the structm e of the ternaiy complex of L. casei DHFR with 
NADPH and methotrexate cleaiiy indicated the existence of interaction between the N-1 
of MTX with the side-chain carboxyl of Asp-26. Exactly the same interaction was also 
observed in the binary complex of E. coli DHFR with MTX (Matthews et a l, 1977).
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These results strongly suggest interaction of the protonated N-1 of MTX with the 
carboxylate group of Asp-26 (Asp-27 for E. coli). Since this Asp is invariant in bacterial 
DHFR and there is a conesponding Glu carboxyl in vertebrate DHFR (Blakley, 1981) the 
interaction makes an important contribution to the binding of methotrexate to DHFR 
from all these sources.
There is also extensive evidence on this subject from other teclmiques, 
particularly concerning the ionic interaction between the protonated ring of the inliibitor 
and a negatively charged group on the enzyme. The first indication of this interaction 
was reported by Balter and Jordan (1965) who studied the effect of pH on the inhibition 
produced by several diamino pyrimidines and triazines with a range of pK^ values. 
Attention was drawn to the increased basicity of N-1 and of the 2-amino group in 2,4- 
diaminopteridines as compared with 2-aniino-4-oxopteridines. Baker (1967) suggested 
that the former compounds bind to the enzyme in the protonated form and that an 
additional coulombic interaction is the basis of their substantially greater affinity for the 
enzyme.
UV Difference spectra have proved to be useful for demonstrating that the bound 
inliibitor is protonated (Erickson & Mathews, 1972; Poe et a l, 1974; Hood & Roberts, 
1978). It was shown by Hood and Roberts (1978), that difference spectra associated with 
complex formation at pH 7.0 between L. casei DHFR and metliotrexate, are similar to 
difference spectra obtained for the free compound at pH 1.0 versus pH 7.0, that is 
between the protonated and neutral forms. However, no spectral evidence could be 
obtained for protonation of bound folate. And, in a summary of the folate results it was 
suggested that folate is bound in the normal keto form, and at pH 7.0 is more than 90% in 
the neutral ionisation state. It was shown that at pH 7.5, where MTX is bound 2000 
times more tightly than folate, one third of the difference in binding energy between the 
two compoimds arises from the differences in charge state (Hood & Roberts, 1978). 
However, subsequent mutagenesis studies, where the Asp-26->Asn mutant enzyme was
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examined, indicated the contribution to be somewhat smaller (Howell et al., 1986; 
London et al., 1986; Jimenez et a l, 1989). Similar results were obtained by others with 
DHFR from E. coli (Poe et a l, 1974) and chicken liver (Subramanian & Kaufman, 
1978). Saperstein et al (1978), reported that the Raman solution spectrum at pH 7.0 for 
the complex MTX with E. coli DHFR exhibits features similar to those in the spectrum 
of free methotrexate at pH 2.0, again suggesting protonation of the bound inliibitor.
Further evidence of the protonated state of boimd MTX and trimethoprim has 
been obtained by NMR spectroscopy. and ^^N-labelled substrate analogues have
proved to be particulaiJy useful for investigating ionisation states in the ligand. For 
example, measurements of chemical shifts of bomid [^^C-2]methotrexate (Cocco et 
a l, 1981a) have shown that the N-1 position of bound methotrexate is protonated in its 
complex with the enzyme. The chemical shift of C-2 is very sensitive to protonation of 
N-1, moving about 6 ppm as the pH is adjusted through the pK^, the data defining a pK^ 
for N-1 of 5.73 ± 0.02 (Cocco et al., 1981b). Wlien the l^C NMR spectrum of the 
labelled ligand was observed in the presence of DHFR, two distinct resonances were 
observed, one of which had a chemical shift varying with pH in the same manner as the 
chemical shift of free MTX. This resonance therefore was assigned to the free MTX in 
slow exchange with the MTX-DHFR complex. It was observed that since the 
dissociation constant for the MTX-DHFR binary complex was very low (Gleisner & 
Blaldey, 1975), exchange slow enough to produce a distinct, sharp resonance for the free 
methotrexate was to be expected.
The second resonance, which did not have a chemical shift at the same position as 
free MTX, evidently corresponded to MTX bound to the enzyme. It was shown that the 
chemical shift of this resonance did not change over the accessible pH range pH 6 - 9  and 
was close to but not identical with that for free protonated inliibitor. Given the 
sensitivity of the chemical shift of C-2 to proton dissociation fi'oni the pteridine ring, this 
clearly indicated that over the pH range pH 6 - 9, there was no change in the state of
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protonation of the pteridine ring of MTX when it was bound to DHFR. However, folate 
boimd to the reductase in either the binary or ternary complex showed the same 
protonation behaviour as in the free state. Hence, it must be concluded that N-1 of folate 
does not interact with the active site carboxyl, a conclusion reached from other data 
(Bolin et a l, 1982). The data indicated that the pK^ of N-1 for MTX is maiicedly 
increased (by at least 5 pH units) on binding, showing that the charged form binds as 
much as 10^-fold more tightly to the enzyme than does the neutral form.
By examining complexes of the enzyme with [l^C-2]trimethoprim it has been 
shown, similaiiy, that the N-1 of bound trimethoprim is also protonated in its bound state 
(Roberts et a l, 1981). In this case the signal for the NH proton could be detected 
directly in the ^H NMR spectra by examining enzyme complexes formed with l^N-1- 
trimethoprim in H2O solution (Bevan et a l, 1985).
Schegel and co-workers (1981) have used ah initio molecular orbital calculations 
on neutral and protonated 2,4-diamino-6-methylpteridine, free and in a highly simplified 
model of the DHFR binding site. They concluded that the ionic bond between N-1 and 
the aspartate carboxyl is the most important component of the binding of protonated 
methotrexate. However, their treatment did not include hydrophobic interactions or the 
binding of the p-aminobenzoylglutamate side chain.
Ionisation states of the protein His residues have also been measured (Birdsall et 
al., 1977a; Feeney et a l, 1980a). It was shown that the pK of His-28 is increased by 
approximately 1 unit when its charged imidazole ring interacts with the y-C0 2 " of the 
glutamate moiety of metliotrexate (or indeed of any folate analogue): NMR studies were 
used to monitor this pK in complexes formed with MTX analogues and thus it was 
possible to detect whether or not the interaction between the y-C02‘ and His-28 was 
talcing place (Antonjulc et a l, 1984).
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3.2.3.2. Multiple Conformations in Complexes o f Substrates with DHFR
Methotrexate is a close structural analogue of the substrate folate, and it was 
initially assumed that the inhibitor and substrate would bind to the enzyme in a very 
similar* manner. However, stereochemical studies (Charlton et a l, 1979, 1985; Hitchings 
& Roth, 1980) have shown that although the inliibitor and substrate occupy essentially 
the same binding site in their complexes with dihydrofolate reductase, the orientation of 
the pteridine ring in the catalytically active form of the substrate-enzyme complex is 
"turned over" by approximately 180° compared with that in the riiethotrexate-enzyriie 
crystal structure (Roberts et ah, 1980). Subsequent NMR studies on complexes of folate 
with Lactobacillus casei dihydrofolate reductase have shown that in the DHFR-folate 
binary complex at least two different conformational states exist, and in the ternary 
complex DHFR-folate-NADP"^ tlir*ee slowly interconverting conformational states are 
found to be present (Birdsall et a l, 1981, 1987). The equilibrimn between the tliree 
states was shown to be pH dependent, and the proportions of the states was estimated by 
measuring the intensities of the resonances observed in the complex containing [3- 
carboxariiide-l^cjNADP’^ . At low pH, form I predominates, whereas at high pH, forms 
Ila and Ilb predominate, with the ratio of these forms being relatively insensitive to 
changes in pH. The different conformational states have been characterised using ^H, 
and ^^P NMR studies which indicate that forms I and Ila have conformations 
similar to each other (Birdsall et a l, 1982, 1989b; Cheung et a l, 1993). Resonances 
have been assigned for all the aromatic protons in the bound ligands in the different 
conformational states, and it has been shown, from the observed chemical shift 
differences for protons in the ligand and protein, that the structural differences between 
the different conformations are localised in the binding site of the enzyme. The COSY 
spectra of the protein in all tln*ee forms ar e very similar to that observed for the enzyme- 
methotrexate-NADP'^ complex, indicating that there can only be small differences in
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protein conformation in the various complexes. Subsequent NOES Y experiments on 
the DHFR-folate-NADP"^ ternaiy complex detected connections between the pteridine 
ring H-7 proton of folate, in the low pH form (form I) and in form Ila (but not form Ilb), 
and the methyl protons of Leu-19 and Leu-27 (Birdsall et ah, 1989b). Similar NOE 
comiections have been detected in the enzyme-methotrexate-NADPH ternary complex 
where the H-7-pteridine is Icnown to be less than 4 Â from the methyl protons of Leu-19 
and Leu-27 in the crystal structure (Bolin et al., 1982). In form Ilb, no NOE connections 
could be detected between the folate H-7 and the Leu methyl protons. More recently 
Cheung and co-workers (Cheimg et al., 1993) have reported the use of l^C NMR 
spectroscopy in combination with folates selectively enriched with at positions 
sensitive to the tautomeric and ionisation states of the pteridine ring system in the 
different boimd forms of folates. In the study, l^C labelling at the proton-bearing C-7 
and C-9 carbons of folate facilitated ^H-^^C HMQC-NOESY experiments which 
allowed detection of protein protons near the folate H-7 and H-9 and provided additional 
characterisation of the different conformational states. These experiments not only 
confirmed the earlier work showing the pteridine ring in a methotrexate-like orientation 
in forms I and Ila, but also provided structural evidence that the pteridine ring of folate in 
form lib has the orientation expected for the active folate complex, that is, turned over 
with respect to the methotrexate orientation. In the ^H-l^C HMQC-NOESY spectrum of 
DHFR-[2,4a,7,9-l^C]folate-NADP'*‘, the H-7 proton in form Ila showed an NOE 
cormection to the methyl protons of Leu-27 (a similar* coimection was also observed in 
the ^H-^^C HMQC-NOESY spectriun of the methotrexate complex). The H-7 proton in 
form Ilb showed a connection with the Ala-97 methyl proton signal, indicating the 
proximity of the protons. Consideration of the crystal structure data of Bolin and co­
workers (1982) for* the L. casei DHFR-MTX-NADPH complex indicated that a "turned 
over" pteridine ring occupying essentially the same binding site would have its H-7 
proton approximately 3 Â from the Ala-97 methyl protons. One-dimensional NOE
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difference spectra selectively irradiating the H-7 proton signals in form I, Ila and Ilb for 
the DHFR-folate-NADP"*" complex at pH 6.5 confirmed that only form Ilb gave a large 
NOE to Ala-97 CH3.
Aia97,Thr45
Leu4
Leu 19
Thrl 16
[Asp26
'Leu27
Thr45 Ala97/
Leu4
Leu 19
T hr 116
WSp26
F igure 3,6. (a) Proposed confonnation of the pteridine ring in the "productive" confonnation of the 
folate-DHFR complex (b) Conformation of the methotrexate pteridine ring in its binding site in DHFR 
(from the data of Matthews and co-workers, 1978).
These observations all suggest that forms I and Ila have the pteridine ring in a 
similar orientation to that in the methotrexate complex while form lib has the pteridine 
ring turned over by 180° about an axis approximately coincident with the C-2-NH2 
bond. Such an orientation would allow the catalytic reduction to proceed with the coiTect 
stereochemistry and has been considered the "productive" confonnation (Figure 3.6(a)). 
Forms I and Ila with the methotrexate-like orientation of the pteridine ring correspond to 
the "non-productive" conformation (Figuie 3.6(b)).
The ionisable group responsible for the pH dependence of the equilibrium 
between the three forms has been estimated to have a pK < 5 in states Ila and lib and pK 
> 7 in state I (Birdsall et a l, 1987). Site-directed mutagenesis studies involving Asp-26
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have provided direct evidence that this is the residue involved in controlling the pH 
dependence of the conformational equilibrium (Jimenez et a l, 1989).
3,2,3.3, Evidence from Complexes Formed with Mutant DHFRs
Site-directed mutagenesis has been used to prépaie several mutant Lactobacillus 
casei dihydrofolate reductases and studies have been undertaken to compare their kinetic 
behaviom, ligand binding properties and structuies with those of the wild-type enzyme 
(London et a l, 1986; Jimenez et a l, 1989; Birdsall et al, 1989a).
3 .2 .3 .31 . Asp-26 Glu and Asp-26 ->  Asii Mutants
Because of the potentially important role of Asp-26 (Asp-27 in E. coli) in both 
catalysis and inhibitor binding, much attention has been focused on site-directed 
mutagenesis involving substitution of this residue (Howell et a l, 1986 & Birdsall et a l, 
1989a).
Birdsall and colleagues (1989a) prepaied the mutant of L. casei DHFR, Asp-26 
Glu by site-directed mutagenesis, and reported the use of NMR spectroscopy to study 
ligand binding, conformation and the dynamic properties of the bound ligand in the 
binary complex with the inhibitor, trimethoprim and the ternary complex with folate and 
NADP"^ (Birdsall et a l, 1989a). The results indicated that some conformational 
adjustments were required to allow the carboxylate of Glu-26 to bind effectively to the 
N-1 proton of inliibitors such as methotrexate and trimethoprim. These indications came 
from the observation of a change in the dynamics of the bound trimethoprim molecule as 
seen from the increased rate of the flipping of the ^^C-labelled benzyl ring and the 
increased rate of the N-1 -H-carboxylate bond breaking.
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The substitution of Asp-26 by Glu did not result in a major pertuitation in 
trimethoprim binding, thus showing that the sequence difference at residue 26, which is a 
conserved Asp residue in bacterial enzymes but a Glu residue in vertebrate enzymes 
(Matthews et a l, 1985), is not in itself responsible for the specificity of binding of 
trimethoprim to bacterial over vertebrate enzymes. It was reported that the binding 
constant for trimethoprim, the conformation of the bound trimethoprim molecule, and the 
trimethoprim and its N-1 chemical shifts are very similar in the complexes with 
DHFR and the mutant enzyme. Although the bound chemical shifts of the trimethoprim 
in its complex with the Asp-26 -> Glu enzyme indicated no large changes in the overall 
bound conformation, the mutation was sufficient to perturb some of the dynamic 
processes within the complex. For example, the rate of breaking and reforming of the 
hydrogen bond between the pyrimidine N-1 proton and the carboxylate group at residue 
26 was increased 50-fold in the complex with the Asp-26 —> Glu mutant. Another 
dynamic process that was reported to be perturbed in this complex is the flipping of the 
trimethoprim benzoyl ring, which is foin times faster in the Asp-26 Glu complex. 
Since it is likely that transient conformational rearrangements of the protein structure are 
required to permit these dynamic processes to occur, the conformational fluctuations in 
the protein must be very sensitive indicators of the structural differences between the 
mutant and wild-type enzyme.
The DHFR-fblate-NADP^ complex has been shown by NMR spectroscopy to 
exist in solution as a mixtuie of tlnee conformational forms (forms I, Ila and IIb)(Birdsall 
et a l, 1982, 1987). The complex formed with the Asp-26 -> Glu enzyme was also 
shown to exist in the same forms showing essentially the same pH dependence with 
respect to the ratios of the different forms (Birdsall et a l, 1989b). However, for the 
fblate-NADP"^ complex formed with the Asp-26 -> Asn mutant, very different behaviour 
has been observed.
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Asp-26->Asn DHFR-Folate-NADP+ DHFR-Folate-NADP+
L118/M128
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Figure 3.7. Comparison of the pH dependence of the high-field region of the 500 MHz ^H NMR specha 
of the enzyme-folate-NAD?"^ complexes of (right) wild-type DHFR and (left) the Asp-26-> Asn mutant. 
In the wild-type complex, the methyl resonance of Leu-118 has two components at high pH, corresponding 
to conformations Ila and (I + Ilb) respectively; in the mutant complex, however, only a single, pH- 
independent resonance from Leu-118 is observed (Jimenez et al., 1989).
NMR studies (Jimenez et a l, 1989) of the mutant enzyme-folate-NADP'*' 
complex showed that essentially only one foim (> 90%) was detected over the pH range 
5.0 to 7,1; this was demonstrated, for example, by the behaviour of the methyl 
resonances of Leu-118 shown in Figure 3.7. The single conformation seen for this 
mutant was reported to correspond to the low-pH conformer (form I, the non-productive, 
"methoti-exate-like" conformation) of the wild-type complex, strongly suggesting that. 
Asp-26 is the ionisable group controlling the pH dependence of the equilibrium in the 
complex fonned with the wild-type enzyme.
It has been shown by several workers (Howell et a l, 1986; London et a l, 1986) 
that the Asp-26 —> Asn mutant (Asp-27 —> Asn for E. colt) results in very low catalytic
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activity. These results provide further evidence that Asp-26 is either directly or 
indirectly involved in assisting in the initial proton donation to N-5 of 7,8-dihydrofolate. 
However, the possibility that tlie Asp-26 -» Asn mutation could result in an unfavourable 
unproductive conformation of the substrate which would result in low catalytic activity, 
can not be discounted.
3.2.3.3.2. Trp-21 —> Leu M utant
Trp-21 is a conserved residue in all the reported sequences of DHFR from 
bacterial and vertebrate sources. In the X-ray crystal structure of the L. casei DHFR- 
methotrexate-NADPH complex (Bolin et a l, 1982), this residue was shown to be fairly 
close to the coenzyme (3.9 Â from Trp-21 C-2 proton to the amide nitrogen of NADPH) 
and inhibitor binding sites (4.6 and 4.7 Â from the indole NH of Trp-21 to the N-1 
proton and N-8 of MTX). Birdsall and co-workers (Birdsall et a l, 1989a) used site- 
directed mutagenesis to change residue Trp-21 to a leucine in order to investigate the role 
of Trp-21 in its complexes with substrates and substrate analogues.
The results from this study indicated that replacement of the conserved Trp-21 by 
a Leu residue caused a decrease in the activity of the enzyme and a reduction of the 
NADPH binding constant by a factor of 400, but the binding of substrates and substrate 
analogues was only slightly effected. The inliibitor, methotrexate, was shown by NMR 
spectroscopy to bind to Trp-21 Leu DHFR by forming the same ionic interactions as 
in the wild-type enzyme; chemical shifts of MTX bound to the mutant enzyme 
indicated that the inliibitor was protonated at N-1 in the complex and the chemical shift 
of the imidazole 2-proton of His-28 in the same complex was consistent with that 
measured in the complex with DHFR (Birdsall et a l, 1977a), thus indicating that the 
methotrexate y-caiboxylate group malces tlie same interaction with His-28 in both 
complexes.
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Evidence that methotiexate adopts essentially the same conformation in the 
mutant and wild-type enzymes was obtained from compai’ison of the chemical shifts of 
the pteridine H-7 of bound methotrexate, which were shown to be virtually identical 
whether bound to DHFR or Trp-21 -> Leu DHFR. Fmther comparison of the complexes 
of methotrexate with the mutant and wild-type enzymes was achieved from their COSY 
spectra. In the aliphatic regions of these specha, several assigned signals for particulai' 
protons were observed to have different chemical shifts. The assigned signals that had 
shifted could be grouped into two categories. The first group ai’ises from those protons 
that are in close proximity to the aromatic rings of Trp-21 and these had different 
chemical shifts in the mutant enzyme, compai’ed with the wild-type, as a result of 
removal of the Trp ring current effects: these included resonances from residues Leu-118, 
Leu-19 and Leu-23. The second group comprised signals from protons in residues that 
are remote from Trp-21 (up to 14 Â fr om the site of substitution): for example, Leu-27, 
Leu-54, Leu-4, Val-110 and Val-115, all have protons that were shifted by more than 
0.05 ppm between the two complexes. From these results it was concluded that although 
methotrexate binds to Tip-21 -> Leu DHFR in essentially the same conformation as 
observed in the wild-type enzyme, the amino acid residues in the binding site were not 
aiTanged around MTX in an identical maimer, and this led to small perturbations in 
chemical shifts of bound MTX and also to small propagated conformational changes in 
the protein structure that could be detected fr om the changes in chemical shift of residues 
remote from Trp-21. These small shift differences could be explained by differences in 
atomic position of only about 0.2 Â (Birdsall et a l, 1989a).
Measurements of the ^H chemical shifts of bound NADPH in the mutant and 
wild-type enzyme complexes indicated that the reduced nicotinamide ring binds 
differently in the two complexes (Birdsall et a l, 1989a). In contrast, and ^H 
chemical shift measurements for nuclei in bound substrate and substrate analogues 
showed that these were binding similarly to the mutant and wild-type enzymes. The
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differences in catalysis and coenzyme binding were attributed by Birdsall and colleagues 
to structural differences involving the coenzyme binding site. It was shown, by analysis 
of the IR chemical shifts observed for NADPH bound to DHFR and Tip-21 Leu 
DHFR, that most parts of the coenzyme structure bind similarly in the two cases, with the 
notable exception of the reduced nicotinamide ring itself. This suggested that the 
reduced nicotinamide ring was probably still binding to the mutant protein within the 
same binding pocket but in a modified maimer. The crystal structure data of Matthews 
and co-workers (1979) shows that the C-Ç2 proton of Trp-21 has a hydrophobic 
interaction with the caiboxamide nitrogen of bound NADPH. It was shown that the 
substitution of Trp-21 by Leu leads to loss of this interaction and to a change in 
orientation of the nicotinamide ring within the binding site. The reduced nicotinamide 
ring is known to contribute a large amoimt to the overall binding energy of NADPH, and 
a pertm’bation of its interaction with the enzyme could account for the 400-fold reduction 
in coenzyme binding. It could also accomit for the substantial decrease observed in the 
rate of hydride transfer, the rate limiting step in the catalytic reaction for Trp -> Leu 
DHFR (Andrews et al, 1989). Similai* behaviour for the coenzyme binding was 
observed with reduced thio-NADPH, where the interaction between the coenzyme 
carboxamide group and the enzyme was altered by modification of the ligand rather than 
the enzyme (Birdsall et a l, 1980).
3,23A, Substrate Binding and Catalytic Activity
In contrast to the detailed structural information available about the binding of 
inliibitors to the enzyme DHFR, much less is known about the catalytic activity of the 
enzyme. Both ultra-violet difference spectroscopy (Hood & Roberts, 1978) and 
NMR spectroscopy (Cocco et a l, 1981a) show that when bound to the enzyme, folate is 
not protonated on N-1, as discussed previously. It has also been shown that there is a
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major difference in orientation of the pteridine ring of the substrates folate and 
dihydrofolate when bound to the enzyme compaied with that observed for the inliibitor 
methotrexate in the crystal (Birdsall et a l, 1977b). This evidence comes from the 
stereochemistry of the catalytic reaction (Charlton et ah, 1979, 1985). It was first noted 
by Matthews et al., from X-ray crystallographic studies that the orientation of the 
pteridine ring of folate would give an absolute ^^-configuration at C-6 for the product 
5,6,7,8-tetrahydrofblate if substmte 7,8-dihydrofolate was bound like methotrexate, but 
an iS-configuration if its pteridine ring was rotated by 180°. Shortly thereafter, 
Fonticella-Canips and colleagues (1979a, b) showed, using X-ray diffraction methods, 
that the biologically active diastereoisomer tetraliydrofolate, in fact, did have the absolute 
iS-configuration at C-6. Subsequently, reports by Charlton and co-workers confirmed 
these findings for dihydrofolate and demonstrated that the same was also true for folate, 
by demonstrating that hydride transfer occurs fr om the 4-pro R hydrogen of NADPH to 
the same corresponding face of these two pteridines (Charlton et a l, 1979, 1985). The 
nicotinamide ring of NADPH, therefore, must be positioned against the re face of 7,8- 
dihydrofolate (the back of the pteridine ring in the orientation of the structur e shown on 
below):
O
HoN
NA N'
NHR
H Hr
H S  H r
^ ^ C O N H ;
N'R
F igure 3.8. Schematic representation of 5,6,7,8-tetrahydrofolate (left) and the dihydronicotinamide ring 
of NADPH (right).
It was shown by the use of (4J()-[4-^H% ]-NADPH, in conjunction with ^H NMR 
spectroscopy that reduction of folate with DHFR had transferred the 4-pro R hydrogen of 
NADPH to the si face at C-7 of folate. Therefore, hydrogen transfer at both C-6 and C-7
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involved the same face of NADPH (4-H^) and the same face of the pteridine system in 
folate (C-6 re, C-7 si). The relationship between the pteridine and nicotinamide rings 
implied by these observations shows that folate and dihydrofolate, on the one hand, and 
methotrexate, on the other, must bind to DHFR to project opposite faces towaid the 
cofactor binding site, and hence, the active site on the enzyme. Figure 3.9. shows a 
schematic representation of (a) proposed interaction of 7,8-dihydrofolate and (b) 
methotrexate with active site residues in L  casei DHFR.
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2 5 3  ' O - H
H-H3
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H-K
. 0 -H-Ô —H  0
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LEU I HTHR 1 1 6
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H - N l
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 H-Q—H 0
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Figure 3.9. Schematic representation of hydrogen bonding between L. cajejdihydrofolate reductase and 
the pteridine portions of (a) 7,8-dihydrofolate (hypothetical) and (b) methotrexate. "R" represents/?- 
aminobenzoyl-L-glutamate. Evidence for the interactions with methotrexate (b) are discussed in Section 
3.2.2.1.2. The unlabelled carbonyl oxygen hydrogen bonded to N8 in the proposed enzyme-substrate 
complex might be Leu-4, Ala-97, or both. (Bolin et al., 1982).
It is generally accepted that reduction of dihydrofolate requires N-5 of the 
pteridine ring to be protonated prior to or in conjunction with hydride transfer from C-4 
of NADPH. While it is known that the 4-pro R hydrogen is transferred directly from C-4 
(Charlton et a l, 1985) the mechanism of N-5 protonation remains obscure. The aspartate 
side chain of Asp-26 (Asp-27 in E. coli), the sole acidic residue in the pteridine binding
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site is thought to be involved in protonation of N-5. Mutation of this residue to 
aspaiagine results in greatly diminished activity toward dihydrofolate at pH 7, but 
activity comparable to native L. casei DHFR at pH values sufficiently low to protonate 
dihydrofolate in solution (Howell et a l, 1986; London et al, 1986). However, because 
the distance between the carboxyl group of Asp-26 and N-5 is approximately 6.3 A, 
proton transfer from Asp-26 can not occm directly, and various mechanisms for proton 
shuttling between Asp-26 and N-5 have been proposed (Morrison & Stone, 1988; 
Uchimaru et a l, 1989; Bystroff et al., 1990). Each of these mechanisms involves 
énolisation of the pteridine 0-4 keto group aided by proton transfer to 0-4, via water-253 
(water-403, E. coli), from the side chain of Asp-26. At the time of these studies, it was 
unclear how the final proton transfer could talce place, since none of the previously 
reported structm es of DHFR contained any group capable of transferring a proton fr om 
0-4 to N-5.
Some authors have proposed that the lone pair on N-5 abstracts a proton from the 
enol form of 0-4 directly (Morrison and Stone, 1988), while it has been argued that 
transfer occurs by way of a transiently-bound water molecule hydrogen-bonded to both 
the 0-4 and N-5 (Bystroff et a l, 1990; Brown and Kraut, 1992). It was proposed by 
Brown and Kraut (1992) that proton transfer via this intervening water molecule was 
more likely for several reasons. First, the geometry between 0-4 and N-5 is not 
favourable for proton transfer (McTigue et a l, 1992), second, a water molecule that 
makes ideal hydrogen bonds to 0-4 and N-5 could be modelled into both the human 
DHFR-folate and E. coli DHFR-fblate-NADP"*" structures with very slight repositionings 
of Phe-31 or Met-20, respectively. Finally, a water molecule, water-756, was observed at 
this position forming just such a hydrogen-bonded linlc between 0-4 and N-5 in the 
recently solved crystal structrue of a ternary complex of chicken DHFR containing 
biopterin and NADP+ (McTigue et a l, 1992). The proposed mechanism for proton 
transfer in this complex involved small conformational changes in residues 31 of
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vertebrate DHFR's or in Met-20 of E. coli DHFR, to assist in transiently binding this 
water molecule for protonation of N-5 and then the water is displaced to allow for 
positive charge build up at C-6 in the transition state (McTigue et al., 1992).
If we now consider the cofactor: refinement of the L  casei DHFR-NADPH-MTX 
ternary complex revealed several rather subtle structural features of the nicotinamide 
binding geometry that influence the nature of the transition state and how it may be 
stabilised by the enzyme (Filman et a l, 1982). It was noted that there aie thiee oxygen 
atoms 0-13, 0-97 and 0-45 that are situated in the plane of the nicotinamide ring and 
close to ring carbons C-2, C-4 and C-6 (Figure 3.10). From the placement of these polar 
groups it has been suggested that the enzyme stabilises a C-4 carbonium electronic 
isomer of oxidised nicotinamide in the transition state.
Ser-48 DIHYDROFOLATE
201Ala-97
H-H Ala-6439Thr-45
H e -13
Figure 3.10. Schematic representation of the proposed enzyme-dihydrofolate-NADPH complex. Polar 
interactions between L  casei dihydrofoiate reductase and the nicotinamide group of bound NADPH are 
emphasised. Also depicted are hydrogen bonds between the side chain of Asp-26 (shown here as the anion) 
and the pteridine portion of dihydrofoiate. Adapted from Filman et al. (1982).
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It was also suggested that pyraniidalisation of the ring nitrogen (N-1) in the 
transition state might be promoted by a fixed water molecule (water-439) positioned to 
donate a hydrogen bond to the N-1 lone pair orbital. Thus Filman et al (1982) favoured 
a view in which the principal catalytic effect of the enzyme is to promote hydride 
donation by NADPH, rather than to facilitate hydride acceptance by dihydrofoiate. 
Clearly, the precise mechanism by which the protein assists hydride transfer is, therefore, 
still unclear', and additional information is required to provide an unambiguous 
definition.
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3.3. EXPERIMENTAL 
3.3.1. Materials and Equipment
Dihydrofoiate reductase was isolated from an Escherichia coli strain into which 
the L  casei gene had been cloned (Andrews et al, 1985) and the enzyme was pui'ified 
using methods described previously (Dann et al, 1976). NADP"*" and NADPH were 
obtained from Sigma Chemical Company and DCl and NaOD were obtained from 
Aldrich. The pH measurements were carried out using a Hanna Instruments HI 8417 pH 
meter equipped with a combination glass electrode. The reported pH values are meter 
readings uncorrected for deuterium isotope effects.
The tritium NMR experiments were carried out on a Bruker AC-300E 
spectrometer, operating at 320 MHz for tritium. Typically 30 000 transients were 
collected for spectra with widths of 3846 Hz and using 16 K data points, zero filled to 32 
K data points. As a precaution against sample spillage, 4 mm Teflon liners with stoppers 
were used inside 5 mm glass screw-capped NMR tubes. The tritium chemical shifts were 
referenced to the highest field methyl resonance in the proton spectrum (calculated to be 
at -4.7 ppm) and the tritium chemical shift calculated by multiplying the proton 
resonance frequency by the ratio of triton to proton magnetogyric ratios (1.06663974, 
Bloxsidge et ah, 1979). Thus the chemical shifts are reported in ppm, downfield of 
dioxan, in order to compare the experimental results with ^H literature values. Tritiirm 
Free Induction Decays (FIDs) were filtered with 5 Hz of Lorentzian line broadening 
before Fourier transformation and phasing. The NMR operating parameters were 
optimised for the enzyme samples (pulse flip angle, 72°; acquisition time, 1.1 secs.; total 
recycle time, 1.6 secs.). Unless otherwise stated, all NMR spectra were recorded in D2O.
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3.3.2. Experimental Methods
3.3.2,1. L. casei DHFR-[7j9-^H]FGlate-NADP^ Ternary Complex
In order to study the pH dependence of the thr ee reported conformational states of 
the L. casei DHFR-folate-NADP+ complex, the ^H NMR spectra of the ternary complex 
containing [7,9-^H]folate (13) were obtained over the pH range pH 7.4 - 5.3, at 25°C.
The initial experiment was conducted at pH 7.4. A 4 niM aliquot of [7,9- 
^H] folate with specific activity 4.1 Ci/mrnol, and a 2 niM aliquot of DHFR-NADP+ 
containing 100 mM KCl and 50 mM potassium phosphate (stored at -18^C) were 
allowed to warm to room temperature. The solution of DHFR-NADP+ binary complex 
was prepared by redissolving the solid in 0.5 cm^ of D2O and carefully rotating to 
ensure all of the enzyme was in solution. The enzyme-NADP"^ solution was then added 
to the solid tritiated folic acid and when all the folic acid had dissolved the pH was 
measured and adjusted with DCl/NaOD to pH 7.4. The DHFR-[7,9-^H]folate-NADP+ 
solution was then transferred to an NMR tube, sealed and ^H and ^H (^H-decoupled) 
(Figure 3.11(a)) NMR spectra were recorded at 25°C to see if any of the ^H signals 
could be observed when the ^H-folate was bormd to the enzyme.
Wlien the NMR experiment was complete, the NMR tube containing the DHFR- 
[7,9-^H]folate-NADP+ complex was stored at 4°C prior to the next NMR experiment. 
The NMR experiments were conducted overnight, to allow for long scanning times, on 
consecutive nights and the solution of the ternary complex was stored at 4^C during the 
intervening daytime periods.
In order to study the DHFR-[7,9-^H]folate-NADP'^ complex at pH 6.6, the pH of 
the solution was altered immediately prior to the NMR experiment. The ternary complex 
solution was transferred ft'om the NMR tube into an Eppendorf vial, a tiny glass-encased 
stirrer bai’ was added and with very gentle stirring the pH of the solution was cai*efully
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adjusted to pH 6.6 with DCl. The solution was then transferred back into the NMR tube, 
sealed and the ^H and ^H (^H-decoupled) (Figure 3.11(b)) NMR spectra were recorded, 
keeping the spectral paiaineters consistent with those employed for the initial NMR 
experiment. Subsequent NMR experiments were carried out at pH 6.0 (Figure 
3.11 (c))and pH 5.3 (Figure 3.11 (d)).
As a final experiment in tliis series, the pH of the sample was readjusted from pH
5.3 to pH 7.4 and the ^H NMR spectrum (Figure 3.12(b)) recorded to assess if the pH 
changes were reversible. Tliis final spectrum was recorded at a lower temperature 
(10°C) in order to examine the effects of exchange.
3.3.2.2. L. caseiDHFR~[3%5'y7'-^H]Folate~NADF^ Ternary Complex
The sample of DHFR-[3',5',7-^H]fblate-NADP"^ ternary complex was prepared as 
described above for the DHFR-[7,9-^H]folate-NADP‘^  complex by adding a solution of 
the DHFR-NADP**" binary complex to an aliquot of solid tritiated folic acid. The ternary 
complex contained 4 rnM [3',5',7-^H]folic acid (12, specific activity 32 Ci/rnmol) and 2 
mM DHFR containing 100 mM KCl and 50 mM potassium phosphate in 0.5 cm^ D2O.
The ^H and ^H (iH-decoupled) NMR spectra were recorded using the same 
spectral parameters as those employed for the DHFR-[7,9-^H]fblate-NADP^ complex in 
solution and the pH adjustments made in the same manner as described previously. The 
pH values used were pH 7.4, 6.86, 6.3 and 5.3 (Figure 3.13).
3.3.2.3. L. casei DHFR-[3\5*,7~^H]Methotrexate Complex and Ternary 
Complex with NADPH
A 1.1 rnM aliquot of [3 ',5',7-^Hjmethotrexate (14) with specific activity 9 
Ci/rmnol and a 1.1 rnM aliquot of DHFR containing 50 rnM potassium phosphate and
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500 mM KCl, were allowed to warm to room temperature. The DHFR was dissolved in 
0.6 cm^ D2O and this was then added to the solid [3',5',7-^H]methotrexate (14) and 
gently swirled to encourage the tritiated methotrexate to dissolve. The pH of the binary 
complex solution was adjusted to pH 6.5 with DCl/NaOD and transferred to an NMR 
tube, sealed and the ^H and ^H (^H-decoupled) NMR spectra were run at 25°C.
Subsequent ^H NMR spectra of the DHFR-[3',5',7-^Hjmethotrexate binary 
complex were recorded, at pH 6.5, at lO^C (Figure 3.14(b)) and 40°C, in an attempt to 
detect signals for the 3',5'-triton nuclei in the bound ligand, as well as the signal observed 
for T-7.
The DHFR- [3 ',5',7-^H]methotrexate ternary complex was prepared by the 
addition of the DHFR-[3',5',7-^H]metliotrexate binary complex solution to a solid sample 
of 1.5 equivalents of NADPH, in an Eppendorf vial. The sample was gently stirred to 
encourage the NADPH to dissolve. When all of the solid NADPH had dissolved, the 
sample was transferred back into the NMR tube and the ^H and (iH-decoupled) 
spectrmn run at pH 6.53, at 25°C, 10°C and 40°C (Figine 3.14(c)).
In a further attempt to detect the signals from the 3',5'-tritiurn nuclei, the ^H 
NMR spectrum of the ternary complex was recorded for a longer period of time (167, 
000 scans) at lO^C.
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3.4. RESULTS
The tritium chemical shifts of the ^H-labelled folic acids and methotrexate in 
their binary and ternary complexes with L  casei DHFR are given in Table 3.2. The 
tritimn chemical shifts are also given for free [3',5',7-3H]folate (12), [7,9-^H]folate (13) 
and [3',5',7-^H]methotrexate (14), recorded prior to the binding studies.
3.4.1. NMR Spectra of the Folate Ternary Complexes Formed 
with L. casei DHFR
The 3h NMR spectra of the DHFR-[7,9-3H]folate-NADP+ and DHFR-[3',5',7- 
^Hjfblate-NADP"^ ternary complexes show multiple signals for each labelled hydrogen 
in the bound folate, thus confirming the presence of multiconforrnational states seen in 
earlier studies (Birdsall et a l, 1981, 1982, 1987, 1989b). The pH dependence of the 
tlrree conformational states in the ternary complex has already been well characterised 
and this information can be used to assign the multiple signals for the 3',5'- and 7-tritons 
to form I, Ila or lib, simply by monitoring the signal intensities as a function of pH for 
the ternary complexes. At low pH (< 5.5) a single conformation, denoted form I, is 
observed, while at high pH (> 7.5) two other forms, denoted Ila and lib have been found 
to coexist in a ratio which is pH independent (Birdsall et al, 1989b). At intermediate pH 
values, all three forms are present. In tlie samples studied, excess tritiated folate was 
present, and separate signals for bound and free species were detected, thus indicating the 
presence of slow exchange between the species.
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3.4.1.1. L. casei DHFR-[7,9-^H]Folate-NADF^ Ternary complex
This complex was examined at a series of pH values in tlie presence of two 
equivalents of [7,9-3H]folate and the ^H spectra are shown in Figure 3.11. At pH 7.4, 
(Figure 3.11(a)) two signals were observed for bound T-7 (4.18 and 5.67 ppm) 
corresponding in chemical shift to the H-7 signals of the two conformations Ila and lib 
observed previously at high pH in ^H 2D exchange experiments.
The T-7 signals of both the bound and fr ee folate are broad {ca. 40 Hz) and this 
reflects exchange between the two species. As the pH is lowered, a new signal appears 
in the T-7 region and this corresponds to the H-7 proton signals detected previously (4.50 
ppm) for form I of the complex. Figine 3.11(d) shows that T-7 signals for all three forms 
are present, at pH 5.3.
Signals for the bound T-9 were also detected in the spectra. At pH 7.4 (Figure 
3.11(a)) these signals appeared at 0.31, 0.08 and -0.59 ppm. The observed signals are 
even broader than the T-7 signals: part of the line broadening is from ^H-^H spin 
coupling (estimated to be ca. 20 Hz), but there could be a further contribution to the line 
width from overlap of signals with different chemical shifts. The two tritons at the 9- 
position will be non-equivalent in bound folate and thus it can be anticipated that there 
will be four signals from the T-9 nuclei, corresponding to two different conformations. 
Johnson and Bovey's (1958) ring cuiTcnt shift calculations, based on the crystal structure 
data of Bolin et al (1982) (for the L. casei DHFR-MTX-NADPH complex), predict that 
one of the two protons (or tritons) on C-9 has an upfield shielding contribution of 
approximately 0.9 ppm. This would correspond closely to the signal observed at -0.59 
ppm.
At pH 5.3, where all tlu'ee conformational forms are present, T-9 signals for 
bound folate are also observed (at 0.13 and -0.56 ppm). There is a similarity in chemical
Chapter 3: Tritium NMR Binding Studies 1 0 6
shifts at pH 7.4 and pH 5.3, and this indicates that the T-9 nuclei aie in similar 
enviromnents in fonns I, Ila and lib.
As a final experiment in the series, the pH of the sample was readjusted from pH
5.3 to pH 7.4 and the ^H NMR spectrum re-recorded (Figuie 3.12(b)). This spectrmn 
indicates that the signals from the different conformational forms show the same 
intensities evident in the earlier spectra recorded at pH 7.4. This indicates that the pH- 
induced interconversion between the conformational states is reversible. The spectrum 
shown in Figme 3.12(b) was recorded at a lower temperature (IG^C), in order to examine 
the effects of exchange. As expected, the observed lines are nairower due to the decrease 
in exchange rates between the bound and free species at a lower temperature.
The sample used to obtain Figure 3.12(b) had been prepared for 6 days and its 
spectrum indicates that there is a small amoimt of folate decomposition. This gives rise 
to a small signal at 5.48 ppm (marked * on Figme 3.12(b)).
3.4.1.2. L. casei DHFR-[3 5 7-^H]Folate~NADF^ Ternary Complex
The 3h  NMR spectrum of this complex recorded at pH 7.4 is shown in Figure 
3.13(a). Again the two distinct T-7 bound signals were detected (at 4.18 and 5.73 ppm) 
confirming the existence of the two conformations present at high pH in this complex 
(forms Ila and lib). In contrast only a single resonance was detected for the 3',5'-3h  
nuclei from the benzoyl ring of bomid folate (1.89 ppm) and there is a substantial 
chemical shift difference between the bound and free species (the signal from the bomid 
is 1.3 ppm upfield of the free). The chemical shift of the 3',5'-3h  nuclei in bomid folate 
at pH 5.3 (1.89 ppm)(Figure 3.13(d)) is the same as observed at pFI 7.4. The appearance 
of a single resonance, well shifted from the position of the free, indicates that the benzoyl 
ring is binding in essentially the same binding site in all three conformations.
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Furthermore, the equivalence of the 3'- and 5'-T chemical shifts shows that this ring is 
undergoing relatively rapid ring flipping.
As the pH is lowered, the intensity of the two T-7 resonances decreases and that 
of another resonance (4.53 ppm), in the same region, increases. By pH 5.3, the 
resonances conesponding to forms Ila and lib (4.18 and 5.73 ppm) are barely detectable. 
The signal observed at 4.53 ppm corresponds to the H-7 proton signals detected 
previously for form I of the complex. As for the DHFR-[7,9-3H]fblate-NADP"^ complex 
the chemical shifts of the tlnee resonances in the T-7 region of this complex are also 
independent of pH; only their relative intensities varies. The observation that the relative 
intensities, but not the chemical shifts, of the tlnee resonances are pH-dependent shows 
that the thi'ee states of the complex which they represent interconvert slowly on the NMR 
time scale.
In the spectrum recorded at pH 6.86 (Figure 3.13(b)) two new signals are present 
(2.5 and 1.1 ppm). The sample used to obtain Figure 3.13(b) had been prepared for 4 
days and its spectrum indicates a lai'ge amount of folate decomposition to be present. 
The signal at 1.1 ppm corresponds to HTO. The position of the other signals (2.5 ppm) 
corresponds closely to the 3',5'-H position observed previously at low pH in the ^H 2D 
exchange experiments for form I (Birdsall et a l, 1989b). However, comparison of the 
spectra recorded over the pH range pH 6.86 - 5.30, indicates that the peak height of this 
resonance at 2.5 ppm is too large and anomalous when compared with the T-7 peak 
heights. Furthermore, the intensity of this resonance is observed to remain constant over 
the pH range. Tliis is also the case for the signal, at 1.1 ppm assigned to HTO, thus 
suggesting tliat these two resonances correspond to signals from decomposition products 
rather than to the 3',5'-T signals from one of the conformational forms whose signal 
intensities ai*e pH dependent.
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3.4.2. NMR Spectra of the Binary and Ternary [3\5\7-
^H]Methotrexate Complexes Formed with L. casei DHFR
The 3h NMR spectra of the binary and ternary DHFR complexes containing 
[3%5',7-3Hjmethotrexate and [3',5',7-3H]methotrexate-NADPH were recorded and the 
chemical shifts of the bound methotrexate measured (Table 3.2). Each tritium gives rise 
to only a single resonance for bound methotrexate, confirming that the inliibitor is bound 
in a single conformational state in the protein (Birdsall et a i, 1989a) in contrast to the 
situation with the E. coli DHFR-methotiexate complex (Falzone et a l, 1991 & Cheung et 
a l, 1992). In the samples studied, there was no excess methotrexate present, hence, only 
signals for the bound methotrexate were observed.
Figme 3.14(a) shows the 3y  NMR spectrmn of free [3',5',7-3H]niethotrexate 
(14). A comparison with the spectrum of the binary complex of DHFR-[3',5',7- 
3Hjmethotrexate is shown in Figme 3.14(b) and indicates that the only bomid ligand 
signal observed is T-7, no signal being seen for the 3',5'-T nuclei. Similar' results were 
obtained for the ternary complex with NADPH (Figure 3.14(c)). Varying the sample 
temperature over the range 10 to 40 did not noticeably change the 3h  spectra of the 
binary or ternary complex. The most obvious explanation for the absence of the 3',5'-T 
sigrial(s) is that they have been broadened by some exchange process such as, for 
example, flipping of the benzoyl ring. This is consistent with previous ^H NMR studies 
of methotrexate complexes with L. casei DHFR where signals for the 3',5'-protons have 
never been detected for eitlier the binary or ternary complexes. Ring current chemical 
shift calculations (Jolinsori and Bovey, 1958) based on the crystal structure data of Bolin 
and co-workers (1982) for the DHFR-MTX-NADPH complex, estimate that the 
difference in chemical shifts of the 3'- and 5'-protons is 1.36 ppm (435 Hz at 320 MHz). 
McConnell's modified Bloch equations (McConnell, 1958) have been used to calculate 
the spectra for signals corresponding to exchange at various rates between two equally
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populated non-equivalent sites having a chemical shift difference of 435 Hz. A noise 
level corresponding to that observed in the experimental spectrum was included in the 
simulation. Figure 3.16 shows the spectra calculated for various rates over the range 250 
s“l to 10^ s"l : for rates between 500 to 4000 s"l the signals are so broad that they would 
not have been detected at the prevailing signal to noise ratio.
The calculated spectra ar e characteristic of nuclei undergoing exchange between 
two equally populated magnetically non-equivalent sites. Because of the chiral nature of 
the binding site, any fixed orientation of the benzoyl ring would be expected to result in 
magnetic non-equivalence of the 3'- and 5'-tritium nuclei. The observed spectra are 
explained by the exchange process that has the effect of interchanging the positions of 
the 3'- and 5'-tritons so that at high temperatme they experience an average environment. 
The exchange process has been shown to involve ring flipping of the benzoyl ring about 
the N-lO-C-4' and C-l'-CO bonds (Clore et a l, 1984). Similar motions about the 
symmetry axis have been detected for other ligands bound to the protein (Cayley et a l, 
1979; Feeney et a l, 1981).
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Table 3.2. Chemical shifts of ligand nuclei in the three conformational states of L  casei DHFR-^H- 
folate-NADP’^  complexes and in the L  casei DHFR-^H-methohexate binary, and the ternary complex with 
NADPH.  ^ ^H data from Birdsall e^ /., 1989b;  ^ ^H data from Wyeth e /<7/ . ,  1980.
Chemical Shift (ppm from dioxan)
T-7 T-3’,5’ T-9
Free [7,9-3HJFolate, pH 7.8 5.01 0.63
DHFR-[7,9-3H]Folate-NADP+
Form I 4.50 0.31,-0.56
Form Ila 4.18 0.08, -0.59
Form lib 5.67 0.08, -0.59
Free [3'.5',7-3H]Folate, pH 7.6 5.2 3.2
DHFR-[3’,5',7-3H]Folate-NADP+
Form I 
Form Ila
4.53
4.18 1.89
Form lib 5.73 1.89
DHFR-Folate-NADP+ (% ) «
Form I 4.50 2.25
Form Ila 4.12 1.84
Form lib 5.58 1.84
Free [3',5',7-3HJMetliotrexate, pH 7.4 4.95 3.27
DHFR-[3',5',7-3H]Methotrexate Binary 4.27Complex
DHFR-[3',5',7-3H]Methotrexate-NADPH 
DHFR-Methotrexate-NADPH ^
4.38
4.15
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Figure 3.11. NMR spectra (^H-decoupled) at 320 MHz of [7,9-^H]folic acid in a 1:1:1 complex with
L. casei uHFk and NADP'*' at 25°C, at different pH values (a) pH 7.4, (b) pH 6.6, (c) pH 6.0, (d) pH 5.3. 
(2 mM DHFR, 4 mM [7,9-^H]folic acid, ICO mM KCl, 50 mM potassium phosphate in D2 O).
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Figure 3.12. NMR spectra (iH-decoupled) at 320 MHz of [7,9-^H]folic acid in a 1:1:1 complex with 
L  casei DHFR and NADP+ at pH 7.4 at different temperatures (a) 25°C, (b) 10°C.
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Figure 3.13, NMR spectra (iH-decoupled) at 320 MHz of [3',5\7-^H]fblic acid in a 1:1:1 complex 
with L, casei DHFR and NADP^ at 25°C at different pH values, (a) pH 7.4, (b) pH 6.86, (c) pH 6.3, (d) 
pH 5.3.
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F igure 3.14. NMR spectra (^H-decoupled) at 320 MHz of [3',5',7-^H]methotrexate (a) alone, (b) in 
a 1:1 complex with I. casei DHFR (1.1 mM) at pH 6.5, 283 K, (c) in a 1:1:1 complex withL. casei DHFR 
and NADPH at pH 6.5, 313 K.
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Figure 3.15. A comparison of (a) NMR spectrum at 300 MHz and (b)^H NMR spectrum (^H- 
decoupled) at 320 MHz of [7,9-^H]folic acid in a 1:1:1 complex withl. casei DHFR and NADP"  ^ at pH 
7.4, 25°C.
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Figure 3.16. Calculated spectra for various exchange rates between two equally populated 
equivalent sites in exchange with each other. non-
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3.5. DISCUSSION
If a ligaiid is strongly bound to an enzyme such that the dissociation rate constant 
is less than dq - op (the shift difference between the bound and free species), sepaiate 
NMR absorption signals are usually obtained for the free and bound states. In NMR 
studies, it is often difficult to identify the resonances from the strongly bound ligand in 
the 1:1 complex because of the presence of the spectrum of the protein. This has been 
the case, for example, in previous studies of NADPH and folate binding to dihydrofolate 
reductase (Roberts et al^ 1974). Even if resonances from the bound ligand can be 
detected, there is often the problem of assigning them to the individual protons of the 
ligand. One general solution to this problem is to examine unlabelled ligands bound to 
deuterated proteins. In tritium NMR work, on the other hand, the problem can be 
circumvented by selectively labelling sites in the ligand with tritium and then examining 
the signals from the ligand. In the present study [3',5',7-3H]folate (12), [7,9- 
3H]folate (13) and [3',5',7-^H]methotrexate (14) have been selectively labelled as 
described in Chapter 2.
Tritium has a relatively high natural sensitivity to NMR detection (1.2 times 
greater than that of nuclei) and because its chemical shifts are directly related to 
chemical shifts, it is easy to compare the and Ut results, the latter often being 
obtained from complex spectra where ambiguities in assignment can arise (Evans et ah, 
1985). There is no difficulty in distinguishing the resonance of the ^H, since tritium has 
effectively zero natural background abundance and of coui'se, there is no assignment 
problem since the site(s) of labelling are Imown.
Figure 3.15 shows a compai'ison of the and NMR spectra of the DFIFR- 
[7,9-3lT]folate-NADP'^ ternary complex. The tritium spectrum (Figure3.15(b)) indicates 
that the only resonances observed aie those of the labelled 7- and 9-positions of the 
ligand in the different conformational states, whereas the NMR spectrum (Figure
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3.15(a)) of the same complex is complicated by severe spectral overlap. Hence, the 
spectrum has been greatly simplified by the use of labelled ligands in conjunction 
with NMR spectroscopy.
3.5.1. Folate Ternary Complexes Formed with L, casei DHFR
The observation of multiple signals for the labelled tritium nuclei in the 
pteridine ring of folate bound to L. casei DHFR confirms the presence of the multiple 
conformations detected in earlier studies (Birdsall et al, 1981, 1982, 1987, 1989b). The 
observed changes in signal intensities as a function of pH confirm the pH dependence of 
the tlnee forms of the complex (forms 1, lia and 11b) in the ternary complex with 
NADP+.
A model for the differences between the tln*ee conformational states has been 
proposed by Birdsall and colleagues from chemical shift data and NOE experiments of 
the DHFR-folate-NADP+ complex (Birdsall et al., 1982, 1987, 1989b). and ^H 
chemical shift data for the coenzyme have shown that the only nuclei whose 
environments differ between the tlnee conformational states are those at the nicotinamide 
end of the bound NADP"*" molecule. The carboxamide and N-2 and N-4 ^H 
resonances of the nicotinamide ring have similar' chemical shifts in conformations 1 and 
11a, but quite different shifts in conformation 11b. Although fewer signals from the bound 
folate molecule have been identified, a similar* trend within its binding site has been 
observed, since there is a substantial difference in chemical shift between the different 
chemical states for the pteridine 7-proton and l^N-5, but no detectable difference for the 
benzoyl carbonyl carbon (Pastore et a l, 1976). In the present study, the T-7 ^H 
resonance of the pteridine ring has similar chemical shifts in conformations 1 and 11a, but 
quite a different shift in conformation 11b (shifted downfield ca. 1 ppm), this is consistent 
with the chemical shifts of the ^H resonances previously observed for the H-7 of the
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same complex (Birdsall et a l, 1989b). These data clearly suggests that the smToundings 
of the nicotinamide and pteridine rings - that is, the centre of the active site - is the likely 
source of the conformational differences between the three conformational states of the 
complex.
Subsequent ligand-protein NOESY experiments confirmed unambiguously the 
indications from the chemical shifts that, while the enviromnent of the pteridine 7-proton 
is similar in states I and Ila, it is quite different in state lib. In the former states the 7- 
proton is within 4 Â of two (conformation Ila) or tlnee (conformation I) methyl groups, 
from Leu-19 and Leu-27, whereas in state lib it is much further from any leucine methyl 
proton. The same NOEs had previously been detected in NOESY spectra of DHFR 
complexes with methotrexate (Birdsall et a l, 1989a) and are those expected from 
consideration of the crystal structure studies of Bolin and co-workers (1982). Therefore 
it was proposed that in states 1 and lia folate has its pteridine ring in a methotrexate-like 
orientation.
In state 11b no NOE was observed between the folate 7-proton and the methyl 
groups of Leu-19 or Leu-27, thus indicating that the distance between the pteridine H-7 
and leucine residues must be greater than 4 Â.
More recent studies (Cheung et a l, 1993) have used 2D ^H-l^c HMQC-NOESY 
experiments to further confirm the chaiacterisation of the pteridine ring orientation in the 
different bound forms of folate. In this study, an NOE was observed between the 
pteridine H-7 proton in form lia, of the DHFR-[2,4a,7,9- ^  ^  C]fblate-NADP"^ ternary 
complex and the methyl protons of Leu-27 (a similar comiection was observed in the ^H- 
HMQC-NOESY spectrum of the methotrexate complex). The H-7 proton in form 
lib showed a connection with the Ala-97 methyl proton signal, thus indicating the 
proximity of these protons. These observations are consistent with previous results and 
consideration of the crystal structure data of Bolin and co-workers (1982) for the L. casei 
DHFR-methotrexate-NADPH complex indicated that if the pteridine ring occupied
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essentially the same binding site, but was 'tuiiied over' by 180°, the H-7 proton would be 
approximately 3 Â from the Ala-97 methyl protons. The results from subsequent NOE 
difference spectra selectively irradiating the H-7 proton signals in forms I, Ila and Ilb for 
the DHFR-folate-NADP'*' complex at pH 6.5 confinned that only form lib gave a large 
NOE to the Ala-97 methyl group.
Some fruther support for this proposed reorientation comes from the fact that a 
qualitative explanation for the pattern of ligand ^H chemical shift differences between 
conformations lia and 11b could be provided. In the binding site the nicotinamide ring of 
the coenzyme is close to the pteridine ring, and the ring current anisotropy of the latter 
will contribute to the chemical shifts of the nicotinamide protons. Taking the position of 
the pteridine and nicotinamide rings in conformation lia as those observed in the crystal 
structure of the enzyme-methotrexate-NADPH complex (Bolin et a l, 1982) and the 
position of the pteridine ring in conformation 11b as described above, Birdsall et al 
showed that the calculated difference in the ring current contribution to the chemical shift 
of the nicotinamide protons between the two conformations was in general agreement 
with their observed experimental values (Birdsall et al, 1989a). The chemical shift of 
the pteridine H-7 has large shielding contributions from the anisotropy of the benzoyl 
ring of methotrexate or folate and from the ring currents of neighbouring aromatic 
residues in the protein (Hammond et al., 1987). Therefore, the change in the mutual 
orientation of these two rings involved in the suggested mode of binding of folate in 
conformation 11b would certainly lead to a substantial downfield shift in the resonance of 
this proton (or triton), as observed experimentally. Similar* arguments can be applied to 
the upfield shift observed for* the folate T-7, in the current study, in forms 1 and lia from 
the free T-7 resonance (Hammond et a l, 1987).
The proposed 180® reorientation of the pteridine ring in conformation lib relative 
to that in the crystal structure of the enzyme-methotrexate-NADPH complex is exactly 
that required to account for the observed stereochemistry of reduction of folate
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(Hitchings & Roth, 1980; Charlton et a l, 1979, 1985). The mode of binding of folate 
that has been proposed for conformation lib of the enzyme-folate-NADP'^ complex thus 
corresponds to the 'productive' mode of binding in the catalytically functional enzyme- 
folate-NADPH complex. The alternative orientation seen in conformations 1 and lia is 
said to represent a non-productive mode of binding of the substrate, since it has been 
shown that the stereochemistry of folate reduction at low pH, where conformation 1 
predominates, is the same as that determined previously at neutral pH. The difference 
between the binding of methotrexate seen in the crystal and the mode of binding of folate 
implied by the stereochemistry of reduction shows that instead of methotrexate binding 
in a unique way which is unavailable to the substrate, the inliibitor binds essentially 
exclusively in only one of the two modes of binding available to the substrate, that 
corresponds to 'non-productive' substrate binding. The preference of methotrexate for 
this orientation must ar ise, at least in part, from the formation of an ion pair between the 
protonated pteridine ring and the caiboxylate of Asp-26 (Bolin et a l, 1982; Cocco et a l, 
1981b) which is possible only in this orientation.
In a recent study, Cheung et a l, (1993) investigated the tautomeric and ionisable 
states of the pteridine rings in forms 1, lia and 11b. The authors compared the ^^C 
chemical shifts of the pteridine ring carbons in the different forms with values obtained 
from 'model' compounds with Imown tautomeric and ionisation states. Conclusions were 
formed from these results and by consideration of ^H chemical shifts of the enzyme 
complexes. Folate in form lib, the catalytically active conformation, was shown to exist 
in the keto form with N-1 unprotonated, whereas folate in form lia and form 1 exist in 
enolic forms. The postulated keto form (N-1 unprotonated) for form lib had one less 
proton than form 1, the enol (N-1 protonated), which could account for the observed pH 
dependent conformational equilibrium. The proposed structure for form lia, the enolate 
(N-1 protonated), would also agree with this explanation.
Chapter 3: Tritium NMR Binding Studies 122
1 11 the present study, it has been possible to detect the signals for the bound T-9 in 
the DHFR-[7,9-3H]folate-NADP"^ ternary complex. At high pH, three separate signals 
(shifted upfield from the free resonance) are present in the T-9 region of the spectrum. 
The resonance of one of these signals (-0.59 ppm) corresponds to that predicted by 
Johnson and Bovey ring shift calculations for one of the tritons on C-9, i.e. an upfield 
shielding contribution of ca. 0.9 ppm. The two tritons at the 9-position will be non­
equivalent in boimd folate and thus, at pH 7.4 where forms Ila and lib predominate, four 
signals for the T-9 nuclei are predicted. If one of these T-9 nuclei in its bound 
enviromnent gives rise to only one broad signal at the position predicted by Jolinson and 
Bovey calculations, then the other two signals (at 0.31 and 0.08 ppm) could correspond 
to forms 11b and lia for the other T-9 nuclei.
At pH 5.3, the T-9 signals for the bound folate still feature the high ring current 
shifted signal at -0.61 ppm, but the lower field signals are now centred at 0.13 ppm. The 
close similarity in position of the resonance signals at 0.08 ppm (pH 7.4) and 0.13 ppm 
(pH 5.3) suggests that the T-9 nuclei in the two forms could be in a similar* environment 
in the binding site, i.e., in forms lia and 1. Thus, the signals at 0.31 and 0.08 ppm could 
correspond to form lib and lia, respectively, and the signal at 0.13 ppm, at pH 5.3 
corresponds to form I of this particular* T-9 nuclei. However, it can be seen that the 
similarity in all of the chemical shifts at pH 7.4 and 5.3 indicates that both the T-9 nuclei 
are in similar* environments in forms 1, lia and 11b.
T lw data consistent with the observation that for* the DHFR-folate-NADP"*" 
ternar y complex, the pteridine ring of folate has different orientations in the binding site, 
in the different forms, whilst the rest of the molecule binds in essentially the same 
orientation in all three forms.
Further evidence for the similarity in binding site of the j?-arninobenzoylglutarnic 
acid portion of the molecule is provided by the NMR spectra of the DHFR-[3',5',7- 
3H]fblate-NADP"*" ternary complex. At pH 7.4, the existence of the two conformations
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present at high pH was confirmed by the observation of two distinct T-7 bound signals. 
Their resonance positions (4.18 and 5.73 ppm) corresponding to those observed for the 
DHFR-[7,9-3 H]folate-NADP+ complex at high pH (Figuie 3.11a). In contrast, only a 
single resonance was detected for the 3',5'-T nuclei from the benzoyl ring of bound folate 
(at 1.89 ppm). This is consistent with the results obtained by Birdsall et al. (1989b), who 
observed only a single ^H resonance (at 1.84 ppm) for forms Ila and lib at high pFI, for 
the enzyme-folate-NADP"*" ternaiy complex. The appearance of a single pealc, well 
shifted from the position of the free {ca. 1.3 ppm upfield of the free), indicates that the 
benzoyl ring is occupying essentially the same binding site in both conformations.
From the 3y NMR results obtained at lower pH values, it is impossible to 
comment on the presence of form 1 of the complex at low pH. Birdsall and co-workers 
(1989b) identified a resonance at 2.25 ppm, as that fr om form 1 of the ternary complex at 
low pH. However, the signal at 2.5 ppm in the 3h spectra (Figures 3.14 (b-d)) has been 
shown to arise from a tritium decomposition product. It is possible that the signal 
observed at pH 5.3 at the same resonance position (1.89 ppm) as that observed at pH 7.4 
corresponds to form 1 of the complex, hence, indicating that the benzoyl ring has the 
same binding site in all tlnee conformations. Fmthermore, the equivalence of the 3', and 
5', chemical shifts shows that the benzoyl ring is undergoing relatively rapid ring 
flipping.
These observations are consistent with the results obtained for the binding of the 
benzoyl ring of folinic acid (5-forrnyl-5,6,7,8-tetrahydrofolic acid, Feeney et a l, 1981). 
Identical shifts for the H-3' and H-5' benzoyl protons (and for the H-2' and H-6' protons) 
were observed for folinic acid in its complexes with DHFR. This equivalence was 
attributed to rapid ring flipping of the benzoyl ring about the N-10-C4' and C-l'-CO 
bonds in the bound state, which would lead to the observed equivalence of shielding 
effects and hence chemical shift. Similar effects have also been observed for the 
trimethoxy benzyl ring of trimethoprim bound to DHFR (Cayley et ah, 1979).
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However, ring flipping will be impeded by the steric interactions between the 
benzoyl ring and residues on the protein. If, as is expected, the benzoyl ring is binding in 
a site similar to that in methotrexate in the enzyme-methotiexate-NADPH complex 
(Matthews et ah, 1978; Bolin et a l, 1982) then the side chains of Leu-27, Phe-49 and 
Leu-54 will be in contact with the ring, and there are also other multiple contacts 
involving both glutamate and pteridine ends of the molecule which contribute to the tight 
binding to the enzyme. It is known that conformational fluctuations can take place 
within protein structuies which can momentarily remove the steric interactions impeding 
ring flipping (Wuthiich and Wagner, 1975). For folinic acid, it has been proposed that 
the flipping motion leading to the equivalence of the aromatic protons in the p- 
aminobenzoyl moiety takes place when the folinic acid is fully bound to the enzyme and 
requires a transient "breathing" of the structur e in the vicinity of the bound ligand.
Hence, from the chemical shifts of the tritons on C-9 and C-3' and C-5' of the 
benzoyl ring in bound folate, it is proposed that the non-pterin part of folate is binding in 
a very similar way in the different forms, with the benzoyl ring undergoing ring flipping 
at a rate sufficiently fast to give an average signal for the 3',5'-tritons.
3.5.2. Binary and Ternary [3’,5’,7-^H]Methotrexate Complexes 
Formed with L, casei DHFR
The observation of a single resonance in the 3h NMR spectra for bound 
methotrexate in both the binary and ternary complex with L. casei DHFR confirms the 
presence of a single conformational state for the inhibitor binding. The observed 
resonance corresponds to the bound pteridine T-7, with no signal being seen for the 3',5'- 
nuclei.
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The availability of crystal structur e data on the ternary complex of L. casei DHFR 
with methotrexate and NADPH (Matthews et a l, 1978; Bolin et a l, 1982) has proved to 
be of vital importance as an aid to assigning the protein and ligand chemical signals and 
in assisting the interpretation of the chemical shift pertiu'bations seen in related 
complexes. From the crystal structure, the amino acid residues close to methotrexate can 
be identified. The shieldings of several of the protons in the amino acid residues in or 
close to the binding site of MTX are directly influenced by ring current contributions 
from the pteridine and benzoyl rings of MTX. Any small relative movements of the 
methotrexate aromatic rings and amino acid residues will thus result in chemical shift 
changes of the protons in these protein residues. Similarly, changes in chemical shifts 
observed for ligand protons may have shielding contributions from ring currents of 
neighbouring aromatic residues in the protein and also from aromatic rings within the 
ligand itself. For example, the H-7 proton of MTX is expected to have ring current shift 
contributions from Phe-30 (-0.248 ppm), from Phe-49 (0.045 ppm) and from the benzoyl 
ring of MTX (-0.365 ppm) (Hannnond et a l, 1987). This gives a total shift of -0.59 
ppm. The observed experimental chemical shift of T-7 in the bound enzyme ternary 
complex is shifted upfield fiom the T-7 signal of the free ligand by 0.57 ppm. Thus, 
there is good agreement between the calculated and experimental values, indicating that 
the pteridine pai’t of methotrexate binds to DHFR in the same way in the crystal and in 
solution. Further evidence for this observation was obtained from NOB experiments as 
described previously.
Although ring flipping of the benzoyl ring has been chai*acterised in the complex 
with 3 ',5'-difluoromethotrexate, similar information for the paient compound has never 
been obtained. A combination of broad methotrexate  ^H signals and the presence of 
overlapping protein signals have made it impossible to detect directly signals for the 
2',3',5',6'-proton signals of bound methotrexate in the ^H spectra. In the present study, 
the absence of the 3',5'-signal(s) in tlie tritium spectra has been explained by the
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suggestion that the exchange process leading to extensive line broadening of these 
signals, is the intermediate ring flipping rates of the benzoyl ring. Using McConnell's 
modified Bloch equations (McConnell, 1958) the line shapes have been calculated for the 
enzyme-[3',5',7-3H]methotrexate complex, assuming exchange between two equally 
populated non-equivalent sites. It is seen from the spectra (Figure 3.16) that at rates 
between 500 to 4000 s“l the signals are so broad that they would not have been detected 
at the prevailing signal to noise ratio. The rates of flipping of the benzoyl ring are not 
known for these complexes but they have been measured for binary and ternary 
complexes of DHFR with 3',5'-difluoromethotrexate and NADPH ( Clore et ah, 1984) 
where values of 7000 s"l at 298 K (binary) and 20 000 s“l at 298 K (ternary) were 
obtained. From the activation energies determined in this study, one can estimate that an 
eight fold increase in rate (from 500 to 4000 s"l) would be achieved by increasing the 
temperature by 30® (from 283 - 313 K). Thus, the observed rates of ring flipping over 
the temperature range used to examine the DHFR complexes with the tritiated 
methotrexate are somewhat lower, but not too dissimilar* from those measured earlier* for 
the complexes with 3',5'-difluoromethotr*exate.
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3.6. CONCLUSIONS
The findings presented in this chapter indicate that tritium NMR spectroscopy 
provides a very direct method for examining multiconformational states and dynamic 
processes in protein-ligand complexes. The presence of the tlnee pH dependent forms of 
bound folate has been confirmed.
The major differences in the conformation of the pterin ring in the different forms 
have been characterised previously. The present results, by providing information on the 
similar* chemical shifts of the tritons C-9 and C-3' and C-5' of the benzoyl ring in bound 
folate, indicate that the non-pterin pait of folate is binding in a similar way in the 
different forms. Ring flipping rates for the benzoyl ring in bound folate aie sufficiently 
fast to give an averaged signal for the 3',5'-ti*itons.
The results for the complexes of L. casei DHFR with methotrexate and NADPH 
indicate that a single major conformation exists for the binary DHFR-methotrexate 
complex and also for the ternary complex with NADPH. The line broadening which 
prevents observation of a signal for the 3',5'-tritons of the benzoyl ring in bound 
methotrexate is consistent with the ring flipping being insufficiently fast to give chemical 
shift averaging of the 3',5'-signals.
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4. NUCLEAR OVERHAUSER EFFECTS IN TRITIUM  
NMR SPECTROSCOPY
4.1. INTRODUCTION
The assignments of resonances in NMR spectra of complex molecules is often far 
from trivial. A variety of chemical perturbations can be helpfi.il in this context (Dwek, 
1973). One way however, that requires only an instrumental pertmbation is to introduce 
a second radio-frequency pulse in the NMR experiment. A subtle example of this double 
irradiation effect is the nucleai’ Overhauser enliancement/effect (NOE), which can lead to 
structural information as well as providing an increase in signal-to-noise ratio, which is 
particularly important in NMR spectroscopy.
The nuclear Overhauser effect is a change of NMR signal intensity brought about 
by pertui'bation of the equilibrimn populations of nuclear spin states; the perturbation is 
usually achieved by selective irradiation of the signal(s) for a particular spin in a double 
irradiation experiment. The spins involved may be either heteronucleai* or chemically 
shifted homonuclear spins. NOEs are due to dipolar interactions (thiough-space) 
between different nuclei and aie correlated with the inverse sixth power of the 
internuclear distance. They are customarily quoted in percent of the unpertmbed 
resonance intensity. Often, one proton resonance in the spectrum of the material under 
study is irradiated continuously while changes in the intensities of other proton signals 
aie observed after the spin system comes to equilibrium.
The potential of the NOE for providing information on the conformation and 
configuration of molecules in solution was first demonstrated by Anet and Bourn (1965) 
and since that time applications in this area have grown rapidly. When combined with
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difference spectroscopy or a two dimensional approach, the nuclear Overhauser effect 
provides one of the most easily exploited methods of structur e determination available.
Observations of nuclear Overhauser enhancements play a central role in
studies of the structmes of biological macromolecules in solution (Wiithrich, 1986). The 
approaches used to provide the requisite assignment of the proton spectrnrn of the system 
of interest, and the estimation of internuclear distances needed for secondary and tertiary 
structure determination from multidimensional NOE experiments have developed 
rapidly. However, these methods begin to falter when proteins are larger than ca. Mj. 
15000, because, with increasing size, spectral crowding and the linewidths of individual 
resonances both increase, thereby reducing resolution. With larger structures it is 
necessary to enrich specific positions with or ^^N (Fesik and Zuiderweg, 1990) or 
introduce an extrinsic nucleus such as l^F (Gerig, 1977, 1980) to obtain structmal 
information.
Tritium NMR spectra from appropriately labelled materials are usefril for 
addressing many questions in a small molecule context (Evans et a l, 1985), but there 
have been few examples of tritium NMR studies with protein systems (Geliring et a l, 
1991; O'Connell et a l, 1993a, b). O'Connell and co-workers (1990) first demonstrated 
the feasibility of 3H{^H} NOE experiments with materials of M  ^25 000 by conducting 
2D 3h{1h} NOE experiments on an a-tritiated tosyl derivative of chymotrypsrn, thus 
revealing through-space dipolar* interaction at the active site of the enzyme. Since this 
report very little has been published on the exploitation of this 3h{1h} NOE technique 
with protein systems.
This chapter presents a description of spin-lattice relaxation (7]), and its 
relationship to the nuclear Overhauser enhancement in systems of small molecules and 
the macromolecular system. For more detailed derivations and explanations the reader is 
referred to Noggle and Schirmer (1971).
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First, the theory and experimental considerations of the NOE and spin-lattice 
relaxation rate are reviewed together, as their origins and interpretation aie related. Next, 
the applications of the NOE difference, heteronuclear NOE and 2D NOESY experiments 
ai'e presented with specific attention to protein-ligand systems, and finally, the use of 
3H(1H} heteronucleai* NOEs is discussed in terms of its current use in small molecules 
and its future applications.
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4.2. THEORY
In the NMR experiment, excess spin population is moved from one energy level 
to another by electromagnetic radiation of the appropriate frequency. This is excitation. 
The radiationless return to equilibrium is called spin-lattice relaxation (7J), because the 
excess energy passes from the spins to the lattice (or surroundings) as heat. These can 
arise from many sources, but for both protons and carbons in diamagnetic molecules, the 
dominant fields are due to the magnetic moments of protons in the same molecules as 
they tumble in solution. This is a dipole-dipole interaction and is the dominant 
relaxation mechanism associated with the nuclear Overhauser effect. The rate, or 
efficiency = 1/7;) of dipole-dipole relaxation depends on both the frequency and 
strength of the fluctuating magnetic fields. These, in turn, depend on three factors (i) the 
distance between the nuclei involved, 1}^ , for nuclei 7 and S, (ii) the effective correlation 
time, T^, of the vector joining the nuclei (this corresponds to the reciprocal of the rate of 
tumbling in solution of the relevant part of the molecule) and (iii) the natine of the nuclei 
themselves. Nuclear* Overhauser enliancernents and the rates at which they increase and 
decay, are also measmes of the strength of the dipole-dipole interaction between two 
spins, and hence are dependent on internuclear* distances and correlation times. This 
dependence of NOEs on internuclear* distances and correlation times leads to their* 
usefulness as structural probes.
4.2.1. Nuclear Overhauser Enhancement in a Two Spin System
4.2.1.1. Steady-State NOEs
The simplest system which can exhibit the NOE consists of two isolated spins 
which are mutually relaxing, but are not J-coupled. Figure 4.1 shows the energy level
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diagram for this system. and are the single quantum transition probabilities for I  
and S  spins respectively; they lead to the normal spectrum. is a double quantiun 
transition probability for the two spins to relax simultaneously in the same direction, 
while Wq is a zero quantum transition probability coiTesponding to a mutual spin flip. 
The latter process gives no net relaxation, but leads to the excess energy being moved 
from one spin to another. This process is particularly important in large molecules. The 
double and zero quantum processes are not detected directly in the NMR spectra, but 
they can be detected tlirough their effects on relaxation.
W,;
Figure 4.1. Energy level diagram for dipole-dipole relaxation in a homonuclear two-spin system. The 
Ws are spin relaxation possibilities.
Spin S is saturated by irradiation of the spin. The populations in the levels linlced 
by ar e rapidly equalised but initially there is no net change in the differences between 
the populations linked hy , levels 1 and 3 having lost equal amounts of populations to 
levels 2 and 4, respectively. If the state of the spin system is read by a pulse immediately 
after such a short pre-irradiation is tuined off, there will be no S signal and the I  signal 
will have its normal intensity. A new population distribution is generated however by 
relaxation tlirough and as irradiation of S is continued. increases the intensity
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of the I  transitions by attempting to establish a Boltzmann distribution between levels 1 
and 4, while decreases the I  intensity by equilibrating levels 2 and 3. The resulting 
net change in the intensity of /  as a result of the competition between and is the 
nuclear Overhauser enhancement. An increase in intensity is a positive NOE and a 
decrease is a negative NOE. Experimentally, the steady-state NOEs are detected without 
interference from decoupling effects using the inverse gated decoupling sequence shown 
in Figme 4.2, the irradiation time is long compared with any of the relaxation times.
iH
Decoupler
AQ
Figure 4.2. Pulse sequence for steady-state NOE experiments
If the initial intensity of I  before irradiation is A ,^ then the fractional nuclear 
Overhauser enliancement {5}, of the total intensity of the resonance of spin I  when 
spin S  is saturated is defined as:
(4.1)
where is the intensity of /w hen S  is irradiated. Noggle and Schirmer (1971) have 
shown by considering the details of population movements between the four levels, that 
if 100% of tlie relaxation of / is  via dipole-dipole relaxation by 5, and if the irradiation is
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continued for a very long time compared with all relaxation times so that a steady state is 
reached, then the full equation is
IsIPi ) (4*2)
where ^  is = (4.3)
and p/ = IW^j + ^  + 1^2 (4.4)
where is the initial intensity of the S resonance, cj^ ,^ and the NOE may be either 
positive or negative depending on the relative sizes of Wj and JVq and they in turn depend 
on the correlation time,
Relaxation tlnough fVj requires magnetic field fluctuations or magnetic noise 
which has a component at, or close to the Lamor precession frequency of the nucleus 
concerned, Vg, i.e. 10^-10^ Hz, while JV2  requires field fluctuations around 2vg. Because 
the necessary field fluctuations aie produced by proton tumbling at a rate (x^.)"’, and 
are most efficient when VgX^. «1. The correlation time, is a measure of how 
rapidly the molecule imdergoes reorientation in solution and for a small molecule such as 
methanol, is about 10"^^ seconds, thus it tumbles in solution rapidly.
The spectral density ./(co) is the intensity, or concentration of fields at a particular 
frequency, co. For molecules, such as methanol, the spectral density near 10^ Hz is very 
low, and are inefficient and the relaxation is very slow, around 0.01 - 0.1 s"l for 
both protons and carbons. Similarly, in large molecules or viscous solvents where 
VgTf. > 1, slow tmnbling cannot give rise to fields at the appropriate frequency for PfJ and 
JV2 . These are then inefficient relaxation processes. When VgX^ . is close to 1, the 
spectral density or intensity of appropriate field fluctuations, is at a maximimi and hence 
the relaxation is most efficient. Thus, spin-lattice relaxation is most rapid at the 'Rj- 
maximum' where « 1. (i?i-maximum traditionally Imown as -minimum). Since
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Vg depends on the field strength, the relaxation rate of a paiticiilar spin is field dependent 
in molecules where VgX^ .^ « 1.
In contrast, PPJ comiects two levels that aie very close in energy. Fields of low 
frequency aie required and it is most efficient when molecular tumbling is very slow. In 
rapidly tumbling molecules Wq is relatively imimportant and the lifetime of the excited 
state is determined almost completely by the processes, and W^ . Wlien VgT^  > 1, 
and W2  are ineffective but Wq is efficient, although spin-lattice relaxation is slow, the 
lifetime of an individual spin state is short because the excitation passes via mutual spin 
flips (Wq) to other spins. Therefore, when VgX^. > 1, tlie spin-lattice relaxation, 7J, is 
long, but the spin-spin relaxation, 7 ,^ is short. As a result of the short 7 ,^ the NMR 
signals are broad. In contrast, when VgT^ . < 1 the molecules are said to be in the extreme 
naiTowing limit (the linewidth is determined by instrumental rather than fundamental 
factors).
In the limit of fast tumbling and complete dipole-dipole relaxation of I  by 5", Eqn. 
(4.2) simplifies to:
= A (4.S)2y/
where y j and y 5. are the magnetogyric ratios of nuclei S and I. For any homonuclear 
decoupling experiment, y j = y^, i.e., when both are protons, the Eqn. (4.5) gives a 
maximum NOE of 0.5, i.e. 50% enliancement, irrespective of the distance between 
nuclei.
In ID experiments with relative line intensities 1 in the absence of NOEs, the line 
intensities with NOE then become:
/ r - l  + Z .W  (4.6)
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In the observation of spectra, inadiation of directly bonded hydrogens can 
result in a maximum NOE of 1.987, i.e., a signal increase of (1 + /c(H}) or 2.987. For 
the analogous case of observing l^N and decoupling ^H, the maximum NOE is -4.93, as 
the ^^N isotope has a negative value of y. Thus, on proton noise decoupling a l^N 
signal with the maximum NOE, the signal is reversed and is 3.93 times as large. 
However, in the case where the dipole-dipole contribution is less than 100% it is possible 
for the NOE to be close to -1, leading to a complete absence of signal.
In the limit of very slow tumbling, Eqn. (4.2) simplifies for the homonuclear case
to:
= (4.7)
which corresponds to a complete loss of the I  signal when S is irradiated and results from 
Wq transferring the saturation of S  to I. In such a very slowly tumbling multi-spin system 
this phenomenon can be a useful means of suppressing macromolecule signals (Stoez et 
a/., 1978). This is possible if the excitation of /passes to the next spin and the next etc., 
irradiating a single resonance thus can abolish the entire spectrum of the molecule. The 
propagation of population disturbance from one spin to another in this way is known as 
spin-diffusion, it is the population information which is actually diffusing, rather than the 
spins themselves. In the extreme slow tumbling limit mentioned above, spin-diffusion is 
both rapid and far-reaching, however in the fast tumbling extreme it is more limited.
It has been seen that steady-state NOE in a two spin system contains no distance 
information. For a fast tumbling homonuclear case a 50% enhancement will always be 
seen, whilst in a slow tumbling system the signal should disappear. However, for a rigid 
molecule tumbling isotropically, the rate at which the enhancement develops (and the 
spins relax) is dependent on the intemucleai- distance, as shown:
Pis ~ Y/Ys^ ’^ c^s (4-8)
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The important terms in Eqn. (4.8) are the IS distance and the correlation time, As 
the internuclear separation, increases, the intensity of the field produced by their 
interaction decreases and so the efficiency of relaxation also decreases. Thus the NOEs 
grow more slowly and the protons will have longer values of . The dependence is a 
crucial point in tlie coiTect application of the NOE.
Any process that induces changes in the population of one spin will lead to a 
NOE at the other spin. Saturation by irradiation is one way in which this population 
change may be brought about. Chemically Induced Dynamic Nuclear Polarisation 
(CIDNP) is another. This procedur e involves the formation of radicals in a solution by 
chemical or photochemical processes and can lead to massive population changes for 
those protons that are coupled to the unpaired electrons. These abnormal populations 
then induce NOEs at nearby spins in the usual way (More et al., 1982; Feeney et al., 
1980b).
4,2,1,2. Transient NOEs
An alternative method for inducing NOEs is to apply a selective 180° pulse on 
one of the resonances. This may be applied using a soft pulse from the decoupler. The 
result is to invert, within a few milliseconds, the populations of the levels associated with 
the S  spin. As in the steady-state experiment, Wq and Wj begin to redistribute this non­
equivalent population, and the NOE at I  starts to build up as before. However, in this 
experiment, the non-equilibrium distribution is not being continuously increased, and 
within a few Tjs both spins will have relaxed back to their original population 
distribution. The NOE at I, therefore is transient; it builds up to a maximum after about 
one and then declines. The pulse sequence for observing transient NOEs is shown in 
Figure 4.3.
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iH
Decoupler
AQ
Figure 4.3. Pulse sequence for observing tiansient NOEs
The NOE growth and decay can be measured by a series of experiments in which 
the delay between selective % pulse and non-selective n il read pulse is varied. The 
evolution is not observed directly; it is mapped by a series of experiments. The resulting 
NOE growth and decay rates can be analysed to give the usual t  and information 
(Noggle and Schirmer, 1971; Sanders and Mersh, 1982a).
The main importance for the transient NOE is as a conceptual introduction to the 
two-dimensional NOE, or NOESY, experiment.
In summary, therefore, the crucial difference between the two experiments, 
steady-state and tiansient NOEs, is that no radioffequency (rf) field is applied during the 
NOE build up in the transient NOE scheme, whereas the build up is driven by continuous 
irradiation in the steady-state NOE experiment. Therefore, the decay of the NOEs by 
spin relaxation is readily observable in the transient NOE experiment, where no fuither 
energy is transferred to the nucleai' spins after the initial 180° pulse. In contrast, a 
steady-state NOE build up, by the continuous irradiation and NOE decay by spin 
relaxation, is attained for long pre-irradiation times in the steady-state NOE.
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4.2.1.3. Two-Dimensional NOEs - NOES Y
The NOES Y experiment is transient in nature and the pulse sequence is presented 
in Figure 4.4 and consists of tlnee 90^ pulses.
iH mi
AQ
7i / 2  -  t  - n/2 - - 7^/2 - Acquire
Figure 4.4. NOESY pulse sequence
where is a 'mixing' time, during which the NOEs develop and x is the delay period. 
Of key importance in the NOESY experiment is the time delay (mixing time, t-^) which 
follows the second pulse. The nuclear Overhauser effects require a certain amount of 
time to build up and the length of time chosen for this mixing period depends quite 
dramatically on the properties of the molecule being investigated. Both size and shape 
are important as both of these affect the correlation time, which in turn affects the spin- 
lattice relaxation time and hence the NOE observed. For small rapidly tumbling 
molecules, with long s, is of the order of 1 - 5 s, whereas for large slowly tumbling 
molecules with short TJs, NOEs build up in a much shorter time and therefore the mixing 
times of the order of 50 - 200 ms are more realistic (Abraliam et a l, 1988).
The two-dimensional experiment in its simplest form is carried out by 
incrementing x, while keeping constant during the experiment, and employing phase 
cycling to suppress axial peaks and other artefacts. The cross-peaks consist of responses
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corresponding to the size of the transient NOE which has built up duiing It is 
possible, by analysis of how the cross-pealc intensity varies with to extract distance 
information from the spectra (Keepers and James, 1984).
A heteronucleai' 2D NOB spectrum can be obtained by applying the third, read, 
pulse to the X-spin of interest (Yu and Levy, 1984). This could be l^C, l^N, or any
other nucleus which relaxes mainly by dipole-dipole interaction with protons.
4.2.2. The NOE in a System with Three Protons
In a tlnee-spin system the combined effects of and distance can become quite 
complicated.
4,2.2,1, The Linear System
Considering thiee spins with geometry such that = 1 (Figure 4.5):
SPIN SPIN SPIN
Figure 4.5. Linear three spin system where — 1-
The relaxation rates p can be calculated and are given in Table 4.1,
/c(B) = p,c/2R^ (4.9tO
f M )  «  iPA» / 2 R , ) / ( 1 - p I c  (4.10)
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f c ( ^ ) ^ - f c ( S ) f „ ( A )  (4.11a)
/ / C ) « - / , ( B ) / „ ( C )  (4.11b)
Using these values the steady state NOEs are calculated using the Equations (4.9), (4.10)
and (4.11) (Noggle and Schinner, 1971) and aie given in Table 4.1.
A B C ÎA Î b f c
Pab 1.0 1.0 - {A} - 25.0 -11.5
Pbc - 1.0 1.0 {B} 49.2 - -49.2
Pa c 0.016 - 0.016 {C} -11.5 25.0 -
1.016 2.0 1.016
Table 4.1. Relaxation and steady-state NOEs in a linear three-spin system withr^g = = 1.
From the data in Table 4.1 it can be seen that the central proton B relaxes almost 
twice as fast as A and C, because it has two equidistant protons providing relaxation 
pathways. This leads to a maximum enhancement for B of 25% when either A or C is 
saturated, as A and C each provide only half of the relaxation of B. Proton C is twice as 
far away from A as B, and so is only 2"^ (i.e. 1/64) as effective (and vica versa). 
Therefore A and C relax more slowly, and satuiating B gives 49.2% NOEs to each, 
according to the equations (Noggle and Schirmer, 1971):
/ c W “ P«c/2^c (4.12b)
The rates p^g and pg  ^ at which the NOEs grow are the same.
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If the distance is doubled in the tlnee spin-system, the relaxation rates and 
steady-state NOEs change and aie given in Table 4.2. Wlien B is saturated, the NOEs 
experienced by A and C are relatively unchanged from the previous case. This is 
because B is still the near est spin to both A and C, and hence dominates their relaxation. 
However, the NOEs at B when A and C are saturated have changed dramatically. p^ ,g 
now contributes very little to the relaxation of B relative to the contribution of pg^ . and 
hence saturation of A gives a very small NOE at B; by contrast, saturation of C entrances 
B by almost 50%.
A B C ÎA Î b f c
Pab 0.016 0.016 - {A} - 0.8 -0.4
Pbc - 1 1 (B) 46.0 - >49.9
Pa g 0.001 - 0.001 (C) -18.6 49.2 -
Rx 0.017 1.016 1.001
Table 4.2. Relaxation and steady-state NOEs in a three-spin system with r^ g =2,rgf. =1.
Because relaxation is a competitive phenomenon, the NOEs between two protons 
X and Y depend as much on their distances from other protons as on . The NOE 
observed at B when C is saturated, in the above case, is radically affected by variations in 
r^ g even when Tg^  is constant. A reduction in r^ g to 0.5, would give a NOE of only
0.8% to B, when C was saturated. All that can be measuied from the steady-state 
experiment is relative distance.
The negative enlialicements shown in Tables 4.1 and 4.2 are indirect, geometry- 
induced effects, quite different from the general negative NOEs that occur when is 
negative or orT^  > 1- In^  the fast tumbling tluee-spin system the result of saturating the A 
spin is to increase the net magnetisation of the B and C spins. Hence, decreasing the
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population difference in A, increases the population difference in B and C. The 
increased population difference in B will lead to a decreased population difference in C
i.e., a negative NOE resulting from spin diffusion. This indirect negative contribution to 
the NOE at C is in competition with the direct positive contribution fr om A. The size of 
tlie indirect contribution is the negative product of the two NOEs involved (Eqn. 4.11). 
Thus the -11.5% enhancement for fc{A )  in Table 4.1 is the sum of the direct 
contribution of 0.8 % and a negative contribution of 12.3% (25% x 49.2%). Increasing 
has a diamatic effect on the indirect NOEs. fc{A )  is very small because /g{^} is 
so small, but the reverse experiment of irradiating C would give an NOE to A of -18.6% 
because both fn{A )  and y^{B}are large.
The lineal* thi'ee-spin system is a favourable geometry because the enliancements 
aie large and can be measured accurately. Relative distances between adjacent spins can 
be determined easily and accurately. The most important enhancements for determining 
the ratio r^ g /fg^ , where spin B is between spins A and C are those when spin B is 
observed. Enhancements between next-neaiest neighbouis will be small and often 
negative in this geometry; distances between next-nearest neighbouis cannot be 
determined accurately.
4,2,2.2. Non-Lin ear Systems
Considering the non-linear system where the A-B-C angle is 0 and r^ g = i*g^  = 1 
(Figure 4.6). As 0 decreases from 180°, decreases and the direct positive NOE 
between A and C increases. As a result of this more effective A-C relaxation, the B-C 
relaxation process becomes relatively less important and the indirect negative A-C 
contribution conespondingly decreases. Wlien 0 = 78®, 1-26 and there is no net
NOE between A and C even though the spins are very close together; the direct positive 
and indirect negative effects are equal and opposite. Compaied to the linear case, the
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enliancements of the non-lineai' case are smaller. In the limiting case of tlnee spins on an 
equilateral triangle, all of the enhancements approach 20% as a maximum.
AB SPINSPIN
SPIN
Figure 4.6. Non-linear spin system where A-B-C angle is 0 a n d “  I-
In slowly tmnbling systems of tliree spins, all direct NOEs are negative and the 
indirect contribution to /^ { Q , calculated using Eqn. (4.11), is negative also. The direct 
and indirect contributions aie in the same direction and larger as a result of Eqn. (4.5), 
than in the small molecule case. It is not possible to distinguish between direct negative 
and indirect negative NOEs by appearance alone. As with the small molecule case, 
however, they can be distinguished on the basis of their kinetic behaviour. The direct 
NOE grows without a lag, and initially follows simple kinetics according to whereas 
the indirect NOE grows only after a lag phase.
For very slowly tumbling systems, if iiTadiation is continued indefinitely, Eqn. 
(4.5) shows that the whole system will experience 100% negative NOE and no signal is 
observed in the spectrum. This spin diffusion removes all the useful distance specificity 
from the NOE experiment in large molecules. However, if the irradiation is restricted to 
a short time, before spin diffusion becomes effective, then the distance specificity is 
restored. This is laiown as truncated NOE. Transient and two-dimensional experiments 
also restore distance specificity provided is sufficiently short.
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4.2.3. Heteronuclear NOEs
The theory for heteronuclear NOEs between spin-1/2 nuclei is similar to that of 
homonucleai* NOEs. However, the ratio of ys given by Eqn. (4.4) indicates that (a) 
unless the ys are nearly equal, only experiments where the spin of lowest y is observed 
are practical; (b) when the spin of lowest y is observed, enliancements may be very large 
compared to those foimd in the homonucleai* cases. The latter point is particularly 
important since spins of low y typically have poor signal-to-noise ratios which can be 
suitably improved by the NOE. This was first demonstrated by Kulilmarm and Grant 
(1968) when they observed the 1^C{^H} NOE in formic acid and obtained 
fç, {H} = 1.98 ± 0.15 compared to the theoretical maximum ratio of 1.988. The maximum 
NOE enhancements for some experiments are listed in Table 4.3.
Observe {iH} (19f }
iH 0.50 0.47
3h 0.47 0.44
13c 1.99 1.87
15n -4.93 -4.64
19p 0.53 0.50
31p 1.24 1.16
Table 4.3. Maximum NOE enhancements for various heteronuclear experiments.
4.2.4. NOE Difference Spectroscopy
The difference method is the most sensitive and rigorous of experiments by which 
NOEs may be detected and spatial and structural information deduced. The theoretical
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lower detection limit is set only by the available dynamic range; in practice the limit is 
usually set by signal-to-noise considerations and instrument stability. Furthermore, the 
signals to be monitored do not even need to be resolved in the normal spectrmn. It is 
possible routinely to observe 1% enliancements of completely liidden multiplets. This 
methodology extends from the fact that NOEs are easier to detect by the subtraction of 
one spectrum or FID from another, resulting in the so-called difference spectrum in 
which unaffected signals disappear leaving only the enliancement itself and the saturated 
resonance. In the first spectrum a signal is saturated, using gated decoupling, whilst in 
the second spectrum irradiation is performed away from any signals. Subtraction of the 
second spectrum fr om the first gives the difference spectrum that uncovers any NOEs.
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4.3. EXPERIMENTAL CONSIDERATIONS
4.3.1. Optimising NOE Difference Spectra
The ideal NOE experiment gives the maximum intensity of enhancements with 
total sensitivity in the irradiation and no artefacts from imperfect subtraction. In practice 
there are certain factors which are not perfect e.g., frequency selectivity and subtraction, 
however caiefrrl design and setting-up of the experiment can dramatically improve both 
the appearance of the spectr um and the chance of a successfril solution to the problem.
4.3.1.1, Maximising Enhancements
In order to obtain the largest possible useful NOE, the contribution of 
intramolecular* dipole-dipole relaxation should be maximised. This can be achieved by 
using dilute solutions in solvents without high concentrations of protons (to avoid 
problems from intermolecular* interactions). In the case of very small molecules tire 
presence of par amagnetic molecules can have a profound effect on the spectrmn. Where 
the paramagnetic species are metal ions tire result may simply be very broad or* 
mrobservable NMR signals. However, the most common paramagnetic species is 
dissolved oxygen and its effects can be extremely severe for the relaxation or* NOE 
experiment. Because y^ iedro,, is about 1000 times bigger than nuclear* relaxation,
being dominated by the unpaired electron, will be rapid. Intramolecular dipole-dipole 
relaxation will be relatively less important and there is a resulting loss of useful proton- 
proton information. In very small molecules, where intrinsic relaxation rates are slow, 
the contribution of dissolved oxygen may dominate relaxation (in organic solvents its 
contribution is of the order of 0.1 s"l) whereas, in contrast its effects will be insignificant 
in larger molecules which relax rapidly. Therefore, for very small molecules, it is
Chapter 4: NOEs in Tritium NMR 15 0
necessary to remove as much dissolved oxygen as possible by de-gassing the sample 
either by the 'freeze-pump-thaw' method or more simply by bubbling dry (oxygen-free) 
nitrogen or argon tlrrough the solution in the NMR tube for a few minutes.
These techniques help to remove external sources of relaxation which slow down 
the overall relaxation rate, but do nothing to increase the rate of dipole-dipole relaxation 
and NOE growth. Wliere is very slow, the use of a higher viscosity solvent can help 
to increase
Hence, when relaxation delays and inadiation times are being set for NOE 
experiments, relaxation times are an important consideration. For the steady-state where 
NOE signal/noise is to be maximised, it is most efficient for the irradiation time to be 1 - 
2 average TJs for the acquisition time to be the minimum consistent with digital 
resolution requirements and for the start of the next irradiation, at the same fr equency, to 
begin inmrediately after the end of the acquisition, with no relaxation delay in-between. 
However, the use of this teclmique for NOEs between distant nuclei and indirect tliree- 
spin and spin diffusion effects is unsatisfactory. For these effects to be observable, 
irradiation times of up to 10TJs would be more appropriate in order to maximise these 
long range and indirect enliancements.
If the acquisition time is short relative to decay rates, then the enliancements will 
build up from one acquisition to the next, eventually approaching the steady-state value. 
In this case, the irradiation time between pulses is virtually irrelevant, provided that a few 
dummy scans aie inserted at the beginning of the sequence to allow enliancements to 
build up before the first acquisition.
4.3.1.2, Acquisition Strategies
In a NOE difference experiment it is necessary to acquire the control and 
irradiated spectium as iieaidy simultaneously as possible, this helps to eliminate any
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artefacts present due to minute phase or frequency shifts between the two spectra which 
can ruin the resulting difference spectium. To achieve this, the separate irradiations are 
interleaved. Wlien phase cycling and quadrature detection are employed, at least eight 
transients are acquired with irradiation at the first frequency v,, then eight irradiating at 
V2, the decoupler frequency being shifted automatically under computer control. The 
control spectrum is generated by irradiating at a frequency which is in a chemical shift 
region that contains no signals. Wlien several different irradiations are required, two 
different experimental methods are available. In the original method (Richarz and 
Wiltlnich, 1978) the FIDs from the control irradiation aie subtracted during acquisition 
so that only the difference accumulates. After a pre-determined number of transients the 
difference FID is stored and the next irradiation experiment begins. In the second 
method (Hall and Sanders, 1980) FIDs from each irradiation aie stored separately for 
later processing. After eight transients have been acquired for iiTadiation at each 
fr equency v^  -  v„, the whole experiment is repeated until adequate signal-to-noise has 
built up. The second method has several advantages:
(i) Only a single control spectrum for all the different n irradiations is required, 
making n + \ experiments in total. If the difference is directly acquired then the control 
is required n times, requiring 2n experiments. This leads to increased lengths of time for 
a given signal-to-noise ratio, for example, when n is 1 0 - 20, which is often the case in 
natural product work.
(ii) The entire sequence can be stopped at any time in the laiowledge that each 
desired irradiation has been completed, as time elapses the signal-to-noise ratio of each 
experiment improves.
(iii) The availability of the control spectrum allows calibration of intensity of 
responses in the difference spectrum.
(iv) With only one control spectrum being acquired it is possible to use a 'liit and 
miss' approach to analyse complex spectra. The maximum number of different
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irradiations is carried out in one experiment (consistent with adequate signal-to-noise for 
each) and the results are analysed afterwards. It is possible that some were unnecessary 
or uninformative, but this is less demanding of instrument time than returning for 
additional experiments and the necessary acquisition of a new control spectrum; it is also 
possible that the NOE can be observed in both directions, along with the possibility that 
the extra irradiations will provide unexpected information (Mersh and Sanders, 1981).
4.3.1.3, Minimising Subtraction Errors
For the difference experiment to be successful the utmost performance of the 
NMR spectrometer is necessary. To eliminate the unaffected signals entirely, the two 
spectra must coincide exactly, with the signals being at the same absolute frequencies.
x256
x256
a.
\
a-4 2 2  ppm -
Figure 4.7. Control and NOE displays of a small portion of a 400 MHz spectrum of heptamethyl 
cobyrinate. (a) Control spectrum (b) uncorrected NOE spectrum (c) the corrected difference spectrum 
obtained after a 0.005 Hz relative shift of the two specti a (Sanders and Mersh, 1982b).
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Imperfect subtraction of signals leads to artefacts which look like dispersion responses. 
In population experiments where the decoupler is off during acquisition, the artefacts 
ar ise fr om small random phase or frequency shifts between acquisitions, the effects of a 
few millihertz or tenths of a degree shift can be quite severe (Sanders and Mersh, 1982b). 
Figure 4.7 shows the effect of corrected and uncorrected NOE difference spectra of 
heptamethyl cobyrinate.
Hence, the fr equency generator of tire instrument must be stable to within narrow 
limits tlrroughout the course of the experiment. A frufher precaution is to acquire a lar ge 
number of transients, preferably overnight. This helps because the artefacts, like other 
random noise, decrease relative to useftil signals as the number of transients is increased.
4.3.2. Optimising NOESY Spectra
In general, ^H-^H NOESY is not the method of choice for very small molecules, 
although it has been successfully applied to the relatively small cytochalasin B (Graden 
and Lynn, 1984). Detailed guides have been given for the application of NOESY and 
other 2D techniques to proteins (Wider et al., 1984) and to ^-RNA (Hare et a l, 1985).
The mixing time, between the mixing and read pulses should be set to around 
7J for the protons involved, in order to maximise the transient NOE which can be 
recorded. In most molecules there is quite a substantial range of relaxation times, and 
one is usually interested in NOEs across a range of distances, so it is fr equently necessary 
to acquire two or three spectra with different mixing times.
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4.4. APPLICATIONS OF THE NOE EXPERIMENT
The most important property of proton-proton NOE difference and 2D NOE 
spectroscopy is the ability to make comiections between nuclei tlirough space, 
independently of any chemical bonding considerations. A second valuable feature is its 
ability to extract, from a mass of overlapping resonances, a single multiplet whose 
chemical shifts and coupling constants can then be measured. The chemical and 
biological problems to which NOEs have been applied fall into four* broad categories: the 
assigrnnent of spectra, determination of covalent structure, the determination of 
conformation and the study of molecular motion. There is much overlap between these 
and to a large extent, a problem in one area can be solved only by maldng assumptions 
about the other tlnee.
4,4.1. Assignment of Spectra
NOE difference spectroscopy was originally developed in order to help assign 
protein spectra, but it has proved to be a powerful method for assigning both simple and 
complex organic molecules (Richarz and Wüthrich, 1978). The ability to reveal hidden 
multiplets is often as important as making tlnough-space comiections.
For the study of protein-ligand complexes, chemical shift degeneracies not only 
make it difficult to assign the NMR spectra to residue types, but also complicate the 
analysis of 2D NOESY experiments. This is particulaiiy difficult when one proton has 
NOE connectivities to several others; any ambiguity in the assignment of the nuclei 
contributing to the NOESY cross-pealcs malces it very difficult to apply the sequential 
assigrnnent method (Wütlirich, 1986) in a straightforward maimer. Although 2D or 3D 
methods (e.g. combining HOHAHA and NOESY) contribute to removing some of the 
ambiguities, the short values of larger proteins malce these methods difficult to use.
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Selective deuteratioii has often been used to simplify the spectra in these cases 
(Birdsall et a l, 1984; Feeney et a l, 1989). By caieftil choice of the deuteratioii pattern it 
is possible to simplify 2D NOESY spectra so that unambiguous comiections can be made 
between the remaining protons in the molecule (Feeney et a l, 1989; Birdsall et a l, 
1990). For proteins which aie too large to assign by using the direct sequential 
assignment method, the NOE data can be used in conjmiction with available 
crystallographic structural information to allow specific assignments to be made 
(Hammond et a l, 1986, 1987). The observed NOE cross-pealcs can be correlated with 
anticipated distances r (or r"^ values) talcen ftom the crystal structure data (assuming the 
solution and crystal structmes are the same). This approach has been used for L. easel 
dihydrofolate reductase (Mj. 18 300) based on the refined crystal structme of the enzyme- 
methotrexate-NADPH complex (Matthews et al., 1979; Bolin et al., 1982).
Birdsall and co-workers (1984) reported the combined use of selective 
deuteratioii and NOE difference experiments to assign the valine and tyrosine resonances 
of L. easel DHFR. Selective deuteration of the enzyme provided information on the 
resonances of the 16 valine residues in the enzyme, but to assign Ifl resonances to 
individual valine residues, the use of NOE experiments was essential to identify residues 
close in space.
By using a combination of ID and 2D NOE methods in conjunction with the 
enzyme-methotrexate-NADPH crystal structure data, Hammond et al (1986) were able 
to assign resonances for all the histidine and tyrosine residues, as well as several valine, 
leucine, isoleucine and phenylalanine residues in L. easel DHFR. Selective deuteration 
of the enzyme provided the necessary selectivity, particulaiiy in ID experiments. Further 
examples of the use of selective deuteration in combination with NOESY experiments to 
assign protein resonances in L. easel DHFR include the identification of signals ftom all 
eight Phe (Feeney et a l, 1989; Birdsall et ah, 1990) and fom* Trp (Birdsall et al., 1990) 
residues.
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One other approach for ftnther simplifying spectra involves 3D or 
isotope editing of NMR spectra and this method has provided new possibilities for 
assigning NMR spectra of larger proteins (Fesik and Zuiderweg, 1988). The utility of 
heteronuclear 3D NMR spectroscopy for resolving spectral overlap is illustrated by the 
studies of Carr and co-workers (1991) who used 3D NOESY-HMQC experiments on 
uniformly l^N-labelled DHFR (as its binary complex with methotrexate) in order to 
obtain sequential resonance assigmnents and to extract secondary structure information 
for the protein in solution (CaiT et ah, 1991).
4.4.2. Determination of Structure
For small molecules, these have generally been of the kind that require the fitting 
together of several Imown fragments of a molecule. The problem may include 
determining the relative stereochemistry of a tertiaiy or quaternary carbon (Chan and 
Matlin, 1981) or a double bond which is tri or tetra substituted. It may even be that of 
finding the correct substitution order of several substituents around an aromatic system. 
There have been many recent uses of the NOE to solve structural and stereochemical 
problems, some of which ar e mentioned in reviews (Noggle and Schirmer, 1971; Sanders 
and Mersh, 1982a).
In relation to the present work, NOESY spectra have been employed to define the 
molecular structure of folic acid in DMSO-dg solution. The solid state structure of folic 
acid has previously been defined, but there have been few investigations on the structure 
of the substrate in solution (Rossi et a l, 1992). Rossi and co-workers combined 
magnetic dipolar connectivities and energy minimisation molecular* mechanics 
calculations in order* to propose the solution structur e of folic acid. Likewise, structural 
information gained by measuring 13c{1h} NOEs on selective saturation of the
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glutamate NH and H-3' of methotrexate (Gaggelli et al, 1993) led to the proposal of a 
'preferred' conformation of methotrexate in DMSO-dg solution.
One- and two-dimensional NOE experiments can also provide structmal 
information about the enzyme binding site by means of the NOEs between protons of the 
ligand and receptor. For example, in the L. easel DHFR-folate-NADP’*' complex, NOEs 
are observed between the nicotinamide 5- and 6-protons of NADP’*' and the methyl 
resonances of Tln-45 at both low and high pH, indicating the position of the 
nicotinamide ring in the enzyme binding site (Birdsall et al, 1989b).
In the DHFR-methotrexate-NADP"^ ternary complex, NOEs are observed 
between the pteridine 7-proton of the inhibitor and the methyl protons of Leu-19 and 
Leu-27 (Hammond et a l, 1986). Subsequent 2D ^H-l^C HMQC-NOESY experiments 
on the DHFR-[4,7,8a,9-13c]methotrexate complex were used to obtain further 
information on the orientation of the inhibitor in the binding site (Cheung et a l, 1993). 
Connections were observed between the C-7 proton and signals at the assigned positions 
for protons in the methyl groups of Leu-19 and Leu-27 as well as those in the N^gCHg 
group of bound methotrexate. The C-9 protons showed connections to Tlu-45(CH3) and 
Phe-49(e, Q and an intramolecular" NOE to N^QCHg of methotrexate. No connections 
were seen between H-9 and the benzoyl ring protons and this was reported to be because 
the latter have broad signals due to slow ring flipping.
The DHFR-fblate-NADP"^ ternary complex is known to exist in three 
interconverting conformational states (Birdsall et al, 1981, 1987) which are pH 
dependent. At low pH, form I predominates whereas, at high pH forms Ila and lib 
predominate. The results from ^H NOESY experiments have been used in conjunction 
with 1h, l^C and NMR studies to characterise the conformation of the tlnee forms 
at the binding site. From NOESY experiments it has been shown that forms I and Ila 
have the pteridine ring in a methotrexate-like orientation (Birdsall et a l, 1989a). NOE 
comiections were established between the pteridine H-7 and the assigned methyl protons
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of Leu-19 and Leu-27, the same as observed in the NOESY spectra of DHFR complexes 
with methotrexate.
More recently, 2D ^H-l^C HMQC-NOESY experiments on ternary complexes 
formed using [2,4a,7,9-^^C]folic acid have been used to establish intermolecular NOEs 
between the folate H-7 and protons on the protein, and these provide further 
characterisation of tlie orientations of the pteridine ring in the different bound forms of 
folate (Cheung et a l, 1993). In the LH-^^c HMQC-NOESY spectrum of DHFR- 
[2,4a,7,9-^^C]folate-NADP'^, the H-7 in form Ila shows an NOE coimection to the 
methyl protons of Leu-27 (a similar connection is seen in the HMQC-NOESY
spectrum of the methotrexate complex). The H-7 in form Ilb shows a connection with 
the Ala-97 methyl proton signal, indicating the proximity of these protons. One­
dimensional NOE difference spectra selectively irradiating the H-7 signals in forms I, Ila 
and lib for the DHFR-folate-NADP'*' complex, at pH 6.5, was used to confirm that only 
form lib gives a large NOE to the methyl group of Ala-97 (Cheung et a l, 1993).
Another teclmique for studying the structure of proteins and protein-ligand 
systems is the use of ^^F-labelled proteins, and employing heteronuclear ^^F{^H} 
NOEs. Heteronuclear ^^F{^H} nuclear" Overhauser enliancement experiments have been 
reported for studying (4-(trifluoromethyl)benzenesulfonyl)-a-chymotrypsin (Gerig, 
1977, 1980, 1981). Transient NOEs have been used to explore the protein
enviromnent of the trifluoromethyl group of the modified enzyme. Computational results 
for a small model spin system which had dynamic properties appropriate for a protein the 
size of chymotrypsin were presented and these suggested that the NOE experiments 
should indicate the chemical shifts of those protons of the protein closest to the CFg 
group. Results from this study and those of a ^^F{^H} time development study on the 
same system (Gerig, 1981) were shown to be consistent with the structural model for the 
immediate enviromnent of the CFg group, proposed in earlier work (Gerig et al., 1979).
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4.4.3. Conformational Investigations
If a molecule is flexible, or can talce up several distinct conformations in solution 
then NOEs can be used to identify which spins are close to each other. Many early 
examples of small molecules were given by Noggle and Schirmer (1971). More recently, 
the bulk of conformational studies using ID and 2D NOEs have concentrated on large 
molecules such as peptides and proteins (Sanders and Mersh, 1982a; Feeney et a l, 1983; 
Wider et a l, 1984), polynucleotides and polysaccharides (Sanders and Mersh, 1982a). 
These tend to be qualitative rather than quantitative, distinguishing, for example between 
P-pleated sheets and a-helices in proteins (Zuiderweg et ah, 1983).
For weakly bound ligands, experimental approaches have been developed to 
circumvent the problems associated with selectively detecting the resonances of the 
ligand in the presence of many signals of the macromolecule to which it is bound. These 
tecliniques involve the measurement of transferred nuclear* Overhauser effects (TNOEs) 
for ligands that exchange rapidly flom the bound to the flee state (Albrand et a l, 1979; 
Cayley et aL, 1979; Clore and Gronenborn, 1982). Negative NOEs due to the bound 
state are observed on the flee or averaged resonances of the ligand which are nar*rower 
than the signals of the macromolecule and easily identified. From an analysis of these 
NOEs the conformation of a ligand bound to a macromolecule can be determined. In 
fact, fl’om the measurements of TNOEs the conformation of ligands bound to proteins 
(Hyde et a l, 1980a;Feeney et a l, 1983; Birdsall et al, 1987), phospholipids (Wakamatsu 
et a l, 1987) and nucleic acids (Gronenborn et a l, 1984) have been reported. The TNOE 
method can provide quantitative conformational information about a ligand bound to a 
protein without the necessity for direct observation of the signals of the bound ligand.
Transferred NOE experiments have been used to determine the conformation of 
the inliibitor trimethoprim bound to L  casei (Cayley et a l, 1979), E. coli and L1210 
(Birdsall et al., 1983) DHFR.
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The chemical shifts of the aromatic proton resonances of trimethoprim in its 
complex with L1210 DHFR have previously been detennined by the saturation-transfer 
method (Forsen and Hoffman, 1963). When excess ligand is present, the protons of 
trimethoprim exist in two environments conesponding to the free and bound states; if the 
rate of exchange between these states is sufficiently slow, separate signals will be seen 
for each state. In this experiment (Birdsall et a l, 1983) the resonances from the excess 
free trimethoprim were clearly visible, while those from the bound ligand were not.
H 2  6
H6
3-5 p p m  3 0
Figure 4.7. (Lower) Aromatic region of 270 MHz spectrum of a sample containing 1 mM 
trimethoprim and 0.2 mM L1210 DHFR. The aromatic proton resonances of the excess, free trimethoprim 
are labelled. (Upper) Difference between tliis spectrum and one in which a satmating radio frequency field 
has been applied at 2.41 ppm, the resonance frequency of H-2',6', in bound trimethoprim. The marked 
decrease in intensity of the H-2',6' resonance of free trimethoprim arises from transfer of saturation and tlie 
smaller effect on the H-6 resonance from a tiansferred NOE effect.
Saturating the resonance of a proton in the bound state, transfers this saturation to 
the fi'ee state by the exchange process and a decrease in intensity of the corresponding 
resonance of free trimethoprim would be observed. Hence, the NOE difference spectr um 
of L I210 DHFR-trimethoprim (Figure 4.7) showed that irradiation at the resonance 
frequency of the H-2',6' bound trimethoprim leads to a small decrease in the intensity of 
the H-6 resonance of fr ee trimethoprim as well as a large decrease in intensity of the H-
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2',6' resonance due to a transfer of saturation. Thus, irradiation at the resonance 
frequency of H-2',6' of bound trimethoprim leads to a decrease in the intensity of the H-6 
resonance of the bormd ligand by cross-relaxation and this effect is transferred to the H-6 
signal of fr ee trimethoprim by the exchange process - the TNOE. Since the sign of the 
NOE depends on the correlation time of the internuclear* vector the observation of a 
negative TNOE (a decrease in intensity) demonstrates that the effect originated from the 
bound ligand. Therefore, it was concluded that the conformation of trimethoprim bound 
to L1210 DHFR is such that H-6 is close to H-2' and/or H-6'; this is also the case for the 
complex with the L. casei enzyme (Cayley et a l, 1979).
A further example of the TNOE has been the use of this teclmique to provide 
information about the glycosidic bond conformations ofNADP"^ and thioNADP+ in their 
complexes with L. casei DHFR (Feeney et aL, 1983). Both NADP"*" and thioNADP"^ 
were shown to have very similar' anti conformations about their adenine glycosidic bonds 
when bound to the enzyme. However, their nicotinamide glycosidic bond conformations 
were shown to be very different; while NADP^ binds in an exclusively anti 
conformation, thioNADP'*’ binds with a distribution of syn/anti conformations very 
similar to that observed in nicotinamide mononucleotides (Egan et a l, 1975).
Another NOE technique that has been used to provide evidence for the existence 
of multiple conformations in protein-ligand systems is two-dimensional/exchange 
spectroscopy (Birdsall et al., 1987). Figure 4.8 shows the NOESY/exchange spectrum of 
the binar y complex of L. casei DHFR with excess folate. The 7-proton resonance of fr ee 
folate is seen at 4.95 ppm, whilst the cross-peaks (off-diagonal peaks) from tliis 
resonance arise from the exchange of folate between free and bound states. As can be 
seen in Figure 4.8 there are two such cross-peaks indicating that there are two bound 
states for the folate molecule, with 7-proton resonances at 4.4 and 5.6 ppm, respectively.
Chapter 4: NOEs in Tritium NMR 162
H7free H7
boundH7bound
5.5 5.0 4.5cua /  ppm
Figure 4.8. (Top) Low-field region of tlie 500 MHz NMR spectnim at 278 K of a sample containing 
DHFR and folate in a ratio of 1:2. The 7-proton resonances of free and bound folate are indicated. 
(Bottom) The corresponding region of the 2D exchange spectrum, showing the cross-peaks linking the 7- 
proton resonances of free and bound folate.
4.4.4. Mobility Studies
Where assignments and interatomic distances are reliably known the p values can 
be used to measure i.e. effective mobilities. For larger molecules, where cot^  > 1 then 
the sign and size of the steady-state enhancement will allow elucidation of an effective 
Thus NOEs from directly attached to or to range from maximum values 
of + 198% and - 493% in the rapid tumbling case to 0% when is very long. The main 
focus of this type of mobility study has been the use of NOEs (and Æ%s) to
probe motion in synthetic polymers (Heatley, 1981) and proteins (McFai'lane and 
Rycroft, 1981). The use of NOEs to measure effective values of x^ has been
much less common, probably because the important internuclear distances are rarely 
known with accuracy.
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Searle and co-workers (1988) have reported the use of and NMR line- 
shape and relaxation measurements to study the fluctuations in conformation of the 
antibacterial drug, trimethoprim when bound to L. casei DHFR. NOEs were
used to calculate the cross relaxation rate which was, in turn, used to
calculate the spectral densities which ar e an expression of the effects of molecular motion 
on the fom* measured relaxation parameters R2 , <^ ch NOE.
4.4.5. Nuclear Overhauser Enhancements
Nuclear Overhauser enhancement of tritium signals measured with proton noise- 
decoupling would be expected to exhibit a maximum value of 0.47, assuming 100% 
dipole-dipole relaxation (Eqn. 4.5). Elvidge and co-workers (Al-Rawi et ah, 1976) when 
first utilising proton noise-decoupling, carried out inverse gating experiments, with a 
delay time of 5 x 7J (proton value) and observed no significant difference in intensity or 
total relative integrated intensity as compared with the normal decoupled spectrum. 
They concluded the NOE defects were absent, possibly due to the presence of radical 
species in solution (derived from radiolytic decay). Altman and Silberman (1977a) 
refening to tire work of Canet (1976) (who pointed out that, where the relaxation times of 
the indicated and observed nuclei are similar, cross-relaxation effects require a delay of 
at least 10 x for decay of the NOE), reported NOE values of up to 0.4. Elvidge and 
co-workers (Bloxsidge et a l, 1977) confirmed these findings of Altman and Silberman, 
but rejected their conclusion that 7^  and NOE measurements had to be made for every 
sample before a useful analysis could be attempted. It is now generally accepted that for 
NOE experiments, a waiting time of 107J is essential for observing the 
maximum possible NOE.
3h(^H} NOEs have been measured for small molecules such as steroids (Altman 
and Silberman, 1977b; Kaspersen et ah, 1987) and macromolecular systems where the
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enzyme is specifically labelled with tritium (O'Connell et al, 1990, 1993a, b). One- and 
two-dimensional NOE experiments on specifically tiitiated tosylchymotrypsin
have been used to examine the properties of the tosyl group in this protein. Irradiation at 
the proton frequency of samples of the tritium labelled enzymes produced a 
NOE which was substantial and negative, consistent with dipolar interactions with 
neighbouring protons being an important component of tritium relaxation. The same 
experiment with enzyme containing a tritiated tosyl group having the remaining tosyl 
protons replaced by deuterium showed a NOE of nearly the same magnitude.
Thus, it was reported that the proton-tritiimi dipole-dipole interactions must take place 
with protons attached to amino acids of the protein that are adjacent to the tosyl group, 
since protons in the methyl group and on the aromatic ring of the tosyl moiety had been 
replaced by deuterium. The authors used tiansient NOE measmements in order
to help define tlie parameters appropriate for multidimensional NOE experiments on the 
protein. Hence, the nature of the tiitium-protein proton interactions was explored further 
by means of 2D proton-tritium Overhauser experiments. The presence of several tritiated 
isotopomers complicated analysis of the experiments and extensive computer simulations 
of relaxation behaviour of tritiated species present were used in conjunction with models 
developed fiom crystallographic results to interpret the observations made (O'Connell et 
a l, 1993a, b).
The application of ID and 2D ^H{1H} NOE experiments to this system has 
clearly demonstrated the usefulness of ^H{^H} NOEs in a system where tritium atoms 
are present. These positive results together with the vast wealth of NMR and 
crystallographic information available on the enzyme DHFR in its complexes with folate 
and methotrexate suggest that ^H{^H) NOEs could be employed to clarify and further 
confirm some of the interactions between the tritium labelled ligand and the amino acid 
residues on the enzyme. In pai'ticular, measuring heteronuclear’ ^H{^H} NOEs from the 
T-7 of methotrexate to near by protons on the protein would enable us to unambiguously
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identify the protein contact residues. Information ftom NOE studies is already 
available which indicates that H-7 is near* to the methyl groups of Leu-19 and Leu-27; 
however, the interpretation of such information is always complicated by the possibility 
of chemical shift degeneracy in the H-7 region of the proton spectrum. Clearly the 
tritiated H-7 would remove this ambiguity.
As a prelude to the experiments with the macromolecular system, ^H{^H} NOE 
experiments were carried out on small molecules. pHjDMSO was chosen to optimise 
the spectrometer conditions employed for observing ^H{1H} NOEs in the steady-state 
experiments. [3',5',7-^H]folic acid and [3',5',7-^H]methotrexate were then irradiated at 
pre-selected proton frequencies and the ^H{lH} NOEs produced were measured and 
recorded.
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4.5. EXPERIMENTAL
[3',5',7-^H]Folic acid and [3',5',7-^H]methotrexate were prepai'ed as described in 
Chapter 2 and the %  and NMR spectra recorded in D2O. pHJDMSO was prepared 
according to Stewart and Jones (1967).
The tritiated samples were placed in 4 mm Teflon liners with stoppers which 
were then placed inside 5 mm screw-cap glass NMR tubes. To remove any dissolved 
oxygen, dry (oxygen-free) nitrogen was bubbled through the solution in the NMR tube 
prior to the NMR experiment.
Tritium NMR spectroscopy was carried out on the Bruker AC-300E system 
mentioned in previous chapters. All spectra were obtained with the sample spinning and 
with the sample temperatme regulated at 298 K by the instrument controller.
Spin-lattice times (7J) were determined by the inversion recovery method using 
the (180°-T-90^-t)i^ pulse sequence.
Steady-state nuclear Overhauser enlrancements were determined with
gated decoupling tecluiiques upon pre-saturation of pre-determined proton resonances. 
In order to account for isotope effects in the NMR spectrum, the spectrum was 
irradiated ca. 9 Hz upfield of the required signal. Typically 32 transients were 
collected for each of tlnee resonance frequencies (one blanlc and two pre-selected 
proton resonances), using four dummy scans before each accumulation with a delay of at 
least lOx the tritium 7J between each accumulation (Altman and Silberman, 1977a). 
About 18 hours were required for each NOE experiment.
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4.6. RESULTS
4.6.1, pH]Dimethyl Sulphoxide
A sample of [^H]DMSO (20 mCi) in dg-DMSO siirroimded by CDCI3 was used 
as a test sample to optimise the conditions necessaiy for observing the steady-state 
NOE in a small molecule. Figure 4.9 shows the NMR spectrum of
CH3SOCH2T with (a) irradiation at 5541.67 Hz (b) irradiation at a blanlc and (c) the 
3h(1h} NOE difference spectrum showing an enliancement of 0.20.
4.6.2. [3’,5’,7-3h ]FoI1c Acid
Irradiation at the proton fiequency of a sample of [3',5',7-3H]folic acid (T-3',5' 
63%, T-7 37%) of specific activity 22.3 Ci/mmol, produces a ^H{^H} NOE which is 
small and positive (Table 4.4) consistent with dipolar interactions with neighbouring 
protons being an important component of tritium relaxation. Figure 4.10 shows (a) the 
^H{^H} NMR spectrum of [3',5',7-^H]folic acid iiTadiated at H-9, (b) the ^H(1H} NMR 
control spectrum and (c) the ^H{^H} NOE difference spectrum. Two resonances are 
present in each ^H NMR spectrum at 5 8.5 and 6.7 ppm, corresponding to T-7 and T-3',5' 
respectively. The presence of these two resonances in the ^H{^H} NOE difference 
spectrum indicates that inadiation at H-9 leads to enhancements of both the T-7 and T- 
3',5' signals. Whereas, iiTadiation at the H-2',6' frequency leads to a ^H{^H} NOE at T- 
3',5' but no enliancement at the T-7 position (Figiue 4.11).
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4.6.3. [3’,5^7-3H]Methotrexate
Irradiation at selective proton frequencies corresponding to H-7, H-3',5', H-2',6' 
and H-9 of a sample of [3',5',7-^Hjmethotrexate (T-3',5' 45%, T-7 55%), of specific 
activity 2.1 Ci/mmol, gave no observable ^Hj^H} NOEs, under the conditions of the 
experiment. The signal-to-noise ratio in the individual tritium spectra was low in all 
cases, due to the relatively low activity of the sample and this is almost certainly a 
contributory factor to the absence of any observable enliancements.
Table 4.4. NOE enhancement factors measured on selective pre-saturation of H-2',6' and H-9
folic acid
Obseiwed H-2',6’ Saturated H-9 Saturated
T-7 0 0.13
T-3',5' 0.04 0.07
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(a )  3h { ^ H} NMR spectrum of [^H]DMSO in which a saturating radio frequency field had been applied 
at 5541.7 Hz
(b) Control spectrum
«. *:  4 * “ - i  4 .'  c  j  a  C 6 r- a  4 a i  a i «  * 5  <«■ 4 ^ t  2 , ; t  i s  ‘ 4 1 7  1
(c ) ^H{^H) NOE Difference spectrum
Figure 4.9. Control and ^H{^H} NOE spectra of [^HJDMSO at 320 MHz
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(a) ^H} NMR spectrum of [3',5',7-^H]folic acid in which a saturating radio frequency had been
applied at 4.4 ppm, the resonance frequency of H-9.
(b) Control spectrum
3.5 o.a i .5  3 a ’ 5 >.a t  s t a  s.s s.* t . i
(c) ^H{  ^H} NOE difference spectium
Figure 4.10. Control and ^Hl^H} NOE spectra of [3',5',7-^H]folic acid at 320 MHz
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( a )  NMR spectrum of [3',5',7-^H]fbIic acid in which a saturating radio frequency field had been
applied at 7.7 ppm, the resonance frequency of H-2',6'
9 . S  9 #  9 . 5  S . a  f.i
(b) Control spectrum
t S E a  s . 5 5 . 0  4 s
g.s 9 . 3  9 . 5  S . a
( c )  ^H{ ^H) N O E  difference spectrum
Figure 4.11. Control and ^H{^H} NOE spectra of [3',5',7-^H]folic acid at 320 MHz
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4.7. DISCUSSION
The NOEs observed for [^HJDMSG and [3',5',7-^H]fblic acid are consistent with 
the results previously seen for small molecules of high activities (Altman and Silberman, 
1977b). However, the absence of the NOE in the [3',5',7-^H]methotrexate experiment 
does not necessaiily mean that the interatomic distances between the pre-selected 
irradiated proton and the tritium atoms aie too laige for the NOEs to be observable. The 
most probable cause for the lack of observable enhancement is the relatively low activity 
of the [3',5',7-^H]methotrexate sample. The experiment was conducted over a period of 
18 hours, the same as for the [3',5',7-^H]folic acid experiment and this is clearly not long 
enough to observe a reasonable signal-to-noise level. To suitably improve the signal-to- 
noise level, the experiment should ideally be conducted over a weekend, but this was not 
possible at the time.
Gaggelli and co-workers (1993) used ^^C{^H} heteronucleai' NOEs witli ^H and 
NMR relaxation measuiements to gain structuial information on methotrexate. 
13c{1h) NOEs were measured on selective saturation of the glutamate NH and H-3'. 
Saturation of H-3' gave NOEs to C-9, C-4', C-3' and C-2' and from ^H NMR relaxation 
parameters, interatomic distances were calculated, r^_y=2.2A and =2.4Â. The 
nature of the proton-proton interactions were explored further by means of 2D ^H-^H 
Overhauser experiments (Moore, 1990). Under the conditions of the experiment, NOEs 
were observed between H-7 and H-9, H-7 and N^^^-CH], H-2',6' and H-3',5', H-7 and H- 
3',5', H-3',5' and N^^^-CHg, H-3' and H-5' and H-6' and H-2'. From these 2D results and 
those of Gaggelli et al (1993), several ^H(1fI} NOEs would be expected to be seen at 
the T-7 and T-3',5' positions in the ^H NMR spectra.
It is therefore concluded that the absence of observable ^H{^H} NOEs in the 
experiment with [3',5',7-^H]methotrexate is due to poor signal-to-noise levels, due to 
short overall experimental times for the given activity of the sample.
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The [^HJDMSO is an ideal system in which to optimise the spectrometer 
conditions for the steady-state NOE experiment; there is only one tritium atom
present in the molecule therefore all of the activity in the sample is present in a single 
signal in the NMR spectrum, hence the signal-to-noise ratio is increased relative to 
the same activity in two non-equivalent sites. The signal-to-noise can be further 
increased in the NOE difference experiments because the [^HJDMSO gives
only one resonance in the NMR spectrum. Irradiation at this resonance frequency 
and irradiation at a control point in the NMR spectrmn means that the total number of 
transients for each of the two frequencies will be greater in a given time, than for 
iiTadiation at thi'ee resonances, i.e., for [3',5',7-^H]folic acid, hence increasing the 
signal-to-noise. However, to simulate the [3',5',7-^H]folic acid experiment a second 
blank irradiation point was used, thus leading to similar' signal-to-noise for the two 
experiments.
The ^H{^H} NOEs observed upon irradiation of the pre-selected ^H resonances 
of [3',5',7-3H]folic acid were small and positive (Table 4.4). The maximum value of 
enhancement of tritium signals measiued with proton noise-decoupling is 0.47 (Eqn 4.5), 
assuming 100% dipole-dipole relaxation. The irradiation positions were selected by 
consideration of the data of Rossi et al (1992), who used NOES Y spectra to provide 
information on the network of proton-proton dipolar* interactions of folic acid which are 
in turn related to internucleai' distances. Analysis of the NOESY spectra provided 
identification of proton pairs in which cross-relaxation contribution was significant. 
These include NH-10 - H-3',5', NH-10 - H-9, H-3',5' - H-9, H-3',5' - H-2',6' and H-7 - H- 
9. Therefore with the tritium label at the T-7 and T-3',5' positions in [3',5',7-^H]folic 
acid, irradiations were made at the H-9 and H-2',6' positions. As expected ^H{1H} 
NOEs were observed between H-9 and T-7, H-9 and T-3',5' (Figure 4.10) and H-2',6' and 
T-3',5' (Figure 4.11), whereas there was no enliancement at T-7 when H-2',6' was
Chapter 4: NOEs in Tritium NMR 17 4
satui'ated, thus indicating tliat the interatomic distance is greater than ca. 0.4 mn, 
the maximum value for NOEs to be observed.
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4.8. CONCLUSIONS
It is evident from the work with small molecules that IR} NOEs are observed 
for tritium obtained under conditions of proton decoupling. One very important 
limitation of the current study has been the relatively wealc signals of the [3',5',7- 
3H]methotrexate leading to the absence of Overhauser enhancements. This can be 
improved by using higher levels of tritiimi gas when labelling tlie methotrexate, to 
achieve maximum specific activities and by running the NOE experiment over a
long weekend to improve the signal-to-noise ratio. However, the use of very high 
activity samples would also lead to increased levels of radiochemical decomposition 
which could, in turn lead to spurious results. It is therefore important to achieve a 
balance between the high levels of radioactivity needed to observe the NOEs and the 
resulting increased levels of radiochemical decomposition possible over the long 
experimental times employed.
The feasibility of the ^H{1H} heteronuclear ID and 2D NOE teclmique in 
protein systems has been demonstrated by O'Comiell et al (1990, 1993a, b). The group 
reported the detection of ^H{1H} Overhauser effects from pH]tosylchymotrypsin, a Mj- 
25 000 protein. From these results and those presented in this chapter for small 
molecules, it is reasonable to assume that it could be possible to use ^H-^H nuclear 
Overhauser enliancements to study the L  casei DHFR-[3',5',7-^H]methotrexate and L  
casei DHFR-[3',5',7,-^H]folic acid binaiy and ternary systems in order to identify 
specific interactions between the tritiated ligands and amino acid residues on the protein.
5
Conclusions 
and Future Work
5.1. Introduction 177
5.2. Original Aims 177
5.3. Achievements 177
5.4. Future work 180
5.4.1. Introduction 180
5.4.2. The Use of Heteronuclear NOE Experiments 180
5.4.3. NMR Studies o f Asp-26 -> Asn DHFR-^H-Folate Complexes 181
5.4.4. NMR Studies o f L. casei DHFR-Trimethoprim Complexes 181
Chapter 5: Conclusions and Future Work 177
5. CONCLUSIONS AND FUTURE WORK
5.1. INTRODUCTION
This final chapter will provide a brief summary of the results in previous 
chapters. These will be discussed in terms of the original aims of the project and the 
goals achieved. Finally, the implications of the results and how they lead to futuie work 
aie described.
5.2. ORIGINAL AIMS
The main objective of this study was to explore the potential of tritium NMR 
spectroscopy as a tool for providing information about protein-ligand complexes. The 
aims were to synthesise selectively tritium labelled ligands and use them in conjunction 
with tritium NMR spectroscopy (a) to characterise the specific interactions between 
groups on the ligand and protein, (b) to characterise conformational changes 
accompanying ligand binding, (c) to measure conformational equilibria in various 
complexes and (d) to monitor the changes in intramolecular* dynamic processes.
5.3. ACHIEVEMENTS
The original aims have been achieved by performing work in two areas, namely 
selectively labelling the ligands with tritium and using NMR spectroscopy to detect 
and assign the signals from the nuclei. These were then used to monitor the 
interactions and dynamic processes in the complexes of the labelled ligands with the 
enzyme Lactobacillus casei dihydrofolate reductase.
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From the literatui-e (Cheung et a l, 1993; Soteriou et a l, 1993) it is clear* that a 
variety of approaches have emerged for studying large molecular* complexes by NMR. 
These recently developed methods rely on the use of isotopically labelled ligands or* 
receptors for* simplifying complicated NMR spectra which facilitates the data analysis 
and allows detailed structural information to be obtained. In the past l^C- or* l^N- 
labelled ligands have been employed (Birdsall et al, 1982), however, this approach 
suffers form the fact that the synthesis requires considerable effort. The results in 
Chapter 2 show that in contrast to the time consuming and expensive 15]^
syntheses, the incorporation of tritium at very high specific activity has been achieved in 
a facile one-step process. By careful choice of the experimental procedure and catalyst 
employed, it has been possible to incorporate tritium labels selectively, into folic acid (5) 
and methotrexate (8) at sites designed to probe multiconformational behaviom* and 
dynamic processes in the complexes of these ligands witli L. casei DHFR, when studied 
by NMR spectroscopy.
The results presented in Chapter 3 indicate that tritium NMR spectroscopy 
provides a very direct method for examining multi-conformational states and dynamic 
processes in protein-ligand complexes. In the NMR spectra (Figure 3.11 and 3.13) of 
the ternary complexes of tritium labelled folic acids with DHFR and NADP+, each 
labelled tritium gave rise to multiple signals confirming previous findings that there are 
tln*ee interconverting conformational forms of bound folate (forms I, Ila and Ilb) in the 
ternary complex (Birdsall et a l, 1989b). The pH dependence of the three forms (Birdsall 
et a l, 1982: Cheung et a l, 1993) was confirmed by the observation of changes in signal 
intensities as a function of pH.
The major differences in the conformation of the pterin ring in the different forms 
have been characterised previously (Birdsall et al, 1987). The results presented here, by 
providing information on similar chemical shifts of the T-9 and T-3' and T-5' indicated 
that the non-pterin part of folate is binding in a similar* manner* in the different forms.
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The appearance of a single resonance for the 3',5'-tritons showed that the benzoyl ring 
was flipping rapidly in all Üiree forms.
The results for the complexes of L. casei DHFR with methotrexate and NADPH 
(Figine 3.14) indicated that a single major conformation exists for the binary DHFR- 
methotrexate complex and also for the ternary complex with NADPH. The line 
broadening wliich prevents observation of a signal for the 3',5'-tritons of the benzoyl ring 
in bound methotrexate was consistent with the ring flipping being insufficiently fast to 
give chemical shift averaging of the 3',5'-signals.
In order to characterise tire specific interactions between groups on the tritium 
labelled ligand and protein by ^H NMR spectroscopy, it is necessary to measure ^H-^H 
heteronuclear NOE effects from the tritium nuclei on the ligand to nearby protons on the 
protein. Chapter 4 details preliminary ^H{^H} NOE experiments on the tritium labelled 
ligands alone. The results indicated that it is possible to detect ^H{1H} nuclear 
Overhauser enhancements with the accessible instrumentation, provided that ^H-labelled 
molecules are available at sufficiently high levels of radioactivity. However, a balance 
must be maintained between the requirement for high levels of activity of the sample and 
the resulting increased radiochemical decomposition during lengthy experimental times 
which are necessaiy for the enhancements to be observed. This is one area where further 
work would provide unambiguous information about the proximity of the tritons on the 
ligand and protons on the protein residues.
Cleaiiy, it has been shown that ^H NMR spectroscopy provides a usefril 
additional method of directly studying protein-ligand complexes. A wealth of 
information is waiting to be unveiled as soon as the full range of 2D ^H and ^H NOE 
experiments can be undertaken.
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5.4. FUTURE WORK
5.4.1. Introduction
Wliile the general aims of the project have been met a number of areas which 
require further study have been identified. Brief outlines of tlnee areas of future work 
are given in this section.
5.4.2. The Use of ^ H-IR Heteronuclear NOE Experiments
In previous studies of L  casei DHFR-folate complexes the different 
conformations have been char acterised in terms of the orientation of the pteridine ring in 
the binding site. From NOESY experiments it has been shown that forms I and Ila had 
the pteridine ring in a 'methotrexate-like' orientation by establishing NOE connections 
between the pteridine H-7 proton and the assigned methyl protons of Leu-27. These 
NOEs had previously been detected in NOESY spectra of DHFR complexes with 
methotrexate (Birdsall et aL, 1989a). Using ^H-labelled folates in conjunction with ^H 
NMR spectroscopy, heteronuclear NOE information from the tritium at the pteridine H-7 
position to the assigned protein ^H signals would assist in defining the H-7 environment 
in the different conformations.
Fmthermore, ^H-^H heteronuclear* NOE experiments could be used to 
characterise the orientation of the pteridine ring of methotrexate in the binding site. 
Measurement of heteronuclear* NOE effects from the T-7 of methotrexate to nearby 
protons on the protein would help to identify the protein contact residues. The absence 
of other* methotrexate protons close to T-7 should make it easier to detect NOE effects on 
nearby protons in the protein. Information from ^H NOE studies is already available 
which indicates that H-7 is near* to the methyl groups of Leu-19 and Leu-27: however, 
the interpretation of such information is always complicated by the possibility of
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chemical shift degeneracy in the H-7 region of the proton spectium. Clearly the tritiated 
H-7 methotrexate will remove this ambiguity.
5.4.3. 3h  NMR Studies of Asp-26 Asn DHFR-^H-Folate 
Complexes
Preliminary information is already available indicating that the mutant enzyme 
Asp-26 -> Asn strongly perturbs tlie multi-conformational equilibria involving folate 
(Jimenez et al., 1989). The use of ^H-labelled folate would allow such effects to be 
explored in detail by ^H NMR spectroscopy.
5.4.4. 3h NMR Studies of Z. casei DHFR-Trimethoprim complexes
The antibacterial drug trimethoprim (TMP, 9) acts by selectively inhibiting the 
enzyme DHFR in bacterial cells. Considerable efforts have been made to understand the 
factors controlling the specificity of trimethoprim binding to the bacterial enzyme and 
numerous structuie-activity studies using tiimethoprim-related inhibitors have been 
reported (Roth & Cheng, 1982). Previously NMR methods have been used to investigate 
the protonation state of the pyrimidine ring of bound trimethoprim (Roberts et a l, 1981; 
Bevan et a l, 1985), to determine its conformation in complexes with both bacterial and 
mammalian DHFR (Cayley et al, 1979; Birdsall et al, 1983) and to investigate the 
presence of multiple conformations in these complexes (Gronenborn Qt a l, 1981). 
However, as previously stated, one of the major problems encountered in studying 
complex NMR spectra is that of assigning the signals to particular nuclei in the protein- 
ligand complexes. This can be largely overcome by using isotopic labelling to simplify 
the NMR spectra of the protein or their bound ligand. An example of this type of study 
has been reported by Cheung and colleagues (1986), who used l^C NMR spectroscopy 
to study the binding of selectively l^C-enriched trimethoprim to L. casei DHFR. The
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work presented in tins thesis illustrates the usefulness of using ^H-labelled ligands and 
NMR spectroscopy to study such interactions. It is therefore reasonable to assume 
that NMR methods could be applied to the DHFR-trimethoprim system provided that 
trimethoprim could be labelled with tritium, in positions of interest.
'OCH3 
O C H 3 
Trimetlioprim (9)
Trimethoprim could be selectively labelled with tritium at the H-6, H-7 and/or H- 
2', H-6' positions. The use of ^H NMR spectroscopy would provide the opportunity to 
characterise multiple conformations and dynamic processes in its binaiy complexes with 
the enzyme and in the ternary complexes with DHFR and coenzyme. Two 
conformations have previously been detected in the DHFR-TMP-NADP"^ complex 
(Cheung et al, 1986) and if this complex was formed with tritiated trimethoprim then 
separate signals for the two conformations would be detectable: this would allow the pait 
of the molecule which is most influenced by the conformational differences to be 
determined. Heteronucleai* NOE measurements could be used in an attempt to identify 
the trimethoprim contact residues on the protein in the two conformations.
The use of specifically tritiated trimethoprim could also offer some advantages in 
studies of dynamic processes in complexes. With tritium at the H-2' and H-6' positions it 
should be possible to use ^H NMR spectroscopy to monitor their chemical shifts in 
bound trimethoprim at low temperatures {ca. 273 K) when the benzyl ring is flipping 
only slowly and two separate signals for each triton should be observed.
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